STUDYID,DOMAIN,USUBJID,SUBJID,RFSTDTC,RFENDTC,RFXSTDTC,RFXENDTC,RFICDTC,RFPENDTC,DTHDTC,DTHFL,SITEID,AGE,AGEU,SEX,RACE,ETHNIC,ARMCD,ARM,ACTARMCD,ACTARM,COUNTRY,DMDTC,DMDY,AESEQ,AESPID,AETERM,AELLT,AELLTCD,AEDECOD,AEPTCD,AEHLT,AEHLTCD,AEHLGT,AEHLGTCD,AEBODSYS,AEBDSYCD,AESOC,AESOCCD,AESEV,AESER,AEACN,AEREL,AEOUT,AESCAN,AESCONG,AESDISAB,AESDTH,AESHOSP,AESLIFE,AESOD,AEDTC,AESTDTC,AEENDTC,AESTDY,AEENDY,VISIT
CDISCPILOT01,AE,01-701-1015,1015,1/2/2014,7/2/2014,1/2/2014,7/2/2014,,2014-07-02T11:45,,,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/26/2013,-7,1,E07,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/16/2014,1/3/2014,,2,,Phase 1
CDISCPILOT01,AE,01-701-1015,1015,1/2/2014,7/2/2014,1/2/2014,7/2/2014,,2014-07-02T11:45,,,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/26/2013,-7,2,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/16/2014,1/3/2014,,2,,Phase 1
CDISCPILOT01,AE,01-701-1015,1015,1/2/2014,7/2/2014,1/2/2014,7/2/2014,,2014-07-02T11:45,,,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/26/2013,-7,3,E06,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/16/2014,1/9/2014,1/11/2014,8,10,Phase 1
CDISCPILOT01,AE,01-701-1023,1023,8/5/2012,9/2/2012,8/5/2012,9/1/2012,,2/18/2013,,,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/22/2012,-14,3,E10,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,,HLT_0415,,HLGT_0086,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/27/2012,8/26/2012,,22,,Phase 1
CDISCPILOT01,AE,01-701-1023,1023,8/5/2012,9/2/2012,8/5/2012,9/1/2012,,2/18/2013,,,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/22/2012,-14,1,E08,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/27/2012,8/7/2012,8/30/2012,3,26,Phase 1
CDISCPILOT01,AE,01-701-1023,1023,8/5/2012,9/2/2012,8/5/2012,9/1/2012,,2/18/2013,,,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/22/2012,-14,2,E09,ERYTHEMA,LOCALIZED ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/27/2012,8/7/2012,,3,,Phase 1
CDISCPILOT01,AE,01-701-1023,1023,8/5/2012,9/2/2012,8/5/2012,9/1/2012,,2/18/2013,,,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/22/2012,-14,4,E08,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/2/2012,8/7/2012,8/30/2012,3,26,Phase 1
CDISCPILOT01,AE,01-701-1028,1028,7/19/2013,1/14/2014,7/19/2013,1/14/2014,,2014-01-14T11:10,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/11/2013,-8,1,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/1/2013,7/21/2013,,3,,Phase 1
CDISCPILOT01,AE,01-701-1028,1028,7/19/2013,1/14/2014,7/19/2013,1/14/2014,,2014-01-14T11:10,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/11/2013,-8,2,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/14/2013,8/8/2013,,21,,Phase 1
CDISCPILOT01,DM,01-701-1033,1033,3/18/2014,4/14/2014,3/18/2014,3/31/2014,,9/15/2014,,,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/10/2014,-8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-701-1034,1034,7/1/2014,12/30/2014,7/1/2014,12/30/2014,,2014-12-30T09:50,,,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/24/2014,-7,1,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/25/2014,8/27/2014,,58,,Phase 1
CDISCPILOT01,AE,01-701-1034,1034,7/1/2014,12/30/2014,7/1/2014,12/30/2014,,2014-12-30T09:50,,,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/24/2014,-7,2,E07,FATIGUE,FATIGUE,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/18/2014,11/2/2014,,125,,Phase 2
CDISCPILOT01,AE,01-701-1047,1047,2/12/2013,3/29/2013,2/12/2013,3/9/2013,,7/28/2013,,,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/22/2013,-21,4,E09,BUNDLE BRANCH BLOCK LEFT,LEFT BUNDLE BRANCH BLOCK,,BUNDLE BRANCH BLOCK LEFT,,HLT_0281,,HLGT_0721,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/10/2013,3/10/2013,,27,,Phase 1
CDISCPILOT01,AE,01-701-1047,1047,2/12/2013,3/29/2013,2/12/2013,3/9/2013,,7/28/2013,,,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/22/2013,-21,1,E06,HIATUS HERNIA,HERNIA HIATAL,,HIATUS HERNIA,,HLT_0159,,HLGT_0109,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/12/2013,2/12/2013,2/12/2013,1,1,Phase 1
CDISCPILOT01,AE,01-701-1047,1047,2/12/2013,3/29/2013,2/12/2013,3/9/2013,,7/28/2013,,,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/22/2013,-21,2,E06,HIATUS HERNIA,HERNIA HIATAL,,HIATUS HERNIA,,HLT_0159,,HLGT_0109,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/25/2013,2/12/2013,2/12/2013,1,1,Phase 1
CDISCPILOT01,AE,01-701-1047,1047,2/12/2013,3/29/2013,2/12/2013,3/9/2013,,7/28/2013,,,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/22/2013,-21,3,E08,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/10/2013,3/6/2013,,23,,Phase 1
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,4,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/26/2014,2/21/2014,,52,,Phase 1
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,10,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/21/2014,2/21/2014,,52,,Phase 1
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,3,E07,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/26/2014,2/20/2014,2/22/2014,51,53,Phase 1
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,1,E04,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/15/2014,1/3/2014,,3,,Phase 1
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,9,E11,NASAL CONGESTION,NASAL CONGESTION,,NASAL CONGESTION,,HLT_0118,,HLGT_0549,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/23/2014,4/19/2014,4/22/2014,109,112,Phase 2
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,8,E10,PHARYNGOLARYNGEAL PAIN,SORE THROAT,,PHARYNGOLARYNGEAL PAIN,,HLT_0130,,HLGT_0402,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/23/2014,4/19/2014,4/22/2014,109,112,Phase 2
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,2,E05,PRURITUS GENERALISED,GENERALIZED PRURITUS,,PRURITUS GENERALISED,,HLT_0123,,HLGT_0689,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/26/2014,2/20/2014,2/20/2014,51,51,Phase 1
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,5,E08,PRURITUS GENERALISED,GENERALIZED PRURITUS,,PRURITUS GENERALISED,,HLT_0123,,HLGT_0689,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/26/2014,3/21/2014,3/21/2014,80,80,Phase 1
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,6,E12,PRURITUS GENERALISED,GENERALIZED PRURITUS,,PRURITUS GENERALISED,,HLT_0123,,HLGT_0689,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/23/2014,3/31/2014,3/31/2014,90,90,Phase 1
CDISCPILOT01,AE,01-701-1097,1097,1/1/2014,7/9/2014,1/1/2014,7/9/2014,,2014-07-09T09:39,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/23/2013,-9,7,E09,PRURITUS GENERALISED,GENERALIZED PRURITUS,,PRURITUS GENERALISED,,HLT_0123,,HLGT_0689,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/23/2014,4/19/2014,4/20/2014,109,110,Phase 2
CDISCPILOT01,AE,01-701-1111,1111,9/7/2012,9/17/2012,9/7/2012,9/16/2012,,2/22/2013,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-13,7,E16,ARTHRALGIA,GENERALIZED JOINT PAIN,,ARTHRALGIA,,HLT_0375,,HLGT_0610,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/17/2012,9/13/2012,,7,,Phase 1
CDISCPILOT01,AE,01-701-1111,1111,9/7/2012,9/17/2012,9/7/2012,9/16/2012,,2/22/2013,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-13,8,E17,CELLULITIS,CELLULITIS OF LEG,,CELLULITIS,,HLT_0613,,HLGT_0066,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/17/2012,9/13/2012,,7,,Phase 1
CDISCPILOT01,AE,01-701-1111,1111,9/7/2012,9/17/2012,9/7/2012,9/16/2012,,2/22/2013,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-13,1,E14,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/5/2012,9/2/2012,9/7/2012,-5,1,Phase 1
CDISCPILOT01,AE,01-701-1111,1111,9/7/2012,9/17/2012,9/7/2012,9/16/2012,,2/22/2013,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-13,4,E14,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/17/2012,9/2/2012,9/7/2012,-5,1,Phase 1
CDISCPILOT01,AE,01-701-1111,1111,9/7/2012,9/17/2012,9/7/2012,9/16/2012,,2/22/2013,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-13,3,E06,LOCALISED INFECTION,LOCALIZED INFECTION,,LOCALISED INFECTION,,HLT_0435,,HLGT_0557,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/17/2012,7/8/2012,,-61,,Phase 1
CDISCPILOT01,AE,01-701-1111,1111,9/7/2012,9/17/2012,9/7/2012,9/16/2012,,2/22/2013,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-13,6,E18,MICTURITION URGENCY,URINARY URGENCY,,MICTURITION URGENCY,,HLT_0294,,HLGT_0483,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/17/2012,9/7/2012,,1,,Phase 1
CDISCPILOT01,AE,01-701-1111,1111,9/7/2012,9/17/2012,9/7/2012,9/16/2012,,2/22/2013,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-13,2,E15,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/5/2012,9/2/2012,9/7/2012,-5,1,Phase 1
CDISCPILOT01,AE,01-701-1111,1111,9/7/2012,9/17/2012,9/7/2012,9/16/2012,,2/22/2013,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-13,5,E15,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/17/2012,9/2/2012,9/7/2012,-5,1,Phase 1
CDISCPILOT01,AE,01-701-1115,1115,11/30/2012,1/23/2013,11/30/2012,1/23/2013,,5/20/2013,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/23/2012,-7,9,E14,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/23/2013,1/19/2013,,51,,Phase 1
CDISCPILOT01,AE,01-701-1115,1115,11/30/2012,1/23/2013,11/30/2012,1/23/2013,,5/20/2013,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/23/2012,-7,1,E09,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/13/2012,12/2/2012,,3,,Phase 1
CDISCPILOT01,AE,01-701-1115,1115,11/30/2012,1/23/2013,11/30/2012,1/23/2013,,5/20/2013,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/23/2012,-7,5,E09,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/23/2013,12/2/2012,,3,,Phase 1
CDISCPILOT01,AE,01-701-1115,1115,11/30/2012,1/23/2013,11/30/2012,1/23/2013,,5/20/2013,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/23/2012,-7,3,E10,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/26/2012,12/26/2012,12/26/2012,27,27,Phase 1
CDISCPILOT01,AE,01-701-1115,1115,11/30/2012,1/23/2013,11/30/2012,1/23/2013,,5/20/2013,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/23/2012,-7,4,E10,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/28/2012,12/26/2012,12/26/2012,27,27,Phase 1
CDISCPILOT01,AE,01-701-1115,1115,11/30/2012,1/23/2013,11/30/2012,1/23/2013,,5/20/2013,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/23/2012,-7,8,E12,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/23/2013,1/19/2013,,51,,Phase 1
CDISCPILOT01,AE,01-701-1115,1115,11/30/2012,1/23/2013,11/30/2012,1/23/2013,,5/20/2013,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/23/2012,-7,2,E11,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/13/2012,12/2/2012,,3,,Phase 1
CDISCPILOT01,AE,01-701-1115,1115,11/30/2012,1/23/2013,11/30/2012,1/23/2013,,5/20/2013,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/23/2012,-7,6,E11,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/23/2013,12/2/2012,,3,,Phase 1
CDISCPILOT01,AE,01-701-1115,1115,11/30/2012,1/23/2013,11/30/2012,1/23/2013,,5/20/2013,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/23/2012,-7,7,E13,FATIGUE,FATIGUE,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/23/2013,1/14/2013,,46,,Phase 1
CDISCPILOT01,AE,01-701-1118,1118,3/12/2014,9/9/2014,3/12/2014,9/9/2014,,2014-09-09T13:28,,,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/27/2014,-13,1,E06,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/10/2014,2003,,,,Phase 1
CDISCPILOT01,AE,01-701-1130,1130,2/15/2014,8/16/2014,2/15/2014,8/16/2014,,2014-08-16T13:10,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/9/2014,-6,5,E09,EYE ALLERGY,EYE ALLERGY,,EYE ALLERGY,,HLT_0256,,HLGT_0071,,EYE DISORDERS,,EYE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/16/2014,5/9/2014,5/9/2014,84,84,Phase 1
CDISCPILOT01,AE,01-701-1130,1130,2/15/2014,8/16/2014,2/15/2014,8/16/2014,,2014-08-16T13:10,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/9/2014,-6,6,E10,EYE PRURITUS,EYE ITCHING,,EYE PRURITUS,,HLT_0523,,HLGT_0240,,EYE DISORDERS,,EYE DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/7/2014,5/22/2014,,97,,Phase 1
CDISCPILOT01,AE,01-701-1130,1130,2/15/2014,8/16/2014,2/15/2014,8/16/2014,,2014-08-16T13:10,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/9/2014,-6,4,E08,EYE SWELLING,EYES SWOLLEN,,EYE SWELLING,,HLT_0008,,HLGT_0466,,EYE DISORDERS,,EYE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/16/2014,5/9/2014,5/9/2014,84,84,Phase 1
CDISCPILOT01,AE,01-701-1130,1130,2/15/2014,8/16/2014,2/15/2014,8/16/2014,,2014-08-16T13:10,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/9/2014,-6,8,E12,NASAL CONGESTION,NASAL CONGESTION,,NASAL CONGESTION,,HLT_0118,,HLGT_0549,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/7/2014,5/22/2014,,97,,Phase 1
CDISCPILOT01,AE,01-701-1130,1130,2/15/2014,8/16/2014,2/15/2014,8/16/2014,,2014-08-16T13:10,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/9/2014,-6,7,E11,PRURITUS,ITCHING BOTH HANDS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/7/2014,5/22/2014,,97,,Phase 1
CDISCPILOT01,AE,01-701-1130,1130,2/15/2014,8/16/2014,2/15/2014,8/16/2014,,2014-08-16T13:10,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/9/2014,-6,2,E07,PYREXIA,FEVER,,PYREXIA,,HLT_0310,,HLGT_0652,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/15/2014,3/9/2014,3/9/2014,23,23,Phase 1
CDISCPILOT01,AE,01-701-1130,1130,2/15/2014,8/16/2014,2/15/2014,8/16/2014,,2014-08-16T13:10,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/9/2014,-6,1,E06,URINARY TRACT INFECTION,URINARY TRACT INFECTION,,URINARY TRACT INFECTION,,HLT_0161,,HLGT_0093,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/15/2014,3/9/2014,3/16/2014,23,30,Phase 1
CDISCPILOT01,AE,01-701-1130,1130,2/15/2014,8/16/2014,2/15/2014,8/16/2014,,2014-08-16T13:10,,,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/9/2014,-6,3,E06,URINARY TRACT INFECTION,URINARY TRACT INFECTION,,URINARY TRACT INFECTION,,HLT_0161,,HLGT_0093,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/17/2014,3/9/2014,3/16/2014,23,30,Phase 1
CDISCPILOT01,AE,01-701-1133,1133,10/28/2012,4/29/2013,10/28/2012,4/28/2013,,2013-04-29T10:13,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/23/2012,-5,1,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/22/2013,12/27/2012,,61,,Phase 1
CDISCPILOT01,AE,01-701-1133,1133,10/28/2012,4/29/2013,10/28/2012,4/28/2013,,2013-04-29T10:13,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/23/2012,-5,3,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/18/2013,12/27/2012,,61,,Phase 1
CDISCPILOT01,AE,01-701-1133,1133,10/28/2012,4/29/2013,10/28/2012,4/28/2013,,2013-04-29T10:13,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/23/2012,-5,2,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/22/2013,12/27/2012,,61,,Phase 1
CDISCPILOT01,AE,01-701-1133,1133,10/28/2012,4/29/2013,10/28/2012,4/28/2013,,2013-04-29T10:13,,,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/23/2012,-5,4,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/18/2013,12/27/2012,,61,,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,5,E12,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/16/2013,6/10/2013,,22,,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,7,E12,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/30/2013,6/10/2013,,22,,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,3,E10,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/3/2013,6/1/2013,6/2/2013,13,14,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,11,E16,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/30/2013,6/26/2013,,38,,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,9,E14,APPLICATION SITE PAIN,APPLICATION SITE PAIN,,APPLICATION SITE PAIN,,HLT_0342,,HLGT_0085,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/30/2013,6/22/2013,,34,,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,6,E13,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/16/2013,6/10/2013,,22,,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,8,E13,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/30/2013,6/10/2013,,22,,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,10,E15,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/30/2013,6/26/2013,,38,,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,4,E11,FATIGUE,FATIGUE,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/3/2013,6/3/2013,,15,,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,1,E09,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/18/2013,5/16/2013,6/2/2013,-4,14,Phase 1
CDISCPILOT01,AE,01-701-1146,1146,5/20/2013,6/30/2013,5/20/2013,6/26/2013,,7/15/2013,,,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/7/2013,-13,2,E09,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/3/2013,5/16/2013,6/2/2013,-4,14,Phase 1
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,10,E27,ACTINIC KERATOSIS,ACTINIC KERATOSIS,,ACTINIC KERATOSIS,,HLT_0609,,HLGT_0490,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/20/2014,2/12/2014,,174,,Phase 2
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,1,E20,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/5/2013,8/25/2013,,3,,Phase 1
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,2,E21,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/5/2013,8/25/2013,,3,,Phase 1
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,6,E25,CALCULUS URETHRAL,URETHRAL CALCULUS,,CALCULUS URETHRAL,,HLT_0550,,HLGT_0414,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/10/2014,12/17/2013,12/17/2013,117,117,Phase 2
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,9,E26,DEPRESSED MOOD,DEPRESSED MOOD,,DEPRESSED MOOD,,HLT_0784,,HLGT_0122,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/8/2014,7/29/2013,,-25,,Phase 1
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,8,E03,DYSPEPSIA,INDIGESTION,,DYSPEPSIA,,HLT_0244,,HLGT_0716,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/8/2014,2012-02,,,,Phase 1
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,7,E28,EPISTAXIS,NOSE BLEED,,EPISTAXIS,,HLT_0386,,HLGT_0577,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/10/2014,1/3/2014,1/3/2014,134,134,Phase 2
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,5,E24,FLANK PAIN,FLANK PAIN,,FLANK PAIN,,HLT_0484,,HLGT_0543,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/10/2014,12/15/2013,12/17/2013,115,117,Phase 2
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,3,E23,LOWER RESPIRATORY TRACT INFECTION,CHEST COLD,,LOWER RESPIRATORY TRACT INFECTION,,HLT_0052,,HLGT_0217,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/18/2013,10/12/2013,11/10/2013,51,80,Phase 1
CDISCPILOT01,AE,01-701-1148,1148,8/23/2013,2/20/2014,8/23/2013,2/20/2014,,2014-02-20T15:07,,,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-9,4,E23,LOWER RESPIRATORY TRACT INFECTION,CHEST COLD,,LOWER RESPIRATORY TRACT INFECTION,,HLT_0052,,HLGT_0217,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/17/2013,10/12/2013,11/10/2013,51,80,Phase 1
CDISCPILOT01,AE,01-701-1153,1153,9/23/2013,4/1/2014,9/23/2013,3/16/2014,,2014-04-01T14:25,,,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/6/2013,-17,1,E06,INCREASED APPETITE,INCREASED APPETITE,,INCREASED APPETITE,,HLT_0566,,HLGT_0769,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/19/2013,10/13/2013,11/6/2013,21,45,Phase 1
CDISCPILOT01,AE,01-701-1153,1153,9/23/2013,4/1/2014,9/23/2013,3/16/2014,,2014-04-01T14:25,,,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/6/2013,-17,2,E06,INCREASED APPETITE,INCREASED APPETITE,,INCREASED APPETITE,,HLT_0566,,HLGT_0769,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/18/2013,10/13/2013,11/6/2013,21,45,Phase 1
CDISCPILOT01,AE,01-701-1180,1180,2/12/2013,3/23/2013,2/12/2013,3/18/2013,,4/7/2013,,,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-15,9,E07,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/23/2013,3/19/2013,,36,,Phase 1
CDISCPILOT01,AE,01-701-1180,1180,2/12/2013,3/23/2013,2/12/2013,3/18/2013,,4/7/2013,,,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-15,8,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/23/2013,3/19/2013,,36,,Phase 1
CDISCPILOT01,AE,01-701-1180,1180,2/12/2013,3/23/2013,2/12/2013,3/18/2013,,4/7/2013,,,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-15,7,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/23/2013,3/19/2013,,36,,Phase 1
CDISCPILOT01,AE,01-701-1180,1180,2/12/2013,3/23/2013,2/12/2013,3/18/2013,,4/7/2013,,,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-15,4,E04,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/11/2013,2002,,,,Phase 1
CDISCPILOT01,AE,01-701-1180,1180,2/12/2013,3/23/2013,2/12/2013,3/18/2013,,4/7/2013,,,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-15,3,E02,MICTURITION URGENCY,URINARY URGENCY,,MICTURITION URGENCY,,HLT_0294,,HLGT_0483,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/25/2013,2/15/2013,3/19/2013,4,36,Phase 1
CDISCPILOT01,AE,01-701-1180,1180,2/12/2013,3/23/2013,2/12/2013,3/18/2013,,4/7/2013,,,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-15,6,E02,MICTURITION URGENCY,URINARY URGENCY,,MICTURITION URGENCY,,HLT_0294,,HLGT_0483,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/23/2013,2/15/2013,3/19/2013,4,36,Phase 1
CDISCPILOT01,AE,01-701-1180,1180,2/12/2013,3/23/2013,2/12/2013,3/18/2013,,4/7/2013,,,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-15,5,E03,NASOPHARYNGITIS,COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/11/2013,3/6/2013,3/7/2013,23,24,Phase 1
CDISCPILOT01,AE,01-701-1180,1180,2/12/2013,3/23/2013,2/12/2013,3/18/2013,,4/7/2013,,,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-15,1,E01,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/12/2013,2/12/2013,2/12/2013,1,1,Phase 1
CDISCPILOT01,AE,01-701-1180,1180,2/12/2013,3/23/2013,2/12/2013,3/18/2013,,4/7/2013,,,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-15,2,E01,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/25/2013,2/12/2013,2/12/2013,1,1,Phase 1
CDISCPILOT01,AE,01-701-1181,1181,12/5/2013,12/12/2013,12/5/2013,12/9/2013,,5/23/2014,,,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,11/26/2013,-9,1,E16,AGITATION,AGITATION,,AGITATION,,HLT_0140,,HLGT_0170,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/12/2013,12/9/2013,12/9/2013,5,5,Phase 1
CDISCPILOT01,AE,01-701-1188,1188,2/15/2013,3/25/2013,2/15/2013,3/24/2013,,8/4/2013,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/3/2013,-12,7,E09,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,,APPLICATION SITE URTICARIA,,HLT_0196,,HLGT_0233,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/25/2013,3/21/2013,,35,,Phase 1
CDISCPILOT01,AE,01-701-1188,1188,2/15/2013,3/25/2013,2/15/2013,3/24/2013,,8/4/2013,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/3/2013,-12,1,E04,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/2/2013,2/16/2013,,2,,Phase 1
CDISCPILOT01,AE,01-701-1188,1188,2/15/2013,3/25/2013,2/15/2013,3/24/2013,,8/4/2013,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/3/2013,-12,3,E04,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/16/2013,2/16/2013,,2,,Phase 1
CDISCPILOT01,AE,01-701-1188,1188,2/15/2013,3/25/2013,2/15/2013,3/24/2013,,8/4/2013,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/3/2013,-12,2,E05,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/2/2013,2/16/2013,,2,,Phase 1
CDISCPILOT01,AE,01-701-1188,1188,2/15/2013,3/25/2013,2/15/2013,3/24/2013,,8/4/2013,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/3/2013,-12,4,E05,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/16/2013,2/16/2013,,2,,Phase 1
CDISCPILOT01,AE,01-701-1188,1188,2/15/2013,3/25/2013,2/15/2013,3/24/2013,,8/4/2013,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/3/2013,-12,5,E06,URTICARIA,WELTS,,URTICARIA,,HLT_0420,,HLGT_0705,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/16/2013,3/4/2013,,18,,Phase 1
CDISCPILOT01,AE,01-701-1188,1188,2/15/2013,3/25/2013,2/15/2013,3/24/2013,,8/4/2013,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/3/2013,-12,6,E06,URTICARIA,WELTS,,URTICARIA,,HLT_0420,,HLGT_0705,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/25/2013,3/4/2013,,18,,Phase 1
CDISCPILOT01,AE,01-701-1188,1188,2/15/2013,3/25/2013,2/15/2013,3/24/2013,,8/4/2013,,,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/3/2013,-12,8,E10,URTICARIA,WELTS,,URTICARIA,,HLT_0420,,HLGT_0705,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/25/2013,3/21/2013,,35,,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,13,E13,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/13/2012,12/5/2012,,137,,Phase 2
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,12,E12,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/13/2012,12/5/2012,12/16/2012,137,148,Phase 2
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,15,E12,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/11/2013,12/5/2012,12/16/2012,137,148,Phase 2
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,14,E14,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/13/2012,12/5/2012,,137,,Phase 2
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,4,E01,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/23/2012,2010-06,,,,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,9,E01,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/14/2012,2010-06,,,,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,3,E09,ERYTHEMA,ERYTHEMA FACIAL,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/7/2012,8/7/2012,9/14/2012,17,55,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,6,E09,ERYTHEMA,ERYTHEMA FACIAL,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/23/2012,8/7/2012,9/14/2012,17,55,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,8,E11,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,,MUSCULAR WEAKNESS,,HLT_0444,,HLGT_0211,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/23/2012,9/7/2012,9/30/2012,48,71,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,11,E11,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,,MUSCULAR WEAKNESS,,HLT_0444,,HLGT_0211,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/14/2012,9/7/2012,9/30/2012,48,71,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,1,E06,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,,NASAL MUCOSA BIOPSY,,HLT_0680,,HLGT_0396,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/7/2012,8/3/2012,8/3/2012,13,13,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,7,E10,PNEUMONIA,PNEUMONIA,,PNEUMONIA,,HLT_0251,,HLGT_0671,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,9/23/2012,9/7/2012,10/6/2012,48,77,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,10,E10,PNEUMONIA,PNEUMONIA,,PNEUMONIA,,HLT_0251,,HLGT_0671,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,10/14/2012,9/7/2012,10/6/2012,48,77,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,2,E08,SECRETION DISCHARGE,SECRETION DISCHARGE,,SECRETION DISCHARGE,,HLT_0683,,HLGT_0575,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/7/2012,8/7/2012,9/14/2012,17,55,Phase 1
CDISCPILOT01,AE,01-701-1192,1192,7/22/2012,1/20/2013,7/22/2012,1/20/2013,,2013-01-20T15:47,,,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/8/2012,-14,5,E08,SECRETION DISCHARGE,SECRETION DISCHARGE,,SECRETION DISCHARGE,,HLT_0683,,HLGT_0575,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/23/2012,8/7/2012,9/14/2012,17,55,Phase 1
CDISCPILOT01,AE,01-701-1203,1203,2/2/2013,8/3/2013,2/2/2013,8/3/2013,,2013-08-03T10:10,,,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/25/2013,-8,1,E05,EYE LASER SURGERY,EYE LASER SURGERY,,EYE LASER SURGERY,,HLT_0355,,HLGT_0189,,SURGICAL AND MEDICAL PROCEDURES,,SURGICAL AND MEDICAL PROCEDURES,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/30/2013,3/21/2013,3/21/2013,48,48,Phase 1
CDISCPILOT01,AE,01-701-1211,1211,11/15/2012,1/14/2013,11/15/2012,1/12/2013,,1/14/2013,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/30/2012,-16,5,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/11/2012,11/29/2012,,15,,Phase 1
CDISCPILOT01,AE,01-701-1211,1211,11/15/2012,1/14/2013,11/15/2012,1/12/2013,,1/14/2013,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/30/2012,-16,1,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/28/2012,11/16/2012,,2,,Phase 1
CDISCPILOT01,AE,01-701-1211,1211,11/15/2012,1/14/2013,11/15/2012,1/12/2013,,1/14/2013,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/30/2012,-16,7,E12,CONFUSIONAL STATE,CONFUSION,,CONFUSIONAL STATE,,HLT_0642,,HLGT_0329,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/14/2013,1/11/2013,,58,,Phase 1
CDISCPILOT01,AE,01-701-1211,1211,11/15/2012,1/14/2013,11/15/2012,1/12/2013,,1/14/2013,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/30/2012,-16,8,E13,DYSPNOEA,SHORTNESS OF BREATH,,DYSPNOEA,,HLT_0296,,HLGT_0255,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/14/2013,1/11/2013,,58,,Phase 1
CDISCPILOT01,AE,01-701-1211,1211,11/15/2012,1/14/2013,11/15/2012,1/12/2013,,1/14/2013,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/30/2012,-16,4,E09,INCONTINENCE,INCONTINENCE,,INCONTINENCE,,HLT_0560,,HLGT_0503,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/28/2012,11/22/2012,,8,,Phase 1
CDISCPILOT01,AE,01-701-1211,1211,11/15/2012,1/14/2013,11/15/2012,1/12/2013,,1/14/2013,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/30/2012,-16,2,E03,JOINT DISLOCATION,SHOULDER DISLOCATION,,JOINT DISLOCATION,,HLT_0035,,HLGT_0227,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/28/2012,11/21/2012,11/21/2012,7,7,Phase 1
CDISCPILOT01,AE,01-701-1211,1211,11/15/2012,1/14/2013,11/15/2012,1/12/2013,,1/14/2013,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/30/2012,-16,3,E04,SHOULDER PAIN,SHOULDER PAIN,,SHOULDER PAIN,,HLT_0527,,HLGT_0288,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/28/2012,11/21/2012,,7,,Phase 1
CDISCPILOT01,AE,01-701-1211,1211,11/15/2012,1/14/2013,11/15/2012,1/12/2013,,1/14/2013,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/30/2012,-16,6,E06,SKIN LACERATION,LACERATION OF FACE,,SKIN LACERATION,,HLT_0075,,HLGT_0118,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/11/2012,12/9/2012,,25,,Phase 1
CDISCPILOT01,AE,01-701-1211,1211,11/15/2012,1/14/2013,11/15/2012,1/12/2013,,1/14/2013,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/30/2012,-16,9,E11,SUDDEN DEATH,SUDDEN DEATH,,SUDDEN DEATH,,HLT_0142,,HLGT_0272,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,NONE,FATAL,N,N,N,Y,N,Y,N,1/14/2013,1/14/2013,1/14/2013,61,61,Phase 1
CDISCPILOT01,DM,01-701-1234,1234,3/30/2013,9/22/2013,3/30/2013,9/22/2013,,2013-09-22T09:25,,,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/20/2013,-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,4,E13,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/25/2014,1/20/2014,2/8/2014,10,29,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,5,E13,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/10/2014,1/20/2014,2/8/2014,10,29,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,1,E11,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/25/2014,1/12/2014,,2,,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,6,E11,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/19/2014,1/12/2014,,2,,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,9,E16,FATIGUE,FATIGUE,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/2/2014,2014-03,,,,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,10,E17,HORDEOLUM,STYE,,HORDEOLUM,,HLT_0604,,HLGT_0290,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/2/2014,2014-04,,,,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,3,E12,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/25/2014,1/13/2014,,3,,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,2,E15,SKIN ODOUR ABNORMAL,SKIN ODOR ABNORMAL,,SKIN ODOUR ABNORMAL,,HLT_0510,,HLGT_0184,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/25/2014,1/12/2014,,2,,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,7,E14,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/6/2014,2/20/2014,3/12/2014,41,61,Phase 1
CDISCPILOT01,AE,01-701-1239,1239,1/11/2014,7/11/2014,1/11/2014,7/10/2014,,2014-07-11T15:40,,,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/28/2013,-14,8,E14,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/2/2014,2/20/2014,3/12/2014,41,61,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,7,E09,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/22/2014,3/12/2014,3/27/2014,34,49,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,9,E09,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/5/2014,3/12/2014,3/27/2014,34,49,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,3,E06,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/7/2014,2/24/2014,6/12/2014,18,126,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,12,E06,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/14/2014,2/24/2014,6/12/2014,18,126,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,8,E10,NASAL CONGESTION,NASAL CONGESTION,,NASAL CONGESTION,,HLT_0118,,HLGT_0549,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/22/2014,3/12/2014,3/27/2014,34,49,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,10,E10,NASAL CONGESTION,NASAL CONGESTION,,NASAL CONGESTION,,HLT_0118,,HLGT_0549,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/5/2014,3/12/2014,3/27/2014,34,49,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,1,E04,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/22/2014,2/13/2014,6/3/2014,7,117,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,11,E04,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/14/2014,2/13/2014,6/3/2014,7,117,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,5,E08,PAROSMIA,STRANGE SMELL SENSATION,,PAROSMIA,,HLT_0258,,HLGT_0471,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/7/2014,2/24/2014,6/3/2014,18,117,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,14,E08,PAROSMIA,STRANGE SMELL SENSATION,,PAROSMIA,,HLT_0258,,HLGT_0471,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/14/2014,2/24/2014,6/3/2014,18,117,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,6,E11,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/7/2014,2/24/2014,6/12/2014,18,126,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,15,E11,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/14/2014,2/24/2014,6/12/2014,18,126,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,4,E07,SALIVARY HYPERSECRETION,HYPERSALIVATION,,SALIVARY HYPERSECRETION,,HLT_0374,,HLGT_0488,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/7/2014,2/24/2014,6/3/2014,18,117,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,13,E07,SALIVARY HYPERSECRETION,HYPERSALIVATION,,SALIVARY HYPERSECRETION,,HLT_0374,,HLGT_0488,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/14/2014,2/24/2014,6/3/2014,18,117,Phase 1
CDISCPILOT01,AE,01-701-1275,1275,2/7/2014,6/14/2014,2/7/2014,5/31/2014,,2014-06-14T12:35,,,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/25/2014,-13,2,E05,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/7/2014,2/23/2014,2/23/2014,17,17,Phase 1
CDISCPILOT01,AE,01-701-1287,1287,1/25/2014,7/26/2014,1/25/2014,7/26/2014,,2014-07-26T13:15,,,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/17/2014,-8,3,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/21/2014,3/9/2014,,44,,Phase 1
CDISCPILOT01,AE,01-701-1287,1287,1/25/2014,7/26/2014,1/25/2014,7/26/2014,,2014-07-26T13:15,,,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/17/2014,-8,2,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/6/2014,2/22/2014,,29,,Phase 1
CDISCPILOT01,AE,01-701-1287,1287,1/25/2014,7/26/2014,1/25/2014,7/26/2014,,2014-07-26T13:15,,,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/17/2014,-8,4,E05,RHINORRHOEA,RUNNY NOSE,,RHINORRHOEA,,HLT_0635,,HLGT_0460,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/12/2014,7/9/2014,7/12/2014,166,169,Phase 2
CDISCPILOT01,AE,01-701-1287,1287,1/25/2014,7/26/2014,1/25/2014,7/26/2014,,2014-07-26T13:15,,,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/17/2014,-8,5,E05,RHINORRHOEA,RUNNY NOSE,,RHINORRHOEA,,HLT_0635,,HLGT_0460,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/26/2014,7/9/2014,7/12/2014,166,169,Phase 2
CDISCPILOT01,AE,01-701-1287,1287,1/25/2014,7/26/2014,1/25/2014,7/26/2014,,2014-07-26T13:15,,,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/17/2014,-8,1,E02,SALIVARY HYPERSECRETION,INCREASED SALIVATION,,SALIVARY HYPERSECRETION,,HLT_0374,,HLGT_0488,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/11/2014,1/26/2014,,2,,Phase 1
CDISCPILOT01,AE,01-701-1294,1294,3/24/2013,6/14/2013,3/24/2013,6/14/2013,,10/8/2013,,,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,3,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/22/2013,5/19/2013,,57,,Phase 1
CDISCPILOT01,AE,01-701-1294,1294,3/24/2013,6/14/2013,3/24/2013,6/14/2013,,10/8/2013,,,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,5,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/14/2013,5/19/2013,,57,,Phase 1
CDISCPILOT01,AE,01-701-1294,1294,3/24/2013,6/14/2013,3/24/2013,6/14/2013,,10/8/2013,,,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,1,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/24/2013,3/22/2013,3/23/2013,-2,-1,Phase 1
CDISCPILOT01,AE,01-701-1294,1294,3/24/2013,6/14/2013,3/24/2013,6/14/2013,,10/8/2013,,,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,2,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/22/2013,5/19/2013,,57,,Phase 1
CDISCPILOT01,AE,01-701-1294,1294,3/24/2013,6/14/2013,3/24/2013,6/14/2013,,10/8/2013,,,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,4,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/14/2013,5/19/2013,,57,,Phase 1
CDISCPILOT01,AE,01-701-1294,1294,3/24/2013,6/14/2013,3/24/2013,6/14/2013,,10/8/2013,,,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,6,E09,RASH ERYTHEMATOUS,ERYTHEMATOUS RASH,,RASH ERYTHEMATOUS,,HLT_0336,,HLGT_0701,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/14/2013,6/10/2013,,79,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,16,E27,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/22/2013,10/15/2013,,48,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,1,E21,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,,APPLICATION SITE PERSPIRATION,,HLT_0283,,HLGT_0403,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,8/30/2013,,2,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,17,E28,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/22/2013,10/15/2013,,48,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,12,E19,CONTUSION,BRUISE,,CONTUSION,,HLT_0713,,HLGT_0381,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,9/5/2013,10/8/2013,8,41,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,15,E19,CONTUSION,BRUISE,,CONTUSION,,HLT_0713,,HLGT_0381,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/22/2013,9/5/2013,10/8/2013,8,41,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,9,E17,DIZZINESS,DIZZY,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/15/2013,9/2/2013,9/3/2013,5,6,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,11,E20,DIZZINESS,LIGHTHEADEDNESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,9/4/2013,,7,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,14,E25,EPISTAXIS,NOSE BLEED,,EPISTAXIS,,HLT_0386,,HLGT_0577,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/8/2013,9/30/2013,,33,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,21,E31,FEELING ABNORMAL,FOGGY FEELING IN HEAD,,FEELING ABNORMAL,,HLT_0524,,HLGT_0749,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/5/2013,10/24/2013,,57,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,13,E23,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,9/15/2013,,18,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,2,E24,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,8/30/2013,,2,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,23,E33,LIBIDO DECREASED,LIBIDO DECREASED,,LIBIDO DECREASED,,HLT_0338,,HLGT_0496,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/5/2013,10/24/2013,,57,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,22,E32,LISTLESS,LISTLESSNESS,,LISTLESS,,HLT_0657,,HLGT_0124,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/5/2013,10/24/2013,,57,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,8,E16,MALAISE,MALAISE,,MALAISE,,HLT_0456,,HLGT_0178,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,9/2/2013,,5,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,18,E16,MALAISE,MALAISE,,MALAISE,,HLT_0456,,HLGT_0178,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/5/2013,9/2/2013,,5,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,10,E18,MYALGIA,MYALGIA,,MYALGIA,,HLT_0700,,HLGT_0121,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,9/2/2013,,5,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,5,E13,NASAL CONGESTION,NASAL CONGESTION,,NASAL CONGESTION,,HLT_0118,,HLGT_0549,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,9/1/2013,,4,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,4,E22,PAIN,STINGING,,PAIN,,HLT_0314,,HLGT_0478,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,8/31/2013,,3,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,6,E14,PHARYNGOLARYNGEAL PAIN,SORE THROAT,,PHARYNGOLARYNGEAL PAIN,,HLT_0130,,HLGT_0402,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,9/2/2013,,5,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,7,E15,PRODUCTIVE COUGH,PRODUCTIVE COUGH,,PRODUCTIVE COUGH,,HLT_0545,,HLGT_0681,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,9/2/2013,,5,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,19,E29,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,,RESPIRATORY TRACT CONGESTION,,HLT_0330,,HLGT_0424,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/5/2013,10/23/2013,,56,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,20,E30,RHINITIS,CORYZA,,RHINITIS,,HLT_0239,,HLGT_0322,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/5/2013,10/23/2013,,56,,Phase 1
CDISCPILOT01,AE,01-701-1302,1302,8/29/2013,11/5/2013,8/29/2013,11/5/2013,,2/13/2014,,,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/20/2013,-9,3,E26,STOMACH DISCOMFORT,STOMACH UPSET,,STOMACH DISCOMFORT,,HLT_0065,,HLGT_0183,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2013,8/30/2013,,2,,Phase 1
CDISCPILOT01,AE,01-701-1317,1317,5/22/2014,11/20/2014,5/22/2014,11/20/2014,,2014-11-20T11:54,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/10/2014,-12,3,E13,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/3/2014,6/23/2014,,33,,Phase 1
CDISCPILOT01,AE,01-701-1317,1317,5/22/2014,11/20/2014,5/22/2014,11/20/2014,,2014-11-20T11:54,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/10/2014,-12,4,E14,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/3/2014,6/23/2014,,33,,Phase 1
CDISCPILOT01,AE,01-701-1317,1317,5/22/2014,11/20/2014,5/22/2014,11/20/2014,,2014-11-20T11:54,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/10/2014,-12,5,E15,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,,APPLICATION SITE URTICARIA,,HLT_0196,,HLGT_0233,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/3/2014,6/23/2014,,33,,Phase 1
CDISCPILOT01,AE,01-701-1317,1317,5/22/2014,11/20/2014,5/22/2014,11/20/2014,,2014-11-20T11:54,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/10/2014,-12,2,E12,CYST,CYST,,CYST,,HLT_0763,,HLGT_0341,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/20/2014,5/13/2014,,-9,,Phase 1
CDISCPILOT01,AE,01-701-1317,1317,5/22/2014,11/20/2014,5/22/2014,11/20/2014,,2014-11-20T11:54,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/10/2014,-12,6,E16,DEPRESSED MOOD,DEPRESSED MOOD,,DEPRESSED MOOD,,HLT_0784,,HLGT_0122,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/22/2014,7/4/2014,,44,,Phase 1
CDISCPILOT01,AE,01-701-1317,1317,5/22/2014,11/20/2014,5/22/2014,11/20/2014,,2014-11-20T11:54,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/10/2014,-12,7,E16,DEPRESSED MOOD,DEPRESSED MOOD,,DEPRESSED MOOD,,HLT_0784,,HLGT_0122,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/9/2014,7/4/2014,,44,,Phase 1
CDISCPILOT01,AE,01-701-1317,1317,5/22/2014,11/20/2014,5/22/2014,11/20/2014,,2014-11-20T11:54,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/10/2014,-12,9,E18,DYSPHONIA,HOARSENESS,,DYSPHONIA,,HLT_0073,,HLGT_0274,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/6/2014,11/3/2014,,166,,Phase 2
CDISCPILOT01,AE,01-701-1317,1317,5/22/2014,11/20/2014,5/22/2014,11/20/2014,,2014-11-20T11:54,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/10/2014,-12,8,E17,FATIGUE,TIREDNESS,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/9/2014,9/12/2014,,114,,Phase 2
CDISCPILOT01,AE,01-701-1317,1317,5/22/2014,11/20/2014,5/22/2014,11/20/2014,,2014-11-20T11:54,,,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/10/2014,-12,1,E11,ONYCHOMYCOSIS,ONYCHOMYCOSIS,,ONYCHOMYCOSIS,,HLT_0275,,HLGT_0243,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/20/2014,5/13/2014,,-9,,Phase 1
CDISCPILOT01,AE,01-701-1324,1324,10/2/2012,4/2/2013,10/2/2012,4/2/2013,,2013-04-02T11:35,,,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/16/2012,-16,1,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/30/2012,10/22/2012,,21,,Phase 1
CDISCPILOT01,AE,01-701-1324,1324,10/2/2012,4/2/2013,10/2/2012,4/2/2013,,2013-04-02T11:35,,,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/16/2012,-16,2,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/25/2012,12/2/2012,,62,,Phase 1
CDISCPILOT01,AE,01-701-1324,1324,10/2/2012,4/2/2013,10/2/2012,4/2/2013,,2013-04-02T11:35,,,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/16/2012,-16,3,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/25/2012,12/25/2012,1/16/2013,85,107,Phase 1
CDISCPILOT01,AE,01-701-1324,1324,10/2/2012,4/2/2013,10/2/2012,4/2/2013,,2013-04-02T11:35,,,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/16/2012,-16,4,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/22/2013,12/25/2012,1/16/2013,85,107,Phase 1
CDISCPILOT01,AE,01-701-1341,1341,1/5/2013,2/7/2013,1/5/2013,1/26/2013,,2/21/2013,,,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/22/2012,-14,2,E10,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/7/2013,1/19/2013,,15,,Phase 1
CDISCPILOT01,AE,01-701-1341,1341,1/5/2013,2/7/2013,1/5/2013,1/26/2013,,2/21/2013,,,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/22/2012,-14,4,E12,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/7/2013,1/26/2013,,22,,Phase 1
CDISCPILOT01,AE,01-701-1341,1341,1/5/2013,2/7/2013,1/5/2013,1/26/2013,,2/21/2013,,,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/22/2012,-14,5,E13,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/7/2013,1/26/2013,1/30/2013,22,26,Phase 1
CDISCPILOT01,AE,01-701-1341,1341,1/5/2013,2/7/2013,1/5/2013,1/26/2013,,2/21/2013,,,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/22/2012,-14,1,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/7/2013,1/19/2013,,15,,Phase 1
CDISCPILOT01,AE,01-701-1341,1341,1/5/2013,2/7/2013,1/5/2013,1/26/2013,,2/21/2013,,,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/22/2012,-14,3,E11,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/7/2013,1/26/2013,1/30/2013,22,26,Phase 1
CDISCPILOT01,DM,01-701-1345,1345,10/8/2013,3/18/2014,10/8/2013,3/18/2014,,2014-03-18T14:12,,,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/1/2013,-7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-701-1360,1360,7/31/2013,8/14/2013,7/31/2013,8/5/2013,,2/11/2014,,,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,7/24/2013,-7,1,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/14/2013,8/2/2013,,3,,Phase 1
CDISCPILOT01,AE,01-701-1360,1360,7/31/2013,8/14/2013,7/31/2013,8/5/2013,,2/11/2014,,,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,7/24/2013,-7,2,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/14/2013,8/2/2013,,3,,Phase 1
CDISCPILOT01,AE,01-701-1360,1360,7/31/2013,8/14/2013,7/31/2013,8/5/2013,,2/11/2014,,,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,7/24/2013,-7,3,E10,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/14/2013,8/5/2013,,6,,Phase 1
CDISCPILOT01,AE,01-701-1363,1363,5/30/2013,11/27/2013,5/30/2013,11/27/2013,,2013-11-27T10:00,,,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/20/2013,-10,3,E11,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/24/2013,7/16/2013,,48,,Phase 1
CDISCPILOT01,AE,01-701-1363,1363,5/30/2013,11/27/2013,5/30/2013,11/27/2013,,2013-11-27T10:00,,,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/20/2013,-10,5,E13,BACK PAIN,BACKACHE,,BACK PAIN,,HLT_0115,,HLGT_0508,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/14/2013,10/13/2013,10/15/2013,137,139,Phase 2
CDISCPILOT01,AE,01-701-1363,1363,5/30/2013,11/27/2013,5/30/2013,11/27/2013,,2013-11-27T10:00,,,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/20/2013,-10,6,E13,BACK PAIN,BACKACHE,,BACK PAIN,,HLT_0115,,HLGT_0508,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/13/2013,10/13/2013,10/15/2013,137,139,Phase 2
CDISCPILOT01,AE,01-701-1363,1363,5/30/2013,11/27/2013,5/30/2013,11/27/2013,,2013-11-27T10:00,,,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/20/2013,-10,2,E03,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/24/2013,1986,,,,Phase 1
CDISCPILOT01,AE,01-701-1363,1363,5/30/2013,11/27/2013,5/30/2013,11/27/2013,,2013-11-27T10:00,,,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/20/2013,-10,4,E03,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/14/2013,1986,,,,Phase 1
CDISCPILOT01,AE,01-701-1363,1363,5/30/2013,11/27/2013,5/30/2013,11/27/2013,,2013-11-27T10:00,,,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/20/2013,-10,1,E09,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/25/2013,6/14/2013,6/15/2013,16,17,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,3,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/2/2013,3/23/2013,3/26/2013,48,51,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,5,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/30/2013,4/12/2013,,68,,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,6,E09,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/30/2013,4/12/2013,,68,,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,8,E09,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/30/2013,4/12/2013,,68,,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,2,E05,APPLICATION SITE PAIN,APPLICATION SITE PAIN,,APPLICATION SITE PAIN,,HLT_0342,,HLGT_0085,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/19/2013,2/7/2013,2/7/2013,4,4,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,1,E04,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/19/2013,2/7/2013,2/7/2013,4,4,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,4,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/2/2013,3/23/2013,,48,,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,7,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/30/2013,3/23/2013,,48,,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,9,E10,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/30/2013,5/7/2013,5/24/2013,93,110,Phase 1
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,10,E11,CHEST DISCOMFORT,CHEST PRESSURE,,CHEST DISCOMFORT,,HLT_0593,,HLGT_0441,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/25/2013,6/24/2013,6/24/2013,141,141,Phase 2
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,12,E13,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/30/2013,7/17/2013,7/26/2013,164,173,Phase 2
CDISCPILOT01,AE,01-701-1383,1383,2/4/2013,8/6/2013,2/4/2013,8/6/2013,,2013-08-06T12:00,,,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/22/2013,-13,11,E12,HEADACHE,FULLNESS HEAD,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/25/2013,6/24/2013,6/24/2013,141,141,Phase 2
CDISCPILOT01,AE,01-701-1387,1387,3/12/2014,3/25/2014,3/12/2014,3/25/2014,,8/27/2014,,,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2014,-17,1,E08,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/25/2014,3/18/2014,3/18/2014,7,7,Phase 1
CDISCPILOT01,AE,01-701-1387,1387,3/12/2014,3/25/2014,3/12/2014,3/25/2014,,8/27/2014,,,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2014,-17,2,E09,HYPERHIDROSIS,SWEATING,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/25/2014,3/18/2014,3/18/2014,7,7,Phase 1
CDISCPILOT01,AE,01-701-1392,1392,10/28/2012,4/28/2013,10/28/2012,4/28/2013,,2013-04-28T11:30,,,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/17/2012,-11,1,E04,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/17/2013,3/16/2013,3/21/2013,140,145,Phase 2
CDISCPILOT01,AE,01-701-1392,1392,10/28/2012,4/28/2013,10/28/2012,4/28/2013,,2013-04-28T11:30,,,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/17/2012,-11,2,E04,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/15/2013,3/16/2013,3/21/2013,140,145,Phase 2
CDISCPILOT01,AE,01-701-1415,1415,9/23/2013,3/24/2014,9/23/2013,3/24/2014,,2014-03-24T12:34,,,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/15/2013,-8,6,E12,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/10/2014,3/9/2014,3/9/2014,168,168,Phase 2
CDISCPILOT01,AE,01-701-1415,1415,9/23/2013,3/24/2014,9/23/2013,3/24/2014,,2014-03-24T12:34,,,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/15/2013,-8,3,E10,MICTURITION URGENCY,URINARY URGENCY,,MICTURITION URGENCY,,HLT_0294,,HLGT_0483,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/21/2013,12/2/2013,,71,,Phase 1
CDISCPILOT01,AE,01-701-1415,1415,9/23/2013,3/24/2014,9/23/2013,3/24/2014,,2014-03-24T12:34,,,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/15/2013,-8,1,E09,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/22/2013,10/21/2013,11/4/2013,29,43,Phase 1
CDISCPILOT01,AE,01-701-1415,1415,9/23/2013,3/24/2014,9/23/2013,3/24/2014,,2014-03-24T12:34,,,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/15/2013,-8,2,E09,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/21/2013,10/21/2013,11/4/2013,29,43,Phase 1
CDISCPILOT01,AE,01-701-1415,1415,9/23/2013,3/24/2014,9/23/2013,3/24/2014,,2014-03-24T12:34,,,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/15/2013,-8,4,E11,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/10/2014,1/21/2014,2/10/2014,121,141,Phase 2
CDISCPILOT01,AE,01-701-1415,1415,9/23/2013,3/24/2014,9/23/2013,3/24/2014,,2014-03-24T12:34,,,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/15/2013,-8,5,E11,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/10/2014,1/21/2014,2/10/2014,121,141,Phase 2
CDISCPILOT01,DM,01-701-1429,1429,3/19/2013,4/30/2013,3/19/2013,4/30/2013,,2013-04-30T12:22,,,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/25/2013,-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,DM,01-701-1440,1440,8/8/2013,2/5/2014,8/8/2013,2/5/2014,,2014-02-05T11:25,,,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/24/2013,-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-701-1442,1442,10/26/2013,4/26/2014,10/26/2013,4/26/2014,,2014-04-26T10:00,,,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/17/2013,-9,1,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/18/2014,1/10/2014,,77,,Phase 1
CDISCPILOT01,AE,01-701-1444,1444,1/5/2013,2/13/2013,1/5/2013,2/12/2013,,6/20/2013,,,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/31/2012,-5,1,E11,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/31/2013,1/19/2013,,15,,Phase 1
CDISCPILOT01,AE,01-701-1444,1444,1/5/2013,2/13/2013,1/5/2013,2/12/2013,,6/20/2013,,,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/31/2012,-5,4,E11,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/13/2013,1/19/2013,,15,,Phase 1
CDISCPILOT01,AE,01-701-1444,1444,1/5/2013,2/13/2013,1/5/2013,2/12/2013,,6/20/2013,,,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/31/2012,-5,6,E15,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/13/2013,2/4/2013,,31,,Phase 1
CDISCPILOT01,AE,01-701-1444,1444,1/5/2013,2/13/2013,1/5/2013,2/12/2013,,6/20/2013,,,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/31/2012,-5,2,E12,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/31/2013,1/19/2013,,15,,Phase 1
CDISCPILOT01,AE,01-701-1444,1444,1/5/2013,2/13/2013,1/5/2013,2/12/2013,,6/20/2013,,,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/31/2012,-5,5,E12,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/13/2013,1/19/2013,,15,,Phase 1
CDISCPILOT01,AE,01-701-1444,1444,1/5/2013,2/13/2013,1/5/2013,2/12/2013,,6/20/2013,,,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/31/2012,-5,7,E16,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/13/2013,2/4/2013,,31,,Phase 1
CDISCPILOT01,AE,01-701-1444,1444,1/5/2013,2/13/2013,1/5/2013,2/12/2013,,6/20/2013,,,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/31/2012,-5,8,E14,PARAESTHESIA,TINGLING,,PARAESTHESIA,,HLT_0481,,HLGT_0534,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/13/2013,2/8/2013,2/8/2013,35,35,Phase 1
CDISCPILOT01,AE,01-701-1444,1444,1/5/2013,2/13/2013,1/5/2013,2/12/2013,,6/20/2013,,,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/31/2012,-5,3,E13,SALIVARY HYPERSECRETION,HYPERSALIVATION,,SALIVARY HYPERSECRETION,,HLT_0374,,HLGT_0488,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/31/2013,1/19/2013,,15,,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,9,E07,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/28/2013,9/9/2013,9/24/2013,46,61,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,2,E03,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,,NEUTROPHIL COUNT INCREASED,,HLT_0326,,HLGT_0625,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/24/2013,7/7/2013,7/26/2013,-19,1,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,6,E03,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,,NEUTROPHIL COUNT INCREASED,,HLT_0326,,HLGT_0625,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/8/2013,7/7/2013,7/26/2013,-19,1,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,7,E06,RECTAL HAEMORRHAGE,RECTAL BLEEDING,,RECTAL HAEMORRHAGE,,HLT_0353,,HLGT_0755,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/6/2013,9/2/2013,9/6/2013,39,43,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,8,E06,RECTAL HAEMORRHAGE,RECTAL BLEEDING,,RECTAL HAEMORRHAGE,,HLT_0353,,HLGT_0755,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/28/2013,9/2/2013,9/6/2013,39,43,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,10,E08,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/17/2013,10/12/2013,10/31/2013,79,98,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,3,E04,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,,URINE ANALYSIS ABNORMAL,,HLT_0783,,HLGT_0295,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/24/2013,7/7/2013,7/24/2013,-19,-2,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,4,E04,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,,URINE ANALYSIS ABNORMAL,,HLT_0783,,HLGT_0295,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/26/2013,7/7/2013,7/24/2013,-19,-2,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,1,E02,WHITE BLOOD CELL COUNT INCREASED,WBC INCREASED,,WHITE BLOOD CELL COUNT INCREASED,,HLT_0417,,HLGT_0465,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/24/2013,7/7/2013,7/26/2013,-19,1,Phase 1
CDISCPILOT01,AE,01-702-1082,1082,7/26/2013,11/17/2013,7/26/2013,10/13/2013,,2013-11-17T12:20,,,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/3/2013,-23,5,E02,WHITE BLOOD CELL COUNT INCREASED,WBC INCREASED,,WHITE BLOOD CELL COUNT INCREASED,,HLT_0417,,HLGT_0465,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/8/2013,7/7/2013,7/26/2013,-19,1,Phase 1
CDISCPILOT01,AE,01-703-1042,1042,3/2/2013,8/31/2013,3/2/2013,8/31/2013,,2013-08-31T11:00,,,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-7,1,E04,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/14/2013,3/4/2013,3/5/2013,3,4,Phase 1
CDISCPILOT01,AE,01-703-1042,1042,3/2/2013,8/31/2013,3/2/2013,8/31/2013,,2013-08-31T11:00,,,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-7,2,E05,INSOMNIA,INSOMNIA,,INSOMNIA,,HLT_0297,,HLGT_0469,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/14/2013,3/5/2013,3/6/2013,4,5,Phase 1
CDISCPILOT01,AE,01-703-1076,1076,10/25/2013,12/24/2013,10/25/2013,12/24/2013,,1/21/2014,,,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-8,5,E09,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/4/2013,11/23/2013,,30,,Phase 1
CDISCPILOT01,AE,01-703-1076,1076,10/25/2013,12/24/2013,10/25/2013,12/24/2013,,1/21/2014,,,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-8,4,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/4/2013,11/23/2013,,30,,Phase 1
CDISCPILOT01,AE,01-703-1076,1076,10/25/2013,12/24/2013,10/25/2013,12/24/2013,,1/21/2014,,,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-8,7,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/17/2013,11/23/2013,,30,,Phase 1
CDISCPILOT01,AE,01-703-1076,1076,10/25/2013,12/24/2013,10/25/2013,12/24/2013,,1/21/2014,,,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-8,2,E01,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERTROPHY,,BENIGN PROSTATIC HYPERPLASIA,,HLT_0215,,HLGT_0568,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/20/2013,11/20/2013,,27,,Phase 1
CDISCPILOT01,AE,01-703-1076,1076,10/25/2013,12/24/2013,10/25/2013,12/24/2013,,1/21/2014,,,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-8,1,E02,BIOPSY PROSTATE,BIOPSY OF PROSTATE,,BIOPSY PROSTATE,,HLT_0553,,HLGT_0725,,INVESTIGATIONS,,INVESTIGATIONS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/20/2013,11/16/2013,11/16/2013,23,23,Phase 1
CDISCPILOT01,AE,01-703-1076,1076,10/25/2013,12/24/2013,10/25/2013,12/24/2013,,1/21/2014,,,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-8,3,E05,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLEMIA,,HYPERCHOLESTEROLAEMIA,,HLT_0025,,HLGT_0703,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/4/2013,2007,,,,Phase 1
CDISCPILOT01,AE,01-703-1076,1076,10/25/2013,12/24/2013,10/25/2013,12/24/2013,,1/21/2014,,,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-8,6,E07,HYPERHIDROSIS,SWEATING,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/4/2013,11/25/2013,,32,,Phase 1
CDISCPILOT01,AE,01-703-1086,1086,9/2/2012,12/24/2012,9/2/2012,12/4/2012,,3/26/2013,,,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/22/2012,-11,1,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/16/2012,9/13/2012,1/2/2013,12,123,Phase 1
CDISCPILOT01,AE,01-703-1086,1086,9/2/2012,12/24/2012,9/2/2012,12/4/2012,,3/26/2013,,,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/22/2012,-11,2,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/30/2012,9/13/2012,1/2/2013,12,123,Phase 1
CDISCPILOT01,AE,01-703-1086,1086,9/2/2012,12/24/2012,9/2/2012,12/4/2012,,3/26/2013,,,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/22/2012,-11,3,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/13/2012,9/13/2012,1/2/2013,12,123,Phase 1
CDISCPILOT01,AE,01-703-1086,1086,9/2/2012,12/24/2012,9/2/2012,12/4/2012,,3/26/2013,,,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/22/2012,-11,6,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/26/2013,9/13/2012,1/2/2013,12,123,Phase 1
CDISCPILOT01,AE,01-703-1086,1086,9/2/2012,12/24/2012,9/2/2012,12/4/2012,,3/26/2013,,,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/22/2012,-11,4,E02,CHILLS,CHILLS,,CHILLS,,HLT_0586,,HLGT_0161,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/13/2012,10/9/2012,10/15/2012,38,44,Phase 1
CDISCPILOT01,AE,01-703-1086,1086,9/2/2012,12/24/2012,9/2/2012,12/4/2012,,3/26/2013,,,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/22/2012,-11,5,E02,CHILLS,CHILLS,,CHILLS,,HLT_0586,,HLGT_0161,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/27/2012,10/9/2012,10/15/2012,38,44,Phase 1
CDISCPILOT01,DM,01-703-1096,1096,1/25/2013,3/29/2013,1/25/2013,3/16/2013,,3/29/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/19/2012,-37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-703-1100,1100,3/13/2013,9/14/2013,3/13/2013,9/14/2013,,2013-09-14T15:00,,,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/28/2013,-13,1,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/12/2013,4/5/2013,4/16/2013,24,35,Phase 1
CDISCPILOT01,AE,01-703-1100,1100,3/13/2013,9/14/2013,3/13/2013,9/14/2013,,2013-09-14T15:00,,,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/28/2013,-13,2,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/14/2013,4/5/2013,4/16/2013,24,35,Phase 1
CDISCPILOT01,AE,01-703-1100,1100,3/13/2013,9/14/2013,3/13/2013,9/14/2013,,2013-09-14T15:00,,,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/28/2013,-13,3,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/24/2013,4/5/2013,4/16/2013,24,35,Phase 1
CDISCPILOT01,AE,01-703-1100,1100,3/13/2013,9/14/2013,3/13/2013,9/14/2013,,2013-09-14T15:00,,,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/28/2013,-13,4,E06,CATARACT OPERATION,CATARACT EXTRACTION,,CATARACT OPERATION,,HLT_0432,,HLGT_0058,,SURGICAL AND MEDICAL PROCEDURES,,SURGICAL AND MEDICAL PROCEDURES,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/8/2013,4/25/2013,4/25/2013,44,44,Phase 1
CDISCPILOT01,AE,01-703-1100,1100,3/13/2013,9/14/2013,3/13/2013,9/14/2013,,2013-09-14T15:00,,,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/28/2013,-13,6,E07,OEDEMA PERIPHERAL,LEG EDEMA,,OEDEMA PERIPHERAL,,HLT_0661,,HLGT_0137,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/31/2013,2/28/2013,9/14/2013,-13,186,Phase 1
CDISCPILOT01,AE,01-703-1100,1100,3/13/2013,9/14/2013,3/13/2013,9/14/2013,,2013-09-14T15:00,,,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/28/2013,-13,8,E07,OEDEMA PERIPHERAL,LEG EDEMA,,OEDEMA PERIPHERAL,,HLT_0661,,HLGT_0137,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/14/2013,2/28/2013,9/14/2013,-13,186,Phase 1
CDISCPILOT01,AE,01-703-1100,1100,3/13/2013,9/14/2013,3/13/2013,9/14/2013,,2013-09-14T15:00,,,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/28/2013,-13,7,E09,OEDEMA PERIPHERAL,LEG EDEMA,,OEDEMA PERIPHERAL,,HLT_0661,,HLGT_0137,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/31/2013,7/17/2013,9/14/2013,127,186,Phase 2
CDISCPILOT01,AE,01-703-1100,1100,3/13/2013,9/14/2013,3/13/2013,9/14/2013,,2013-09-14T15:00,,,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/28/2013,-13,9,E09,OEDEMA PERIPHERAL,LEG EDEMA,,OEDEMA PERIPHERAL,,HLT_0661,,HLGT_0137,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/14/2013,7/17/2013,9/14/2013,127,186,Phase 2
CDISCPILOT01,AE,01-703-1100,1100,3/13/2013,9/14/2013,3/13/2013,9/14/2013,,2013-09-14T15:00,,,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/28/2013,-13,5,E08,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/5/2013,5/27/2013,6/3/2013,76,83,Phase 1
CDISCPILOT01,AE,01-703-1119,1119,2/20/2013,6/13/2013,2/20/2013,6/13/2013,,8/24/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/2/2013,-18,1,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/21/2013,3/16/2013,,25,,Phase 1
CDISCPILOT01,AE,01-703-1119,1119,2/20/2013,6/13/2013,2/20/2013,6/13/2013,,8/24/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/2/2013,-18,2,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/17/2013,3/16/2013,,25,,Phase 1
CDISCPILOT01,AE,01-703-1119,1119,2/20/2013,6/13/2013,2/20/2013,6/13/2013,,8/24/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/2/2013,-18,3,E05,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/17/2013,5/4/2013,,74,,Phase 1
CDISCPILOT01,AE,01-703-1119,1119,2/20/2013,6/13/2013,2/20/2013,6/13/2013,,8/24/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/2/2013,-18,4,E05,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SEVERE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/13/2013,5/4/2013,,74,,Phase 1
CDISCPILOT01,AE,01-703-1175,1175,12/20/2013,12/31/2013,12/20/2013,12/26/2013,,2013-12-31T13:15,,,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/13/2013,-7,1,E01,ATRIOVENTRICULAR BLOCK SECOND DEGREE,HEART BLOCK SECOND DEGREE,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,,HLT_0415,,HLGT_0086,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,SEVERE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/18/2013,12/18/2013,,-2,,Phase 1
CDISCPILOT01,AE,01-703-1182,1182,10/17/2013,12/12/2013,10/17/2013,12/11/2013,,1/14/2014,,,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/8/2013,-9,1,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/31/2013,10/31/2013,,15,,Phase 1
CDISCPILOT01,AE,01-703-1182,1182,10/17/2013,12/12/2013,10/17/2013,12/11/2013,,1/14/2014,,,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/8/2013,-9,2,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/28/2013,10/31/2013,,15,,Phase 1
CDISCPILOT01,AE,01-703-1182,1182,10/17/2013,12/12/2013,10/17/2013,12/11/2013,,1/14/2014,,,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/8/2013,-9,3,E07,SOMNOLENCE,DROWSINESS,,SOMNOLENCE,,HLT_0160,,HLGT_0254,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/28/2013,11/22/2013,,37,,Phase 1
CDISCPILOT01,AE,01-703-1182,1182,10/17/2013,12/12/2013,10/17/2013,12/11/2013,,1/14/2014,,,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/8/2013,-9,4,E07,SOMNOLENCE,DROWSINESS,,SOMNOLENCE,,HLT_0160,,HLGT_0254,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/12/2013,11/22/2013,,37,,Phase 1
CDISCPILOT01,DM,01-703-1197,1197,6/16/2013,7/22/2013,6/16/2013,6/29/2013,,7/22/2013,,,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/1/2013,-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-703-1210,1210,3/16/2013,9/6/2013,3/16/2013,9/6/2013,,2013-09-06T13:30,,,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/8/2013,-8,2,E04,DECREASED APPETITE,DECREASED APPETITE,,DECREASED APPETITE,,HLT_0574,,HLGT_0231,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/10/2013,5/4/2013,,50,,Phase 1
CDISCPILOT01,AE,01-703-1210,1210,3/16/2013,9/6/2013,3/16/2013,9/6/2013,,2013-09-06T13:30,,,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/8/2013,-8,3,E04,DECREASED APPETITE,DECREASED APPETITE,,DECREASED APPETITE,,HLT_0574,,HLGT_0231,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/24/2013,5/4/2013,,50,,Phase 1
CDISCPILOT01,AE,01-703-1210,1210,3/16/2013,9/6/2013,3/16/2013,9/6/2013,,2013-09-06T13:30,,,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/8/2013,-8,1,E01,DISORIENTATION,DISORIENTATION,,DISORIENTATION,,HLT_0299,,HLGT_0307,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/12/2013,4/2/2013,,18,,Phase 1
CDISCPILOT01,AE,01-703-1258,1258,7/20/2012,1/21/2013,7/20/2012,1/11/2013,,1/28/2013,,,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/10/2012,-10,4,E08,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/4/2012,9/4/2012,1/25/2013,47,190,Phase 1
CDISCPILOT01,AE,01-703-1258,1258,7/20/2012,1/21/2013,7/20/2012,1/11/2013,,1/28/2013,,,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/10/2012,-10,6,E08,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/14/2012,9/4/2012,1/25/2013,47,190,Phase 1
CDISCPILOT01,AE,01-703-1258,1258,7/20/2012,1/21/2013,7/20/2012,1/11/2013,,1/28/2013,,,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/10/2012,-10,7,E08,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/28/2013,9/4/2012,1/25/2013,47,190,Phase 1
CDISCPILOT01,AE,01-703-1258,1258,7/20/2012,1/21/2013,7/20/2012,1/11/2013,,1/28/2013,,,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/10/2012,-10,2,E06,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/4/2012,2001,,,,Phase 1
CDISCPILOT01,AE,01-703-1258,1258,7/20/2012,1/21/2013,7/20/2012,1/11/2013,,1/28/2013,,,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/10/2012,-10,5,E06,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/14/2012,2001,,,,Phase 1
CDISCPILOT01,AE,01-703-1258,1258,7/20/2012,1/21/2013,7/20/2012,1/11/2013,,1/28/2013,,,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/10/2012,-10,1,E07,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/17/2012,8/11/2012,8/19/2012,23,31,Phase 1
CDISCPILOT01,AE,01-703-1258,1258,7/20/2012,1/21/2013,7/20/2012,1/11/2013,,1/28/2013,,,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/10/2012,-10,3,E07,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/4/2012,8/11/2012,8/19/2012,23,31,Phase 1
CDISCPILOT01,DM,01-703-1279,1279,5/13/2013,6/22/2013,5/13/2013,6/3/2013,,6/22/2013,,,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/27/2013,-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-703-1295,1295,11/21/2013,5/19/2014,11/21/2013,4/19/2014,,2014-05-19T14:45,,,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/24/2013,-28,1,E06,ARTHRITIS,ARTHRITIS,,ARTHRITIS,,HLT_0019,,HLGT_0587,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/1/2014,12/28/2013,,38,,Phase 1
CDISCPILOT01,AE,01-703-1299,1299,9/12/2012,3/13/2013,9/12/2012,3/13/2013,,3/27/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/7/2012,-5,3,E01,GLAUCOMA,GLAUCOMA,,GLAUCOMA,,HLT_0556,,HLGT_0734,,EYE DISORDERS,,EYE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/1/2013,1992,,,,Phase 1
CDISCPILOT01,AE,01-703-1299,1299,9/12/2012,3/13/2013,9/12/2012,3/13/2013,,3/27/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/7/2012,-5,4,E05,HYPOTENSION,HYPOTENSION,,HYPOTENSION,,HLT_0761,,HLGT_0412,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/1/2013,3/1/2013,,171,,Phase 2
CDISCPILOT01,AE,01-703-1299,1299,9/12/2012,3/13/2013,9/12/2012,3/13/2013,,3/27/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/7/2012,-5,6,E05,HYPOTENSION,HYPOTENSION,,HYPOTENSION,,HLT_0761,,HLGT_0412,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/13/2013,3/1/2013,,171,,Phase 2
CDISCPILOT01,AE,01-703-1299,1299,9/12/2012,3/13/2013,9/12/2012,3/13/2013,,3/27/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/7/2012,-5,8,E07,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/13/2013,3/13/2013,,183,,Phase 2
CDISCPILOT01,AE,01-703-1299,1299,9/12/2012,3/13/2013,9/12/2012,3/13/2013,,3/27/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/7/2012,-5,5,E06,TACHYCARDIA,TACHYCARDIA,,TACHYCARDIA,,HLT_0082,,HLGT_0574,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/1/2013,3/1/2013,,171,,Phase 2
CDISCPILOT01,AE,01-703-1299,1299,9/12/2012,3/13/2013,9/12/2012,3/13/2013,,3/27/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/7/2012,-5,7,E06,TACHYCARDIA,TACHYCARDIA,,TACHYCARDIA,,HLT_0082,,HLGT_0574,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/13/2013,3/1/2013,,171,,Phase 2
CDISCPILOT01,AE,01-703-1299,1299,9/12/2012,3/13/2013,9/12/2012,3/13/2013,,3/27/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/7/2012,-5,1,E02,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/28/2012,9/27/2012,10/6/2012,16,25,Phase 1
CDISCPILOT01,AE,01-703-1299,1299,9/12/2012,3/13/2013,9/12/2012,3/13/2013,,3/27/2013,,,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/7/2012,-5,2,E02,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/10/2012,9/27/2012,10/6/2012,16,25,Phase 1
CDISCPILOT01,AE,01-703-1335,1335,3/17/2014,5/24/2014,3/17/2014,5/7/2014,,2014-05-24T12:15,,,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/28/2014,-17,1,E01,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,,HLT_0415,,HLGT_0086,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/15/2014,3/15/2014,3/30/2014,-2,14,Phase 1
CDISCPILOT01,AE,01-703-1335,1335,3/17/2014,5/24/2014,3/17/2014,5/7/2014,,2014-05-24T12:15,,,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/28/2014,-17,2,E01,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,,HLT_0415,,HLGT_0086,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/31/2014,3/15/2014,3/30/2014,-2,14,Phase 1
CDISCPILOT01,DM,01-703-1379,1379,9/22/2013,3/21/2014,9/22/2013,3/21/2014,,2014-03-21T10:55,,,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/12/2013,-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-703-1403,1403,12/12/2012,12/19/2012,12/12/2012,12/13/2012,,1/8/2013,,,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,12/5/2012,-7,4,E03,CHEST DISCOMFORT,CHEST TIGHTNESS,,CHEST DISCOMFORT,,HLT_0593,,HLGT_0441,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/19/2012,12/15/2012,12/16/2012,4,5,Phase 1
CDISCPILOT01,AE,01-703-1403,1403,12/12/2012,12/19/2012,12/12/2012,12/13/2012,,1/8/2013,,,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,12/5/2012,-7,2,E01,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/19/2012,12/13/2012,12/14/2012,2,3,Phase 1
CDISCPILOT01,AE,01-703-1403,1403,12/12/2012,12/19/2012,12/12/2012,12/13/2012,,1/8/2013,,,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,12/5/2012,-7,3,E02,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/19/2012,12/13/2012,12/14/2012,2,3,Phase 1
CDISCPILOT01,AE,01-703-1403,1403,12/12/2012,12/19/2012,12/12/2012,12/13/2012,,1/8/2013,,,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,12/5/2012,-7,1,E07,WEIGHT DECREASED,WEIGHT LOSS,,WEIGHT DECREASED,,HLT_0158,,HLGT_0778,,INVESTIGATIONS,,INVESTIGATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/19/2012,12/12/2012,12/19/2012,1,8,Phase 1
CDISCPILOT01,AE,01-703-1403,1403,12/12/2012,12/19/2012,12/12/2012,12/13/2012,,1/8/2013,,,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,12/5/2012,-7,5,E07,WEIGHT DECREASED,WEIGHT LOSS,,WEIGHT DECREASED,,HLT_0158,,HLGT_0778,,INVESTIGATIONS,,INVESTIGATIONS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/8/2013,12/12/2012,12/19/2012,1,8,Phase 1
CDISCPILOT01,AE,01-703-1439,1439,3/12/2014,9/11/2014,3/12/2014,9/11/2014,,2014-09-11T12:40,,,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,3/4/2014,-8,1,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/5/2014,4/24/2014,,44,,Phase 1
CDISCPILOT01,AE,01-703-1439,1439,3/12/2014,9/11/2014,3/12/2014,9/11/2014,,2014-09-11T12:40,,,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,3/4/2014,-8,2,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/30/2014,4/24/2014,,44,,Phase 1
CDISCPILOT01,AE,01-704-1008,1008,1/13/2013,2/25/2013,1/13/2013,2/21/2013,,2013-02-25T11:00,,,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/6/2013,-7,1,E03,HYPERHIDROSIS,SWEATING INCREASED,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/9/2013,1/30/2013,,18,,Phase 1
CDISCPILOT01,AE,01-704-1008,1008,1/13/2013,2/25/2013,1/13/2013,2/21/2013,,2013-02-25T11:00,,,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/6/2013,-7,3,E05,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/25/2013,2/25/2013,,44,,Phase 1
CDISCPILOT01,AE,01-704-1008,1008,1/13/2013,2/25/2013,1/13/2013,2/21/2013,,2013-02-25T11:00,,,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/6/2013,-7,2,E06,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,,TRANSIENT ISCHAEMIC ATTACK,,HLT_0041,,HLGT_0433,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2/25/2013,2/21/2013,2/21/2013,40,40,Phase 1
CDISCPILOT01,AE,01-704-1009,1009,8/27/2013,10/2/2013,8/27/2013,9/25/2013,,10/2/2013,,,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-7,5,E07,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/2/2013,9/17/2013,,22,,Phase 1
CDISCPILOT01,AE,01-704-1009,1009,8/27/2013,10/2/2013,8/27/2013,9/25/2013,,10/2/2013,,,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-7,1,E09,FATIGUE,FATIGUE,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/14/2013,9/5/2013,,10,,Phase 1
CDISCPILOT01,AE,01-704-1009,1009,8/27/2013,10/2/2013,8/27/2013,9/25/2013,,10/2/2013,,,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-7,2,E10,MALAISE,MALAISE,,MALAISE,,HLT_0456,,HLGT_0178,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/14/2013,9/5/2013,9/27/2013,10,32,Phase 1
CDISCPILOT01,AE,01-704-1009,1009,8/27/2013,10/2/2013,8/27/2013,9/25/2013,,10/2/2013,,,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-7,4,E10,MALAISE,MALAISE,,MALAISE,,HLT_0456,,HLGT_0178,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/2/2013,9/5/2013,9/27/2013,10,32,Phase 1
CDISCPILOT01,AE,01-704-1009,1009,8/27/2013,10/2/2013,8/27/2013,9/25/2013,,10/2/2013,,,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-7,6,E08,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/2/2013,9/22/2013,9/23/2013,27,28,Phase 1
CDISCPILOT01,AE,01-704-1009,1009,8/27/2013,10/2/2013,8/27/2013,9/25/2013,,10/2/2013,,,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-7,3,E03,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/14/2013,9/14/2013,,19,,Phase 1
CDISCPILOT01,AE,01-704-1010,1010,2/21/2014,7/9/2014,2/21/2014,7/8/2014,,2014-07-09T11:00,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/8/2014,-13,6,E07,ARTHRALGIA,KNEE PAIN,,ARTHRALGIA,,HLT_0375,,HLGT_0610,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/9/2014,7/6/2014,,136,,Phase 2
CDISCPILOT01,AE,01-704-1010,1010,2/21/2014,7/9/2014,2/21/2014,7/8/2014,,2014-07-09T11:00,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/8/2014,-13,7,E08,CONTUSION,BRUISE OF HEAD,,CONTUSION,,HLT_0713,,HLGT_0381,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/9/2014,7/6/2014,,136,,Phase 2
CDISCPILOT01,AE,01-704-1010,1010,2/21/2014,7/9/2014,2/21/2014,7/8/2014,,2014-07-09T11:00,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/8/2014,-13,1,E01,CYSTITIS,BLADDER INFECTION,,CYSTITIS,,HLT_0739,,HLGT_0129,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/8/2014,2/27/2014,3/6/2014,7,14,Phase 1
CDISCPILOT01,AE,01-704-1010,1010,2/21/2014,7/9/2014,2/21/2014,7/8/2014,,2014-07-09T11:00,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/8/2014,-13,3,E04,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/9/2014,7/5/2014,7/6/2014,135,136,Phase 2
CDISCPILOT01,AE,01-704-1010,1010,2/21/2014,7/9/2014,2/21/2014,7/8/2014,,2014-07-09T11:00,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/8/2014,-13,4,E05,EXCORIATION,ABRASION NOS,,EXCORIATION,,HLT_0738,,HLGT_0511,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/9/2014,7/6/2014,,136,,Phase 2
CDISCPILOT01,AE,01-704-1010,1010,2/21/2014,7/9/2014,2/21/2014,7/8/2014,,2014-07-09T11:00,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/8/2014,-13,5,E06,SKIN LACERATION,SKIN TEAR,,SKIN LACERATION,,HLT_0075,,HLGT_0118,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/9/2014,7/6/2014,,136,,Phase 2
CDISCPILOT01,AE,01-704-1010,1010,2/21/2014,7/9/2014,2/21/2014,7/8/2014,,2014-07-09T11:00,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/8/2014,-13,2,E03,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/9/2014,7/5/2014,7/6/2014,135,136,Phase 2
CDISCPILOT01,AE,01-704-1017,1017,10/6/2013,11/24/2013,10/6/2013,11/18/2013,,12/6/2013,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/20/2013,-16,4,E16,CARDIAC DISORDER,CARDIAC DISORDER,,CARDIAC DISORDER,,HLT_0507,,HLGT_0126,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/9/2013,11/1/2013,,27,,Phase 1
CDISCPILOT01,AE,01-704-1017,1017,10/6/2013,11/24/2013,10/6/2013,11/18/2013,,12/6/2013,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/20/2013,-16,3,E13,INFLUENZA,FLU,,INFLUENZA,,HLT_0125,,HLGT_0081,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/9/2013,11/1/2013,11/8/2013,27,34,Phase 1
CDISCPILOT01,AE,01-704-1017,1017,10/6/2013,11/24/2013,10/6/2013,11/18/2013,,12/6/2013,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/20/2013,-16,1,E14,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/19/2013,10/19/2013,,14,,Phase 1
CDISCPILOT01,AE,01-704-1017,1017,10/6/2013,11/24/2013,10/6/2013,11/18/2013,,12/6/2013,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/20/2013,-16,6,E12,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/9/2013,11/5/2013,11/22/2013,31,48,Phase 1
CDISCPILOT01,AE,01-704-1017,1017,10/6/2013,11/24/2013,10/6/2013,11/18/2013,,12/6/2013,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/20/2013,-16,8,E12,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/24/2013,11/5/2013,11/22/2013,31,48,Phase 1
CDISCPILOT01,AE,01-704-1017,1017,10/6/2013,11/24/2013,10/6/2013,11/18/2013,,12/6/2013,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/20/2013,-16,5,E11,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/9/2013,11/5/2013,11/22/2013,31,48,Phase 1
CDISCPILOT01,AE,01-704-1017,1017,10/6/2013,11/24/2013,10/6/2013,11/18/2013,,12/6/2013,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/20/2013,-16,7,E11,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/24/2013,11/5/2013,11/22/2013,31,48,Phase 1
CDISCPILOT01,AE,01-704-1017,1017,10/6/2013,11/24/2013,10/6/2013,11/18/2013,,12/6/2013,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/20/2013,-16,2,E15,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,,VENTRICULAR SEPTAL DEFECT,,HLT_0589,,HLGT_0747,,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/19/2013,10/19/2013,,14,,Phase 1
CDISCPILOT01,AE,01-704-1025,1025,9/27/2013,11/29/2013,9/27/2013,10/24/2013,,2013-11-29T12:00,,,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/18/2013,-9,3,E05,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,,HLT_0610,,HLGT_0220,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/11/2013,10/11/2013,10/25/2013,15,29,Phase 1
CDISCPILOT01,AE,01-704-1025,1025,9/27/2013,11/29/2013,9/27/2013,10/24/2013,,2013-11-29T12:00,,,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/18/2013,-9,5,E05,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,,HLT_0610,,HLGT_0220,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/29/2013,10/11/2013,10/25/2013,15,29,Phase 1
CDISCPILOT01,AE,01-704-1025,1025,9/27/2013,11/29/2013,9/27/2013,10/24/2013,,2013-11-29T12:00,,,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/18/2013,-9,2,E02,PALPITATIONS,PALPITATIONS,,PALPITATIONS,,HLT_0493,,HLGT_0593,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/11/2013,9/28/2013,9/30/2013,2,4,Phase 1
CDISCPILOT01,AE,01-704-1025,1025,9/27/2013,11/29/2013,9/27/2013,10/24/2013,,2013-11-29T12:00,,,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/18/2013,-9,1,E01,VERTIGO,VERTIGO,,VERTIGO,,HLT_0255,,HLGT_0147,,EAR AND LABYRINTH DISORDERS,,EAR AND LABYRINTH DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/11/2013,9/28/2013,9/30/2013,2,4,Phase 1
CDISCPILOT01,AE,01-704-1025,1025,9/27/2013,11/29/2013,9/27/2013,10/24/2013,,2013-11-29T12:00,,,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/18/2013,-9,4,E06,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROM,,WOLFF-PARKINSON-WHITE SYNDROME,,HLT_0612,,HLGT_0218,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/25/2013,10/25/2013,11/29/2013,29,64,Phase 1
CDISCPILOT01,AE,01-704-1025,1025,9/27/2013,11/29/2013,9/27/2013,10/24/2013,,2013-11-29T12:00,,,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/18/2013,-9,6,E06,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROM,,WOLFF-PARKINSON-WHITE SYNDROME,,HLT_0612,,HLGT_0218,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/29/2013,10/25/2013,11/29/2013,29,64,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,1,E13,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,,ABDOMINAL DISCOMFORT,,HLT_0012,,HLGT_0332,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/7/2013,10/26/2013,,3,,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,4,E12,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/25/2013,11/9/2013,,17,,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,3,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/7/2013,10/27/2013,,4,,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,7,E16,CHILLS,CHILLS,,CHILLS,,HLT_0586,,HLGT_0161,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/25/2013,11/17/2013,11/17/2013,25,25,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,9,E18,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/20/2013,12/15/2013,12/15/2013,53,53,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,8,E17,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/25/2013,11/17/2013,11/17/2013,25,25,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,6,E15,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/25/2013,11/9/2013,,17,,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,5,E14,MALAISE,MALAISE,,MALAISE,,HLT_0456,,HLGT_0178,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/25/2013,11/9/2013,,17,,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,2,E07,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/7/2013,10/27/2013,,4,,Phase 1
CDISCPILOT01,AE,01-704-1065,1065,10/24/2013,12/24/2013,10/24/2013,12/22/2013,,2/17/2014,,,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/17/2013,-7,10,E19,SINUS BRADYCARDIA,BRADYCARDIA SINUS,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/24/2013,12/24/2013,,62,,Phase 1
CDISCPILOT01,AE,01-704-1074,1074,1/22/2014,3/31/2014,1/22/2014,3/20/2014,,2014-03-31T10:30,,,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/19/2014,-3,2,E09,ERYTHEMA,SKIN RED,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/9/2014,2/9/2014,,19,,Phase 1
CDISCPILOT01,AE,01-704-1074,1074,1/22/2014,3/31/2014,1/22/2014,3/20/2014,,2014-03-31T10:30,,,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/19/2014,-3,1,E08,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/22/2014,1/22/2014,,1,,Phase 1
CDISCPILOT01,AE,01-704-1093,1093,3/15/2013,6/20/2013,3/15/2013,6/17/2013,,12/25/2013,,,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/22/2013,-21,1,E02,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,,BLOOD GLUCOSE INCREASED,,HLT_0450,,HLGT_0188,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/30/2013,3/30/2013,4/13/2013,16,30,Phase 1
CDISCPILOT01,AE,01-704-1093,1093,3/15/2013,6/20/2013,3/15/2013,6/17/2013,,12/25/2013,,,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/22/2013,-21,2,E02,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,,BLOOD GLUCOSE INCREASED,,HLT_0450,,HLGT_0188,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/17/2013,3/30/2013,4/13/2013,16,30,Phase 1
CDISCPILOT01,AE,01-704-1093,1093,3/15/2013,6/20/2013,3/15/2013,6/17/2013,,12/25/2013,,,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/22/2013,-21,4,E06,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/11/2013,5/4/2013,,51,,Phase 1
CDISCPILOT01,AE,01-704-1093,1093,3/15/2013,6/20/2013,3/15/2013,6/17/2013,,12/25/2013,,,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/22/2013,-21,3,E05,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/11/2013,5/4/2013,,51,,Phase 1
CDISCPILOT01,AE,01-704-1114,1114,1/23/2013,7/8/2013,1/23/2013,7/7/2013,,2013-07-08T09:56,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/9/2013,-14,1,E06,ERYTHEMA,REDNESS,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/13/2013,2/21/2013,2/23/2013,30,32,Phase 1
CDISCPILOT01,AE,01-704-1114,1114,1/23/2013,7/8/2013,1/23/2013,7/7/2013,,2013-07-08T09:56,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/9/2013,-14,5,E07,INFLUENZA,FLU,,INFLUENZA,,HLT_0125,,HLGT_0081,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/16/2013,6/7/2013,6/13/2013,136,142,Phase 2
CDISCPILOT01,AE,01-704-1114,1114,1/23/2013,7/8/2013,1/23/2013,7/7/2013,,2013-07-08T09:56,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/9/2013,-14,2,E03,OEDEMA,EDEMA,,OEDEMA,,HLT_0656,,HLGT_0036,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/13/2013,2/23/2013,,32,,Phase 1
CDISCPILOT01,AE,01-704-1114,1114,1/23/2013,7/8/2013,1/23/2013,7/7/2013,,2013-07-08T09:56,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/9/2013,-14,4,E05,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/26/2013,3/23/2013,,60,,Phase 1
CDISCPILOT01,AE,01-704-1114,1114,1/23/2013,7/8/2013,1/23/2013,7/7/2013,,2013-07-08T09:56,,,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/9/2013,-14,3,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/26/2013,3/23/2013,,60,,Phase 1
CDISCPILOT01,AE,01-704-1120,1120,12/2/2013,2/3/2014,12/2/2013,2/1/2014,,3/10/2014,,,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/18/2013,-14,2,E02,NASOPHARYNGITIS,COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/29/2013,12/28/2013,2/3/2014,27,64,Phase 1
CDISCPILOT01,AE,01-704-1120,1120,12/2/2013,2/3/2014,12/2/2013,2/1/2014,,3/10/2014,,,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/18/2013,-14,6,E02,NASOPHARYNGITIS,COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/10/2014,12/28/2013,2/3/2014,27,64,Phase 1
CDISCPILOT01,AE,01-704-1120,1120,12/2/2013,2/3/2014,12/2/2013,2/1/2014,,3/10/2014,,,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/18/2013,-14,4,E04,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/27/2014,1/27/2014,,57,,Phase 1
CDISCPILOT01,AE,01-704-1120,1120,12/2/2013,2/3/2014,12/2/2013,2/1/2014,,3/10/2014,,,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/18/2013,-14,5,E04,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/3/2014,1/27/2014,,57,,Phase 1
CDISCPILOT01,AE,01-704-1120,1120,12/2/2013,2/3/2014,12/2/2013,2/1/2014,,3/10/2014,,,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/18/2013,-14,1,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/29/2013,12/23/2013,,22,,Phase 1
CDISCPILOT01,AE,01-704-1120,1120,12/2/2013,2/3/2014,12/2/2013,2/1/2014,,3/10/2014,,,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/18/2013,-14,3,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/27/2014,12/23/2013,,22,,Phase 1
CDISCPILOT01,DM,01-704-1127,1127,10/2/2013,3/31/2014,10/2/2013,3/31/2014,,2014-03-31T11:30,,,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/16/2013,-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-704-1135,1135,10/31/2013,5/16/2014,10/31/2013,5/16/2014,,2014-05-16T09:45,,,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/23/2013,-8,1,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/11/2013,12/8/2013,,39,,Phase 1
CDISCPILOT01,AE,01-704-1135,1135,10/31/2013,5/16/2014,10/31/2013,5/16/2014,,2014-05-16T09:45,,,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/23/2013,-8,2,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SEVERE,N,,,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/19/2014,12/8/2013,,39,,Phase 1
CDISCPILOT01,AE,01-704-1164,1164,9/19/2012,4/4/2013,9/19/2012,4/4/2013,,4/4/2013,,,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/11/2012,-8,1,E02,INFLUENZA,FLU,,INFLUENZA,,HLT_0125,,HLGT_0081,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/4/2012,9/27/2012,10/7/2012,9,19,Phase 1
CDISCPILOT01,AE,01-704-1164,1164,9/19/2012,4/4/2013,9/19/2012,4/4/2013,,4/4/2013,,,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/11/2012,-8,2,E02,INFLUENZA,FLU,,INFLUENZA,,HLT_0125,,HLGT_0081,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/21/2012,9/27/2012,10/7/2012,9,19,Phase 1
CDISCPILOT01,AE,01-704-1164,1164,9/19/2012,4/4/2013,9/19/2012,4/4/2013,,4/4/2013,,,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/11/2012,-8,3,E07,OEDEMA PERIPHERAL,SWELLING OF FEET,,OEDEMA PERIPHERAL,,HLT_0661,,HLGT_0137,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/14/2013,2/4/2013,2/13/2013,139,148,Phase 2
CDISCPILOT01,AE,01-704-1218,1218,11/19/2012,5/27/2013,11/19/2012,5/27/2013,,2013-05-27T11:20,,,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/11/2012,-8,1,E05,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,,BLOOD GLUCOSE INCREASED,,HLT_0450,,HLGT_0188,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/30/2012,12/30/2012,,42,,Phase 1
CDISCPILOT01,DM,01-704-1233,1233,3/21/2013,7/14/2013,3/21/2013,4/4/2013,,7/14/2013,,,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/8/2013,-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-704-1241,1241,8/25/2013,10/31/2013,8/25/2013,10/9/2013,,1/22/2014,,,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-11,2,E03,DYSPNOEA,RESPIRATION LABORED,,DYSPNOEA,,HLT_0296,,HLGT_0255,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/9/2013,9/28/2013,,35,,Phase 1
CDISCPILOT01,AE,01-704-1241,1241,8/25/2013,10/31/2013,8/25/2013,10/9/2013,,1/22/2014,,,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/14/2013,-11,1,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/9/2013,8/14/2013,,-11,,Phase 1
CDISCPILOT01,DM,01-704-1260,1260,8/30/2012,1/18/2013,8/30/2012,11/4/2012,,1/18/2013,,,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/23/2012,-7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,4,E13,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,,ATRIAL FIBRILLATION,,HLT_0365,,HLGT_0012,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/8/2013,11/8/2013,12/6/2013,27,55,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,13,E13,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,,ATRIAL FIBRILLATION,,HLT_0365,,HLGT_0012,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/3/2014,11/8/2013,12/6/2013,27,55,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,3,E12,ATRIAL FLUTTER,ATRIAL FLUTTER,,ATRIAL FLUTTER,,HLT_0477,,HLGT_0627,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/27/2013,10/27/2013,11/8/2013,15,27,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,5,E12,ATRIAL FLUTTER,ATRIAL FLUTTER,,ATRIAL FLUTTER,,HLT_0477,,HLGT_0627,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/10/2013,10/27/2013,11/8/2013,15,27,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,7,E16,BLISTER,BLISTERING,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/22/2013,11/15/2013,12/14/2013,34,63,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,14,E16,BLISTER,BLISTERING,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/3/2014,11/15/2013,12/14/2013,34,63,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,2,E10,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/27/2013,10/17/2013,12/23/2013,5,72,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,9,E10,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/6/2013,10/17/2013,12/23/2013,5,72,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,12,E10,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/3/2014,10/17/2013,12/23/2013,5,72,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,11,E18,ERYTHEMA,REDNESS,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/6/2013,12/6/2013,12/23/2013,55,72,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,16,E18,ERYTHEMA,REDNESS,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/3/2014,12/6/2013,12/23/2013,55,72,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,6,E15,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/10/2013,11/9/2013,12/4/2013,28,53,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,10,E15,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/6/2013,11/9/2013,12/4/2013,28,53,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,8,E17,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/22/2013,11/15/2013,12/23/2013,34,72,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,15,E17,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/3/2014,11/15/2013,12/23/2013,34,72,Phase 1
CDISCPILOT01,AE,01-704-1266,1266,10/13/2013,12/6/2013,10/13/2013,12/6/2013,,1/3/2014,,,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/5/2013,-8,1,E11,SEASONAL ALLERGY,HAY FEVER,,SEASONAL ALLERGY,,HLT_0714,,HLGT_0782,,IMMUNE SYSTEM DISORDERS,,IMMUNE SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/11/2013,10/6/2013,,-7,,Phase 1
CDISCPILOT01,AE,01-704-1323,1323,7/8/2013,8/8/2013,7/8/2013,8/5/2013,,10/1/2013,,,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/13/2013,-25,4,E10,OEDEMA,EDEMA,,OEDEMA,,HLT_0656,,HLGT_0036,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/4/2013,8/4/2013,,28,,Phase 1
CDISCPILOT01,AE,01-704-1323,1323,7/8/2013,8/8/2013,7/8/2013,8/5/2013,,10/1/2013,,,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/13/2013,-25,3,E09,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/4/2013,8/4/2013,,28,,Phase 1
CDISCPILOT01,AE,01-704-1323,1323,7/8/2013,8/8/2013,7/8/2013,8/5/2013,,10/1/2013,,,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/13/2013,-25,2,E08,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/4/2013,8/4/2013,,28,,Phase 1
CDISCPILOT01,AE,01-704-1323,1323,7/8/2013,8/8/2013,7/8/2013,8/5/2013,,10/1/2013,,,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/13/2013,-25,1,E07,VIRAL INFECTION,VIRAL INFECTION,,VIRAL INFECTION,,HLT_0733,,HLGT_0408,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/4/2013,7/30/2013,8/3/2013,23,27,Phase 1
CDISCPILOT01,AE,01-704-1325,1325,4/23/2014,8/6/2014,4/23/2014,7/4/2014,,2014-08-06T13:30,,,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2014,-7,2,E05,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/16/2014,7/4/2014,,73,,Phase 1
CDISCPILOT01,AE,01-704-1325,1325,4/23/2014,8/6/2014,4/23/2014,7/4/2014,,2014-08-06T13:30,,,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2014,-7,1,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/4/2014,5/23/2014,,31,,Phase 1
CDISCPILOT01,AE,01-704-1332,1332,12/9/2013,2/16/2014,12/9/2013,2/14/2014,,2/24/2014,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-15,4,E05,BURNING SENSATION,BURNING SENSATION,,BURNING SENSATION,,HLT_0775,,HLGT_0456,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/3/2014,2/3/2014,,57,,Phase 1
CDISCPILOT01,AE,01-704-1332,1332,12/9/2013,2/16/2014,12/9/2013,2/14/2014,,2/24/2014,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-15,2,E02,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/20/2014,1/18/2014,2/24/2014,41,78,Phase 1
CDISCPILOT01,AE,01-704-1332,1332,12/9/2013,2/16/2014,12/9/2013,2/14/2014,,2/24/2014,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-15,6,E02,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/24/2014,1/18/2014,2/24/2014,41,78,Phase 1
CDISCPILOT01,AE,01-704-1332,1332,12/9/2013,2/16/2014,12/9/2013,2/14/2014,,2/24/2014,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-15,1,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/23/2013,12/10/2013,2/24/2014,2,78,Phase 1
CDISCPILOT01,AE,01-704-1332,1332,12/9/2013,2/16/2014,12/9/2013,2/14/2014,,2/24/2014,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-15,3,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/3/2014,12/10/2013,2/24/2014,2,78,Phase 1
CDISCPILOT01,AE,01-704-1332,1332,12/9/2013,2/16/2014,12/9/2013,2/14/2014,,2/24/2014,,,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-15,5,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/24/2014,12/10/2013,2/24/2014,2,78,Phase 1
CDISCPILOT01,AE,01-704-1351,1351,10/12/2013,4/18/2014,10/12/2013,4/18/2014,,2014-04-18T10:30,,,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/26/2013,-16,2,E03,FLATULENCE,GAS,,FLATULENCE,,HLT_0356,,HLGT_0504,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/7/2013,10/27/2013,4/4/2014,16,175,Phase 1
CDISCPILOT01,AE,01-704-1351,1351,10/12/2013,4/18/2014,10/12/2013,4/18/2014,,2014-04-18T10:30,,,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/26/2013,-16,4,E03,FLATULENCE,GAS,,FLATULENCE,,HLT_0356,,HLGT_0504,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/18/2014,10/27/2013,4/4/2014,16,175,Phase 1
CDISCPILOT01,AE,01-704-1351,1351,10/12/2013,4/18/2014,10/12/2013,4/18/2014,,2014-04-18T10:30,,,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/26/2013,-16,1,E02,POLLAKIURIA,URINARY FREQUENCY,,POLLAKIURIA,,HLT_0393,,HLGT_0560,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/7/2013,10/27/2013,4/4/2014,16,175,Phase 1
CDISCPILOT01,AE,01-704-1351,1351,10/12/2013,4/18/2014,10/12/2013,4/18/2014,,2014-04-18T10:30,,,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/26/2013,-16,3,E02,POLLAKIURIA,URINARY FREQUENCY,,POLLAKIURIA,,HLT_0393,,HLGT_0560,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/18/2014,10/27/2013,4/4/2014,16,175,Phase 1
CDISCPILOT01,AE,01-704-1388,1388,12/7/2012,6/19/2013,12/7/2012,6/11/2013,,2013-06-19T12:30,,,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/28/2012,-9,1,E01,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/27/2013,8/23/2012,,-10,,Phase 1
CDISCPILOT01,AE,01-704-1435,1435,11/17/2012,1/12/2013,11/17/2012,1/9/2013,,2013-01-12T12:00,,,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/1/2012,-16,1,E08,PARKINSON'S DISEASE,DISEASE PARKINSON'S,,PARKINSON'S DISEASE,,HLT_0279,,HLGT_0313,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/12/2013,1/6/2013,,51,,Phase 1
CDISCPILOT01,AE,01-704-1445,1445,5/11/2014,11/1/2014,5/11/2014,11/1/2014,,11/1/2014,20,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/1/2014,-10,1,E06,COMPLETED SUICIDE,SUICIDE,,COMPLETED SUICIDE,,HLT_0625,,HLGT_0013,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,SEVERE,N,,NONE,FATAL,N,N,N,Y,N,N,N,11/1/2014,10/31/2014,10/31/2014,174,174,Phase 2
CDISCPILOT01,DM,01-705-1018,1018,7/5/2013,7/12/2013,7/5/2013,,,7/12/2013,,,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/30/2013,-5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-705-1031,1031,11/27/2013,5/11/2014,11/27/2013,12/18/2013,,2014-05-11T09:55,,,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/17/2013,-10,1,E02,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/25/2013,12/25/2013,,29,,Phase 1
CDISCPILOT01,AE,01-705-1059,1059,8/5/2013,12/5/2013,8/5/2013,12/5/2013,,2/6/2014,,,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/2/2013,-3,1,E02,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/7/2013,11/2/2013,,90,,Phase 1
CDISCPILOT01,AE,01-705-1186,1186,1/8/2014,2/7/2014,1/8/2014,1/26/2014,,2014-02-07T15:20,,,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/3/2014,-5,1,E02,HYPERBILIRUBINAEMIA,HYPERBILIRUBINEMIA,,HYPERBILIRUBINAEMIA,,HLT_0478,,HLGT_0087,,HEPATOBILIARY DISORDERS,,HEPATOBILIARY DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/7/2014,1/26/2014,,19,,Phase 1
CDISCPILOT01,AE,01-705-1199,1199,9/16/2013,9/29/2013,9/16/2013,9/28/2013,,2013-09-29T10:30,,,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/11/2013,-5,1,E06,DYSPEPSIA,PYROSIS,,DYSPEPSIA,,HLT_0244,,HLGT_0716,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/29/2013,9/17/2013,9/29/2013,2,14,Phase 1
CDISCPILOT01,AE,01-705-1199,1199,9/16/2013,9/29/2013,9/16/2013,9/28/2013,,2013-09-29T10:30,,,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/11/2013,-5,2,E06,DYSPEPSIA,PYROSIS,,DYSPEPSIA,,HLT_0244,,HLGT_0716,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/29/2013,9/17/2013,9/29/2013,2,14,Phase 1
CDISCPILOT01,AE,01-705-1280,1280,1/17/2014,7/25/2014,1/17/2014,7/25/2014,,7/25/2014,,,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/11/2014,-6,1,E01,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/16/2014,4/20/2014,,94,,Phase 1
CDISCPILOT01,AE,01-705-1281,1281,11/28/2013,3/17/2014,11/28/2013,2/27/2014,,4/20/2014,,,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/26/2013,-2,2,E05,EXCORIATION,ABRASIONS,,EXCORIATION,,HLT_0738,,HLGT_0511,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/18/2014,1/30/2014,,64,,Phase 1
CDISCPILOT01,AE,01-705-1281,1281,11/28/2013,3/17/2014,11/28/2013,2/27/2014,,4/20/2014,,,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/26/2013,-2,1,E04,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/18/2014,1/30/2014,,64,,Phase 1
CDISCPILOT01,AE,01-705-1281,1281,11/28/2013,3/17/2014,11/28/2013,2/27/2014,,4/20/2014,,,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/26/2013,-2,3,E04,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/17/2014,1/30/2014,,64,,Phase 1
CDISCPILOT01,DM,01-705-1282,1282,12/26/2012,6/24/2013,12/26/2012,6/24/2013,,2013-06-24T15:25,,,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/23/2012,-3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-705-1292,1292,10/14/2013,5/14/2014,10/14/2013,5/13/2014,,2014-05-14T13:33,,,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/11/2013,-3,2,E02,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/3/2014,2/13/2014,,123,,Phase 2
CDISCPILOT01,AE,01-705-1292,1292,10/14/2013,5/14/2014,10/14/2013,5/13/2014,,2014-05-14T13:33,,,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/11/2013,-3,1,E01,PRURITUS,ITCHY,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/29/2013,10/28/2013,,15,,Phase 1
CDISCPILOT01,AE,01-705-1303,1303,12/16/2013,6/2/2014,12/16/2013,12/30/2013,,6/2/2014,,,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2013,-6,1,E02,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/10/2014,2/5/2014,3/3/2014,52,78,Phase 1
CDISCPILOT01,AE,01-705-1303,1303,12/16/2013,6/2/2014,12/16/2013,12/30/2013,,6/2/2014,,,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2013,-6,3,E02,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/7/2014,2/5/2014,3/3/2014,52,78,Phase 1
CDISCPILOT01,AE,01-705-1303,1303,12/16/2013,6/2/2014,12/16/2013,12/30/2013,,6/2/2014,,,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2013,-6,2,E03,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/10/2014,2/5/2014,3/3/2014,52,78,Phase 1
CDISCPILOT01,AE,01-705-1303,1303,12/16/2013,6/2/2014,12/16/2013,12/30/2013,,6/2/2014,,,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2013,-6,4,E03,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/7/2014,2/5/2014,3/3/2014,52,78,Phase 1
CDISCPILOT01,AE,01-705-1310,1310,11/2/2013,1/23/2014,11/2/2013,1/23/2014,,2/24/2014,,,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/26/2013,-7,1,E02,RASH PRURITIC,PRURITIC RASH,,RASH PRURITIC,,HLT_0127,,HLGT_0753,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/22/2013,11/14/2013,,13,,Phase 1
CDISCPILOT01,AE,01-705-1310,1310,11/2/2013,1/23/2014,11/2/2013,1/23/2014,,2/24/2014,,,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/26/2013,-7,2,E03,WOUND HAEMORRHAGE,WOUND BLEEDING,,WOUND HAEMORRHAGE,,HLT_0154,,HLGT_0162,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/23/2014,1/9/2014,,69,,Phase 1
CDISCPILOT01,AE,01-705-1349,1349,3/10/2013,9/8/2013,3/10/2013,9/8/2013,,2013-09-08T10:10,,,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/24/2013,-14,4,E06,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,,HLT_0610,,HLGT_0220,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/25/2013,8/25/2013,,169,,Phase 2
CDISCPILOT01,AE,01-705-1349,1349,3/10/2013,9/8/2013,3/10/2013,9/8/2013,,2013-09-08T10:10,,,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/24/2013,-14,1,E03,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/17/2013,4/8/2013,4/8/2013,30,30,Phase 1
CDISCPILOT01,AE,01-705-1349,1349,3/10/2013,9/8/2013,3/10/2013,9/8/2013,,2013-09-08T10:10,,,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/24/2013,-14,3,E05,VENTRICULAR HYPERTROPHY,LEFT VENTRICULAR HYPERTROPHY,,VENTRICULAR HYPERTROPHY,,HLT_0104,,HLGT_0259,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/25/2013,8/25/2013,,169,,Phase 2
CDISCPILOT01,AE,01-705-1349,1349,3/10/2013,9/8/2013,3/10/2013,9/8/2013,,2013-09-08T10:10,,,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/24/2013,-14,2,E04,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/17/2013,4/11/2013,4/11/2013,33,33,Phase 1
CDISCPILOT01,DM,01-705-1377,1377,1/4/2014,3/7/2014,1/4/2014,1/25/2014,,3/7/2014,,,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/29/2013,-6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,DM,01-705-1382,1382,5/13/2013,5/13/2013,5/13/2013,,,5/13/2013,,,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,5/9/2013,-4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-705-1393,1393,9/7/2012,2/20/2013,9/7/2012,2/1/2013,,4/25/2013,,,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/2/2012,-5,1,E01,ABDOMINAL PAIN,ABDOMINAL CRAMPS,,ABDOMINAL PAIN,,HLT_0217,,HLGT_0419,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/27/2012,9/19/2012,9/24/2012,13,18,Phase 1
CDISCPILOT01,AE,01-705-1393,1393,9/7/2012,2/20/2013,9/7/2012,2/1/2013,,4/25/2013,,,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/2/2012,-5,3,E05,COLON CANCER,COLON CANCER,,COLON CANCER,,HLT_0597,,HLGT_0339,,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",,SEVERE,N,,NONE,RECOVERED/RESOLVED,Y,N,N,N,Y,N,N,2/20/2013,1/21/2013,1/24/2013,137,140,Phase 2
CDISCPILOT01,AE,01-705-1393,1393,9/7/2012,2/20/2013,9/7/2012,2/1/2013,,4/25/2013,,,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/2/2012,-5,2,E04,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/5/2012,12/5/2011,2/20/2013,-27,167,Phase 1
CDISCPILOT01,AE,01-705-1393,1393,9/7/2012,2/20/2013,9/7/2012,2/1/2013,,4/25/2013,,,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/2/2012,-5,4,E04,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/25/2013,12/5/2011,2/20/2013,-27,167,Phase 1
CDISCPILOT01,AE,01-705-1431,1431,6/23/2013,12/19/2013,6/23/2013,12/19/2013,,2013-12-19T10:05,,,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/16/2013,-7,2,E04,ANXIETY,FEELING ANXIOUS,,ANXIETY,,HLT_0559,,HLGT_0570,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/7/2013,7/4/2013,7/6/2013,12,14,Phase 1
CDISCPILOT01,AE,01-705-1431,1431,6/23/2013,12/19/2013,6/23/2013,12/19/2013,,2013-12-19T10:05,,,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/16/2013,-7,1,E05,RASH ERYTHEMATOUS,ERYTHEMATOUS RASH,,RASH ERYTHEMATOUS,,HLT_0336,,HLGT_0701,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/23/2013,6/22/2013,,-1,,Phase 1
CDISCPILOT01,AE,01-706-1041,1041,12/31/2013,7/29/2014,12/31/2013,7/28/2014,,2014-07-29T13:45,,,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2013,-10,1,E02,ANXIETY,ANXIETY ATTACK,,ANXIETY,,HLT_0559,,HLGT_0570,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/14/2014,2012-05,,,,Phase 1
CDISCPILOT01,AE,01-706-1041,1041,12/31/2013,7/29/2014,12/31/2013,7/28/2014,,2014-07-29T13:45,,,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2013,-10,7,E02,ANXIETY,ANXIETY ATTACK,,ANXIETY,,HLT_0559,,HLGT_0570,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/6/2014,2012-05,,,,Phase 1
CDISCPILOT01,AE,01-706-1041,1041,12/31/2013,7/29/2014,12/31/2013,7/28/2014,,2014-07-29T13:45,,,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2013,-10,2,E01,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/14/2014,1/7/2014,1/8/2014,8,9,Phase 1
CDISCPILOT01,AE,01-706-1041,1041,12/31/2013,7/29/2014,12/31/2013,7/28/2014,,2014-07-29T13:45,,,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2013,-10,3,E07,EXCORIATION,ABRASIONS,,EXCORIATION,,HLT_0738,,HLGT_0511,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/14/2014,1/14/2014,1/28/2014,15,29,Phase 1
CDISCPILOT01,AE,01-706-1041,1041,12/31/2013,7/29/2014,12/31/2013,7/28/2014,,2014-07-29T13:45,,,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2013,-10,5,E07,EXCORIATION,ABRASIONS,,EXCORIATION,,HLT_0738,,HLGT_0511,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/30/2014,1/14/2014,1/28/2014,15,29,Phase 1
CDISCPILOT01,AE,01-706-1041,1041,12/31/2013,7/29/2014,12/31/2013,7/28/2014,,2014-07-29T13:45,,,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2013,-10,4,E03,IRRITABILITY,IRRITABILITY,,IRRITABILITY,,HLT_0627,,HLGT_0461,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/28/2014,1/15/2014,7/29/2014,16,211,Phase 1
CDISCPILOT01,AE,01-706-1041,1041,12/31/2013,7/29/2014,12/31/2013,7/28/2014,,2014-07-29T13:45,,,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2013,-10,8,E03,IRRITABILITY,IRRITABILITY,,IRRITABILITY,,HLT_0627,,HLGT_0461,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/29/2014,1/15/2014,7/29/2014,16,211,Phase 1
CDISCPILOT01,AE,01-706-1041,1041,12/31/2013,7/29/2014,12/31/2013,7/28/2014,,2014-07-29T13:45,,,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2013,-10,6,E08,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/4/2014,3/4/2014,7/29/2014,64,211,Phase 1
CDISCPILOT01,AE,01-706-1041,1041,12/31/2013,7/29/2014,12/31/2013,7/28/2014,,2014-07-29T13:45,,,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2013,-10,9,E08,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/29/2014,3/4/2014,7/29/2014,64,211,Phase 1
CDISCPILOT01,AE,01-706-1049,1049,5/14/2013,6/25/2013,5/14/2013,6/18/2013,,11/26/2013,,,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/30/2013,-14,1,E01,SYNCOPE,FAINTING,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/11/2013,6/3/2013,6/3/2013,21,21,Phase 1
CDISCPILOT01,AE,01-706-1049,1049,5/14/2013,6/25/2013,5/14/2013,6/18/2013,,11/26/2013,,,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/30/2013,-14,2,E02,SYNCOPE,SYNCOPAL ATTACK,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,6/25/2013,6/18/2013,6/18/2013,36,36,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,1,E03,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2012,9/15/2012,9/29/2012,1,15,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,6,E03,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/22/2013,9/15/2012,9/29/2012,1,15,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,4,E01,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/29/2012,9/23/2012,9/29/2012,9,15,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,9,E01,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/22/2013,9/23/2012,9/29/2012,9,15,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,3,E05,EXCORIATION,ABRASIONS,,EXCORIATION,,HLT_0738,,HLGT_0511,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2012,9/15/2012,9/29/2012,1,15,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,8,E05,EXCORIATION,ABRASIONS,,EXCORIATION,,HLT_0738,,HLGT_0511,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/22/2013,9/15/2012,9/29/2012,1,15,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,2,E04,PRURITUS,PRURITIS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/15/2012,9/15/2012,9/29/2012,1,15,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,7,E04,PRURITUS,PRURITIS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/22/2013,9/15/2012,9/29/2012,1,15,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,5,E06,PRURITUS,PRURITIS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/29/2012,9/23/2012,9/29/2012,9,15,Phase 1
CDISCPILOT01,AE,01-706-1384,1384,9/15/2012,9/29/2012,9/15/2012,9/24/2012,,6/22/2013,,,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2012,-21,10,E06,PRURITUS,PRURITIS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/22/2013,9/23/2012,9/29/2012,9,15,Phase 1
CDISCPILOT01,DM,01-707-1037,1037,12/20/2013,1/8/2014,12/20/2013,12/24/2013,,2014-01-08T12:40,,,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/12/2013,-8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-707-1206,1206,10/28/2013,4/27/2014,10/28/2013,4/26/2014,,2014-04-27T08:00,,,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/20/2013,-8,2,E03,BLOOD CREATINE PHOSPHOKINASE INCREASED,CPK INCREASE,,BLOOD CREATINE PHOSPHOKINASE INCREASED,,HLT_0404,,HLGT_0008,,INVESTIGATIONS,,INVESTIGATIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/27/2013,11/26/2013,12/9/2013,30,43,Phase 1
CDISCPILOT01,AE,01-707-1206,1206,10/28/2013,4/27/2014,10/28/2013,4/26/2014,,2014-04-27T08:00,,,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/20/2013,-8,4,E03,BLOOD CREATINE PHOSPHOKINASE INCREASED,CPK INCREASE,,BLOOD CREATINE PHOSPHOKINASE INCREASED,,HLT_0404,,HLGT_0008,,INVESTIGATIONS,,INVESTIGATIONS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/23/2013,11/26/2013,12/9/2013,30,43,Phase 1
CDISCPILOT01,AE,01-707-1206,1206,10/28/2013,4/27/2014,10/28/2013,4/26/2014,,2014-04-27T08:00,,,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/20/2013,-8,7,E06,CONJUNCTIVITIS,CONJUNCTIVITIS,,CONJUNCTIVITIS,,HLT_0584,,HLGT_0335,,EYE DISORDERS,,EYE DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/16/2014,2/8/2014,2/22/2014,104,118,Phase 2
CDISCPILOT01,AE,01-707-1206,1206,10/28/2013,4/27/2014,10/28/2013,4/26/2014,,2014-04-27T08:00,,,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/20/2013,-8,8,E06,CONJUNCTIVITIS,CONJUNCTIVITIS,,CONJUNCTIVITIS,,HLT_0584,,HLGT_0335,,EYE DISORDERS,,EYE DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/16/2014,2/8/2014,2/22/2014,104,118,Phase 2
CDISCPILOT01,AE,01-707-1206,1206,10/28/2013,4/27/2014,10/28/2013,4/26/2014,,2014-04-27T08:00,,,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/20/2013,-8,3,E05,POSTNASAL DRIP,POSTNASAL DRIP,,POSTNASAL DRIP,,HLT_0172,,HLGT_0032,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/9/2013,12/3/2013,12/10/2013,37,44,Phase 1
CDISCPILOT01,AE,01-707-1206,1206,10/28/2013,4/27/2014,10/28/2013,4/26/2014,,2014-04-27T08:00,,,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/20/2013,-8,5,E05,POSTNASAL DRIP,POSTNASAL DRIP,,POSTNASAL DRIP,,HLT_0172,,HLGT_0032,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/23/2013,12/3/2013,12/10/2013,37,44,Phase 1
CDISCPILOT01,AE,01-707-1206,1206,10/28/2013,4/27/2014,10/28/2013,4/26/2014,,2014-04-27T08:00,,,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/20/2013,-8,1,E04,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,,SINUS ARRHYTHMIA,,HLT_0094,,HLGT_0630,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/25/2013,11/25/2013,12/23/2013,29,57,Phase 1
CDISCPILOT01,AE,01-707-1206,1206,10/28/2013,4/27/2014,10/28/2013,4/26/2014,,2014-04-27T08:00,,,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/20/2013,-8,6,E04,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,,SINUS ARRHYTHMIA,,HLT_0094,,HLGT_0630,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/19/2014,11/25/2013,12/23/2013,29,57,Phase 1
CDISCPILOT01,AE,01-708-1019,1019,12/20/2013,1/23/2014,12/20/2013,1/1/2014,,2014-01-23T10:10,,,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/10/2013,-10,5,E06,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/23/2014,1/1/2014,1/1/2014,13,13,Phase 1
CDISCPILOT01,AE,01-708-1019,1019,12/20/2013,1/23/2014,12/20/2013,1/1/2014,,2014-01-23T10:10,,,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/10/2013,-10,1,E02,HEADACHE,FRONTAL HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/23/2014,12/31/2013,12/31/2013,12,12,Phase 1
CDISCPILOT01,AE,01-708-1019,1019,12/20/2013,1/23/2014,12/20/2013,1/1/2014,,2014-01-23T10:10,,,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/10/2013,-10,2,E03,STUPOR,STUPOR,,STUPOR,,HLT_0595,,HLGT_0513,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/23/2014,1/1/2014,1/1/2014,13,13,Phase 1
CDISCPILOT01,AE,01-708-1019,1019,12/20/2013,1/23/2014,12/20/2013,1/1/2014,,2014-01-23T10:10,,,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/10/2013,-10,3,E04,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,,TRANSIENT ISCHAEMIC ATTACK,,HLT_0041,,HLGT_0433,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/23/2014,1/1/2014,1/1/2014,13,13,Phase 1
CDISCPILOT01,AE,01-708-1019,1019,12/20/2013,1/23/2014,12/20/2013,1/1/2014,,2014-01-23T10:10,,,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/10/2013,-10,4,E05,VISION BLURRED,BLURRED VISION,,VISION BLURRED,,HLT_0120,,HLGT_0598,,EYE DISORDERS,,EYE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/23/2014,1/1/2014,1/1/2014,13,13,Phase 1
CDISCPILOT01,AE,01-708-1032,1032,2/9/2013,3/9/2013,2/9/2013,3/1/2013,,2013-03-09T10:45,,,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/2/2013,-7,1,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/9/2013,2/26/2013,3/9/2013,18,29,Phase 1
CDISCPILOT01,AE,01-708-1084,1084,5/9/2013,11/11/2013,5/9/2013,11/11/2013,,2013-11-11T10:00,,,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/1/2013,-8,1,E02,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/23/2013,5/23/2013,15,15,Phase 1
CDISCPILOT01,AE,01-708-1084,1084,5/9/2013,11/11/2013,5/9/2013,11/11/2013,,2013-11-11T10:00,,,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/1/2013,-8,2,E02,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/9/2013,5/23/2013,5/23/2013,15,15,Phase 1
CDISCPILOT01,AE,01-708-1084,1084,5/9/2013,11/11/2013,5/9/2013,11/11/2013,,2013-11-11T10:00,,,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/1/2013,-8,3,E07,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/9/2013,6/9/2013,6/9/2013,32,32,Phase 1
CDISCPILOT01,AE,01-708-1084,1084,5/9/2013,11/11/2013,5/9/2013,11/11/2013,,2013-11-11T10:00,,,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/1/2013,-8,4,E07,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/11/2013,6/9/2013,6/9/2013,32,32,Phase 1
CDISCPILOT01,AE,01-708-1084,1084,5/9/2013,11/11/2013,5/9/2013,11/11/2013,,2013-11-11T10:00,,,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/1/2013,-8,5,E06,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/23/2013,6/23/2013,6/23/2013,46,46,Phase 1
CDISCPILOT01,AE,01-708-1084,1084,5/9/2013,11/11/2013,5/9/2013,11/11/2013,,2013-11-11T10:00,,,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/1/2013,-8,6,E06,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/7/2013,6/23/2013,6/23/2013,46,46,Phase 1
CDISCPILOT01,AE,01-708-1087,1087,10/22/2012,4/28/2013,10/22/2012,4/28/2013,,2013-04-28T12:40,,,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/6/2012,-16,3,E03,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/16/2013,2/4/2013,2/8/2013,106,110,Phase 2
CDISCPILOT01,AE,01-708-1087,1087,10/22/2012,4/28/2013,10/22/2012,4/28/2013,,2013-04-28T12:40,,,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/6/2012,-16,4,E02,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/16/2013,2/16/2013,,118,,Phase 2
CDISCPILOT01,AE,01-708-1087,1087,10/22/2012,4/28/2013,10/22/2012,4/28/2013,,2013-04-28T12:40,,,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/6/2012,-16,1,E05,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,,HEART RATE IRREGULAR,,HLT_0765,,HLGT_0140,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/19/2013,1/19/2013,1/19/2013,90,90,Phase 1
CDISCPILOT01,AE,01-708-1087,1087,10/22/2012,4/28/2013,10/22/2012,4/28/2013,,2013-04-28T12:40,,,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/6/2012,-16,2,E05,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,,HEART RATE IRREGULAR,,HLT_0765,,HLGT_0140,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/16/2013,1/19/2013,1/19/2013,90,90,Phase 1
CDISCPILOT01,AE,01-708-1087,1087,10/22/2012,4/28/2013,10/22/2012,4/28/2013,,2013-04-28T12:40,,,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/6/2012,-16,5,E06,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,,HEART RATE IRREGULAR,,HLT_0765,,HLGT_0140,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/16/2013,3/16/2013,3/16/2013,146,146,Phase 2
CDISCPILOT01,AE,01-708-1087,1087,10/22/2012,4/28/2013,10/22/2012,4/28/2013,,2013-04-28T12:40,,,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/6/2012,-16,6,E06,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,,HEART RATE IRREGULAR,,HLT_0765,,HLGT_0140,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/10/2013,3/16/2013,3/16/2013,146,146,Phase 2
CDISCPILOT01,AE,01-708-1158,1158,2/8/2014,3/22/2014,2/8/2014,3/21/2014,,2014-03-22T11:15,,,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/1/2014,-7,1,E05,AGITATION,AGITATION,,AGITATION,,HLT_0140,,HLGT_0170,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/26/2014,2/25/2014,,18,,Phase 1
CDISCPILOT01,AE,01-708-1158,1158,2/8/2014,3/22/2014,2/8/2014,3/21/2014,,2014-03-22T11:15,,,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/1/2014,-7,2,E07,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/22/2014,3/22/2014,3/22/2014,43,43,Phase 1
CDISCPILOT01,DM,01-708-1171,1171,12/6/2012,6/4/2013,12/6/2012,6/4/2013,,6/4/2013,,,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/25/2012,-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-708-1178,1178,12/29/2013,4/6/2014,12/29/2013,4/6/2014,,2014-04-06T08:50,,,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2013,-16,9,E13,ALCOHOL USE,ALCOHOL USE,,ALCOHOL USE,,HLT_0138,,HLGT_0182,,SOCIAL CIRCUMSTANCES,,SOCIAL CIRCUMSTANCES,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/6/2014,3/24/2014,3/24/2014,86,86,Phase 1
CDISCPILOT01,AE,01-708-1178,1178,12/29/2013,4/6/2014,12/29/2013,4/6/2014,,2014-04-06T08:50,,,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2013,-16,3,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/9/2014,3/9/2014,4/6/2014,71,99,Phase 1
CDISCPILOT01,AE,01-708-1178,1178,12/29/2013,4/6/2014,12/29/2013,4/6/2014,,2014-04-06T08:50,,,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2013,-16,5,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/6/2014,3/9/2014,4/6/2014,71,99,Phase 1
CDISCPILOT01,AE,01-708-1178,1178,12/29/2013,4/6/2014,12/29/2013,4/6/2014,,2014-04-06T08:50,,,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2013,-16,7,E10,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,,ATRIAL FIBRILLATION,,HLT_0365,,HLGT_0012,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,SEVERE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,4/6/2014,3/24/2014,3/26/2014,86,88,Phase 1
CDISCPILOT01,AE,01-708-1178,1178,12/29/2013,4/6/2014,12/29/2013,4/6/2014,,2014-04-06T08:50,,,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2013,-16,8,E11,CYSTITIS,BLADDER INFECTION,,CYSTITIS,,HLT_0739,,HLGT_0129,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/6/2014,3/24/2014,3/28/2014,86,90,Phase 1
CDISCPILOT01,AE,01-708-1178,1178,12/29/2013,4/6/2014,12/29/2013,4/6/2014,,2014-04-06T08:50,,,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2013,-16,6,E09,DIZZINESS,LIGHT-HEADED,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,4/6/2014,3/24/2014,3/26/2014,86,88,Phase 1
CDISCPILOT01,AE,01-708-1178,1178,12/29/2013,4/6/2014,12/29/2013,4/6/2014,,2014-04-06T08:50,,,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2013,-16,1,E03,FLANK PAIN,FLANK PAIN,,FLANK PAIN,,HLT_0484,,HLGT_0543,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/19/2013,12/19/2013,,-10,,Phase 1
CDISCPILOT01,AE,01-708-1178,1178,12/29/2013,4/6/2014,12/29/2013,4/6/2014,,2014-04-06T08:50,,,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2013,-16,2,E05,NASOPHARYNGITIS,COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/9/2014,3/1/2014,3/8/2014,63,70,Phase 1
CDISCPILOT01,AE,01-708-1178,1178,12/29/2013,4/6/2014,12/29/2013,4/6/2014,,2014-04-06T08:50,,,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2013,-16,4,E08,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,,VENTRICULAR SEPTAL DEFECT,,HLT_0589,,HLGT_0747,,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/9/2014,3/9/2014,,71,,Phase 1
CDISCPILOT01,AE,01-708-1213,1213,2/9/2013,2/26/2013,2/9/2013,2/22/2013,,2/26/2013,,,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2/1/2013,-8,1,E03,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,,ATRIAL FIBRILLATION,,HLT_0365,,HLGT_0012,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/22/2013,2/22/2013,2/22/2013,14,14,Phase 1
CDISCPILOT01,AE,01-708-1213,1213,2/9/2013,2/26/2013,2/9/2013,2/22/2013,,2/26/2013,,,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2/1/2013,-8,2,E03,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,,ATRIAL FIBRILLATION,,HLT_0365,,HLGT_0012,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/26/2013,2/22/2013,2/22/2013,14,14,Phase 1
CDISCPILOT01,AE,01-708-1216,1216,10/24/2012,12/6/2012,10/24/2012,11/29/2012,,1/9/2013,,,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2012,-10,2,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/8/2012,11/6/2012,12/13/2012,14,51,Phase 1
CDISCPILOT01,AE,01-708-1216,1216,10/24/2012,12/6/2012,10/24/2012,11/29/2012,,1/9/2013,,,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2012,-10,4,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/9/2013,11/6/2012,12/13/2012,14,51,Phase 1
CDISCPILOT01,AE,01-708-1216,1216,10/24/2012,12/6/2012,10/24/2012,11/29/2012,,1/9/2013,,,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2012,-10,1,E01,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/8/2012,11/6/2012,,14,,Phase 1
CDISCPILOT01,AE,01-708-1216,1216,10/24/2012,12/6/2012,10/24/2012,11/29/2012,,1/9/2013,,,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2012,-10,3,E02,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,,APPLICATION SITE SWELLING,,HLT_0105,,HLGT_0236,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/22/2012,11/22/2012,,30,,Phase 1
CDISCPILOT01,DM,01-708-1236,1236,9/21/2013,9/26/2013,9/21/2013,9/21/2013,,9/26/2013,,,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,9/8/2013,-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-708-1253,1253,5/7/2013,11/5/2013,5/7/2013,11/5/2013,,11/5/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/26/2013,-11,2,E04,CONJUNCTIVITIS,CONJUNCTIVITIS,,CONJUNCTIVITIS,,HLT_0584,,HLGT_0335,,EYE DISORDERS,,EYE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/7/2013,5/6/2013,5/16/2013,-1,10,Phase 1
CDISCPILOT01,AE,01-708-1253,1253,5/7/2013,11/5/2013,5/7/2013,11/5/2013,,11/5/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/26/2013,-11,5,E04,CONJUNCTIVITIS,CONJUNCTIVITIS,,CONJUNCTIVITIS,,HLT_0584,,HLGT_0335,,EYE DISORDERS,,EYE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/21/2013,5/6/2013,5/16/2013,-1,10,Phase 1
CDISCPILOT01,AE,01-708-1253,1253,5/7/2013,11/5/2013,5/7/2013,11/5/2013,,11/5/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/26/2013,-11,1,E03,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/7/2013,5/6/2013,5/16/2013,-1,10,Phase 1
CDISCPILOT01,AE,01-708-1253,1253,5/7/2013,11/5/2013,5/7/2013,11/5/2013,,11/5/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/26/2013,-11,4,E03,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/21/2013,5/6/2013,5/16/2013,-1,10,Phase 1
CDISCPILOT01,AE,01-708-1253,1253,5/7/2013,11/5/2013,5/7/2013,11/5/2013,,11/5/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/26/2013,-11,7,E05,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/7/2013,6/7/2013,6/7/2013,32,32,Phase 1
CDISCPILOT01,AE,01-708-1253,1253,5/7/2013,11/5/2013,5/7/2013,11/5/2013,,11/5/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/26/2013,-11,8,E05,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/9/2013,6/7/2013,6/7/2013,32,32,Phase 1
CDISCPILOT01,AE,01-708-1253,1253,5/7/2013,11/5/2013,5/7/2013,11/5/2013,,11/5/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/26/2013,-11,3,E02,HEART RATE INCREASED,HEART RATE INCREASED,,HEART RATE INCREASED,,HLT_0646,,HLGT_0673,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/7/2013,5/7/2013,5/10/2013,1,4,Phase 1
CDISCPILOT01,AE,01-708-1253,1253,5/7/2013,11/5/2013,5/7/2013,11/5/2013,,11/5/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/26/2013,-11,6,E02,HEART RATE INCREASED,HEART RATE INCREASED,,HEART RATE INCREASED,,HLT_0646,,HLGT_0673,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/21/2013,5/7/2013,5/10/2013,1,4,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,4,E11,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/7/2013,2/27/2013,2/27/2013,22,22,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,5,E08,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/7/2013,3/1/2013,3/7/2013,24,30,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,8,E08,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/9/2013,3/1/2013,3/7/2013,24,30,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,1,E12,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/21/2013,2/11/2013,2/11/2013,6,6,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,7,E10,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/7/2013,3/7/2013,3/7/2013,30,30,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,10,E10,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/9/2013,3/7/2013,3/7/2013,30,30,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,11,E14,HOT FLUSH,HOT FLASHES,,HOT FLUSH,,HLT_0737,,HLGT_0773,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/20/2013,3/19/2013,3/19/2013,42,42,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,2,E13,MUSCLE SPASMS,LEG CRAMPS,,MUSCLE SPASMS,,HLT_0078,,HLGT_0750,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,SEVERE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/21/2013,2/18/2013,2/18/2013,13,13,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,6,E09,NASOPHARYNGITIS,COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/7/2013,3/1/2013,3/7/2013,24,30,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,9,E09,NASOPHARYNGITIS,COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/9/2013,3/1/2013,3/7/2013,24,30,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,3,E05,VENTRICULAR EXTRASYSTOLES,VENTRICULAR BIGEMINY,,VENTRICULAR EXTRASYSTOLES,,HLT_0050,,HLGT_0594,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/21/2013,2/21/2013,3/20/2013,16,43,Phase 1
CDISCPILOT01,AE,01-708-1272,1272,2/6/2013,4/4/2013,2/6/2013,3/22/2013,,2013-04-04T11:05,,,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/22/2013,-15,12,E05,VENTRICULAR EXTRASYSTOLES,VENTRICULAR BIGEMINY,,VENTRICULAR EXTRASYSTOLES,,HLT_0050,,HLGT_0594,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/4/2013,2/21/2013,3/20/2013,16,43,Phase 1
CDISCPILOT01,AE,01-708-1286,1286,9/10/2013,3/8/2014,9/10/2013,3/8/2014,,2014-03-08T09:50,,,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/25/2013,-16,3,E08,ABDOMINAL PAIN,ABDOMINAL PAIN,,ABDOMINAL PAIN,,HLT_0217,,HLGT_0419,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/23/2014,2/18/2014,2/18/2014,162,162,Phase 2
CDISCPILOT01,AE,01-708-1286,1286,9/10/2013,3/8/2014,9/10/2013,3/8/2014,,2014-03-08T09:50,,,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/25/2013,-16,1,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/23/2013,9/12/2013,,3,,Phase 1
CDISCPILOT01,AE,01-708-1286,1286,9/10/2013,3/8/2014,9/10/2013,3/8/2014,,2014-03-08T09:50,,,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/25/2013,-16,4,E09,CONSTIPATION,CONSTIPATION,,CONSTIPATION,,HLT_0402,,HLGT_0635,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/23/2014,2/18/2014,2/18/2014,162,162,Phase 2
CDISCPILOT01,AE,01-708-1286,1286,9/10/2013,3/8/2014,9/10/2013,3/8/2014,,2014-03-08T09:50,,,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/25/2013,-16,2,E04,MYOCARDIAL INFARCTION,INFERIOR MYOCARDIAL INFARCTIO,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/23/2013,9/23/2013,,14,,Phase 1
CDISCPILOT01,AE,01-708-1296,1296,6/14/2013,12/12/2013,6/14/2013,12/12/2013,,2013-12-12T09:30,,,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/7/2013,-7,3,E04,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/4/2013,9/4/2013,9/18/2013,83,97,Phase 1
CDISCPILOT01,AE,01-708-1296,1296,6/14/2013,12/12/2013,6/14/2013,12/12/2013,,2013-12-12T09:30,,,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/7/2013,-7,4,E04,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/2/2013,9/4/2013,9/18/2013,83,97,Phase 1
CDISCPILOT01,AE,01-708-1296,1296,6/14/2013,12/12/2013,6/14/2013,12/12/2013,,2013-12-12T09:30,,,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/7/2013,-7,5,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/30/2013,10/4/2013,10/30/2013,113,139,Phase 2
CDISCPILOT01,AE,01-708-1296,1296,6/14/2013,12/12/2013,6/14/2013,12/12/2013,,2013-12-12T09:30,,,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/7/2013,-7,6,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/27/2013,10/4/2013,10/30/2013,113,139,Phase 2
CDISCPILOT01,AE,01-708-1296,1296,6/14/2013,12/12/2013,6/14/2013,12/12/2013,,2013-12-12T09:30,,,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/7/2013,-7,1,E03,ATRIAL HYPERTROPHY,LEFT ATRIAL HYPERTROPHY,,ATRIAL HYPERTROPHY,,HLT_0271,,HLGT_0067,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/27/2013,6/27/2013,6/27/2013,14,14,Phase 1
CDISCPILOT01,AE,01-708-1296,1296,6/14/2013,12/12/2013,6/14/2013,12/12/2013,,2013-12-12T09:30,,,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/7/2013,-7,2,E03,ATRIAL HYPERTROPHY,LEFT ATRIAL HYPERTROPHY,,ATRIAL HYPERTROPHY,,HLT_0271,,HLGT_0067,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/10/2013,6/27/2013,6/27/2013,14,14,Phase 1
CDISCPILOT01,AE,01-708-1296,1296,6/14/2013,12/12/2013,6/14/2013,12/12/2013,,2013-12-12T09:30,,,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/7/2013,-7,7,E07,PAIN IN EXTREMITY,PAIN IN THIGH,,PAIN IN EXTREMITY,,HLT_0213,,HLGT_0764,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/12/2013,12/7/2013,12/7/2013,177,177,Phase 2
CDISCPILOT01,AE,01-708-1297,1297,1/25/2013,5/8/2013,1/25/2013,5/3/2013,,6/7/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/15/2013,-10,1,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/16/2013,4/2/2013,,68,,Phase 1
CDISCPILOT01,AE,01-708-1297,1297,1/25/2013,5/8/2013,1/25/2013,5/3/2013,,6/7/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/15/2013,-10,2,E03,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,,APPLICATION SITE SWELLING,,HLT_0105,,HLGT_0236,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/16/2013,4/2/2013,,68,,Phase 1
CDISCPILOT01,AE,01-708-1297,1297,1/25/2013,5/8/2013,1/25/2013,5/3/2013,,6/7/2013,,,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/15/2013,-10,3,E04,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/8/2013,5/8/2013,,104,,Phase 2
CDISCPILOT01,AE,01-708-1316,1316,8/23/2013,3/1/2014,8/23/2013,3/1/2014,,2014-03-01T10:25,,,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/15/2013,-8,2,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/15/2014,2/15/2014,,177,,Phase 2
CDISCPILOT01,AE,01-708-1316,1316,8/23/2013,3/1/2014,8/23/2013,3/1/2014,,2014-03-01T10:25,,,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/15/2013,-8,1,E05,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/15/2014,1/29/2014,,160,,Phase 2
CDISCPILOT01,AE,01-708-1336,1336,12/7/2012,6/5/2013,12/7/2012,6/5/2013,,7/5/2013,,,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/21/2012,-16,5,E11,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/23/2013,4/10/2013,6/5/2013,125,181,Phase 2
CDISCPILOT01,AE,01-708-1336,1336,12/7/2012,6/5/2013,12/7/2012,6/5/2013,,7/5/2013,,,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/21/2012,-16,7,E11,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/5/2013,4/10/2013,6/5/2013,125,181,Phase 2
CDISCPILOT01,AE,01-708-1336,1336,12/7/2012,6/5/2013,12/7/2012,6/5/2013,,7/5/2013,,,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/21/2012,-16,2,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/15/2013,1/12/2013,1/12/2013,37,37,Phase 1
CDISCPILOT01,AE,01-708-1336,1336,12/7/2012,6/5/2013,12/7/2012,6/5/2013,,7/5/2013,,,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/21/2012,-16,4,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/23/2013,4/10/2013,6/5/2013,125,181,Phase 2
CDISCPILOT01,AE,01-708-1336,1336,12/7/2012,6/5/2013,12/7/2012,6/5/2013,,7/5/2013,,,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/21/2012,-16,6,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/5/2013,4/10/2013,6/5/2013,125,181,Phase 2
CDISCPILOT01,AE,01-708-1336,1336,12/7/2012,6/5/2013,12/7/2012,6/5/2013,,7/5/2013,,,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/21/2012,-16,1,E06,DIZZINESS,LIGHTHEADEDNESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/21/2012,12/18/2012,12/18/2012,12,12,Phase 1
CDISCPILOT01,AE,01-708-1336,1336,12/7/2012,6/5/2013,12/7/2012,6/5/2013,,7/5/2013,,,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/21/2012,-16,3,E09,DIZZINESS,LIGHT HEADEDNESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/27/2013,2/2/2013,2/2/2013,58,58,Phase 1
CDISCPILOT01,DM,01-708-1342,1342,12/29/2012,6/28/2013,12/29/2012,6/28/2013,,2013-06-28T09:40,,,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/21/2012,-8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-708-1347,1347,4/20/2013,6/18/2013,4/20/2013,6/18/2013,,8/2/2013,,,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-9,3,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/13/2013,6/13/2013,6/25/2013,55,67,Phase 1
CDISCPILOT01,AE,01-708-1347,1347,4/20/2013,6/18/2013,4/20/2013,6/18/2013,,8/2/2013,,,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-9,7,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/2/2013,6/13/2013,6/25/2013,55,67,Phase 1
CDISCPILOT01,AE,01-708-1347,1347,4/20/2013,6/18/2013,4/20/2013,6/18/2013,,8/2/2013,,,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-9,4,E05,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,,APPLICATION SITE SWELLING,,HLT_0105,,HLGT_0236,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/13/2013,6/13/2013,6/25/2013,55,67,Phase 1
CDISCPILOT01,AE,01-708-1347,1347,4/20/2013,6/18/2013,4/20/2013,6/18/2013,,8/2/2013,,,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-9,8,E05,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,,APPLICATION SITE SWELLING,,HLT_0105,,HLGT_0236,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/2/2013,6/13/2013,6/25/2013,55,67,Phase 1
CDISCPILOT01,AE,01-708-1347,1347,4/20/2013,6/18/2013,4/20/2013,6/18/2013,,8/2/2013,,,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-9,2,E03,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/13/2013,6/13/2013,6/25/2013,55,67,Phase 1
CDISCPILOT01,AE,01-708-1347,1347,4/20/2013,6/18/2013,4/20/2013,6/18/2013,,8/2/2013,,,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-9,6,E03,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/2/2013,6/13/2013,6/25/2013,55,67,Phase 1
CDISCPILOT01,AE,01-708-1347,1347,4/20/2013,6/18/2013,4/20/2013,6/18/2013,,8/2/2013,,,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-9,1,E02,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/13/2013,6/13/2013,6/25/2013,55,67,Phase 1
CDISCPILOT01,AE,01-708-1347,1347,4/20/2013,6/18/2013,4/20/2013,6/18/2013,,8/2/2013,,,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-9,5,E02,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/2/2013,6/13/2013,6/25/2013,55,67,Phase 1
CDISCPILOT01,AE,01-708-1348,1348,8/5/2013,2/13/2014,8/5/2013,2/13/2014,,2014-02-13T10:25,,,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/28/2013,-8,3,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/1/2013,12/1/2013,,119,,Phase 2
CDISCPILOT01,AE,01-708-1348,1348,8/5/2013,2/13/2014,8/5/2013,2/13/2014,,2014-02-13T10:25,,,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/28/2013,-8,1,E04,MYOCARDIAL INFARCTION,ANTEROSEPTAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/19/2013,8/18/2013,8/31/2013,14,27,Phase 1
CDISCPILOT01,AE,01-708-1348,1348,8/5/2013,2/13/2014,8/5/2013,2/13/2014,,2014-02-13T10:25,,,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/28/2013,-8,2,E04,MYOCARDIAL INFARCTION,ANTEROSEPTAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/2/2013,8/18/2013,8/31/2013,14,27,Phase 1
CDISCPILOT01,AE,01-708-1353,1353,7/4/2013,9/10/2013,7/4/2013,8/28/2013,,2013-09-10T13:15,,,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/17/2013,-17,1,E09,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/18/2013,8/18/2013,9/10/2013,46,69,Phase 1
CDISCPILOT01,AE,01-708-1353,1353,7/4/2013,9/10/2013,7/4/2013,8/28/2013,,2013-09-10T13:15,,,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/17/2013,-17,2,E09,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/10/2013,8/18/2013,9/10/2013,46,69,Phase 1
CDISCPILOT01,AE,01-708-1353,1353,7/4/2013,9/10/2013,7/4/2013,8/28/2013,,2013-09-10T13:15,,,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/17/2013,-17,3,E10,HYPOTENSION,LOW BLOOD PRESSURE,,HYPOTENSION,,HLT_0761,,HLGT_0412,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/10/2013,8/28/2013,9/10/2013,56,69,Phase 1
CDISCPILOT01,AE,01-708-1372,1372,4/12/2013,5/10/2013,4/12/2013,4/19/2013,,5/10/2013,,,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,4/3/2013,-9,1,E03,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,,HLT_0415,,HLGT_0086,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/10/2013,4/10/2013,,-2,,Phase 1
CDISCPILOT01,DM,01-708-1378,1378,9/3/2013,1/28/2014,9/3/2013,1/28/2014,,2014-01-28T13:00,,,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/24/2013,-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-708-1406,1406,12/26/2013,7/2/2014,12/26/2013,7/2/2014,,2014-07-02T13:45,,,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/6/2013,-20,1,E03,OEDEMA PERIPHERAL,SWELLING OF LEGS,,OEDEMA PERIPHERAL,,HLT_0661,,HLGT_0137,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/16/2014,6/16/2014,,173,,Phase 2
CDISCPILOT01,AE,01-708-1406,1406,12/26/2013,7/2/2014,12/26/2013,7/2/2014,,2014-07-02T13:45,,,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/6/2013,-20,2,E04,OEDEMA PERIPHERAL,SWELLING OF LEGS,,OEDEMA PERIPHERAL,,HLT_0661,,HLGT_0137,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/16/2014,6/16/2014,,173,,Phase 2
CDISCPILOT01,AE,01-708-1428,1428,11/9/2013,1/31/2014,11/9/2013,12/14/2013,,2014-01-31T11:10,,,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/2/2013,-7,3,E02,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/10/2013,12/10/2013,12/21/2013,32,43,Phase 1
CDISCPILOT01,AE,01-708-1428,1428,11/9/2013,1/31/2014,11/9/2013,12/14/2013,,2014-01-31T11:10,,,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/2/2013,-7,6,E02,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/26/2013,12/10/2013,12/21/2013,32,43,Phase 1
CDISCPILOT01,AE,01-708-1428,1428,11/9/2013,1/31/2014,11/9/2013,12/14/2013,,2014-01-31T11:10,,,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/2/2013,-7,2,E01,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/10/2013,12/10/2013,12/21/2013,32,43,Phase 1
CDISCPILOT01,AE,01-708-1428,1428,11/9/2013,1/31/2014,11/9/2013,12/14/2013,,2014-01-31T11:10,,,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/2/2013,-7,5,E01,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/26/2013,12/10/2013,12/21/2013,32,43,Phase 1
CDISCPILOT01,AE,01-708-1428,1428,11/9/2013,1/31/2014,11/9/2013,12/14/2013,,2014-01-31T11:10,,,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/2/2013,-7,4,E03,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,,APPLICATION SITE WARMTH,,HLT_0260,,HLGT_0301,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/10/2013,12/10/2013,12/21/2013,32,43,Phase 1
CDISCPILOT01,AE,01-708-1428,1428,11/9/2013,1/31/2014,11/9/2013,12/14/2013,,2014-01-31T11:10,,,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/2/2013,-7,7,E03,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,,APPLICATION SITE WARMTH,,HLT_0260,,HLGT_0301,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/26/2013,12/10/2013,12/21/2013,32,43,Phase 1
CDISCPILOT01,AE,01-708-1428,1428,11/9/2013,1/31/2014,11/9/2013,12/14/2013,,2014-01-31T11:10,,,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/2/2013,-7,1,E04,EPISTAXIS,NOSE BLEED,,EPISTAXIS,,HLT_0386,,HLGT_0577,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/23/2013,11/22/2013,11/22/2013,14,14,Phase 1
CDISCPILOT01,DM,01-709-1001,1001,10/8/2013,4/8/2014,10/8/2013,4/8/2014,,4/8/2014,,,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/20/2013,-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-709-1007,1007,7/31/2012,9/1/2012,7/31/2012,8/28/2012,,9/7/2012,,,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/21/2012,-10,1,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/18/2012,8/16/2012,8/19/2012,17,20,Phase 1
CDISCPILOT01,AE,01-709-1007,1007,7/31/2012,9/1/2012,7/31/2012,8/28/2012,,9/7/2012,,,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/21/2012,-10,2,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/1/2012,8/16/2012,8/19/2012,17,20,Phase 1
CDISCPILOT01,AE,01-709-1007,1007,7/31/2012,9/1/2012,7/31/2012,8/28/2012,,9/7/2012,,,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/21/2012,-10,3,E03,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/1/2012,8/21/2012,,22,,Phase 1
CDISCPILOT01,AE,01-709-1007,1007,7/31/2012,9/1/2012,7/31/2012,8/28/2012,,9/7/2012,,,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/21/2012,-10,4,E04,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/1/2012,8/30/2012,8/30/2012,31,31,Phase 1
CDISCPILOT01,AE,01-709-1020,1020,12/1/2012,6/1/2013,12/1/2012,6/1/2013,,2013-06-01T10:40,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/22/2012,-9,3,E03,ABDOMINAL PAIN,ABDOMINAL PAIN,,ABDOMINAL PAIN,,HLT_0217,,HLGT_0419,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/12/2013,1/3/2013,1/11/2013,34,42,Phase 1
CDISCPILOT01,AE,01-709-1020,1020,12/1/2012,6/1/2013,12/1/2012,6/1/2013,,2013-06-01T10:40,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/22/2012,-9,1,E01,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/27/2012,12/27/2012,,27,,Phase 1
CDISCPILOT01,AE,01-709-1020,1020,12/1/2012,6/1/2013,12/1/2012,6/1/2013,,2013-06-01T10:40,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/22/2012,-9,4,E04,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/26/2013,1/15/2013,,46,,Phase 1
CDISCPILOT01,AE,01-709-1020,1020,12/1/2012,6/1/2013,12/1/2012,6/1/2013,,2013-06-01T10:40,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/22/2012,-9,2,E02,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/12/2013,1/3/2013,1/11/2013,34,42,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,2,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/21/2013,1/17/2013,,24,,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,10,E11,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/15/2013,5/12/2013,5/19/2013,139,146,Phase 2
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,13,E11,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/12/2013,5/12/2013,5/19/2013,139,146,Phase 2
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,3,E07,MUSCLE SPASMS,CRAMP,,MUSCLE SPASMS,,HLT_0078,,HLGT_0750,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/6/2013,1/24/2013,2/27/2013,31,65,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,5,E07,MUSCLE SPASMS,CRAMP,,MUSCLE SPASMS,,HLT_0078,,HLGT_0750,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/20/2013,1/24/2013,2/27/2013,31,65,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,1,E09,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/9/2013,1/9/2013,2/19/2013,16,57,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,4,E09,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/20/2013,1/9/2013,2/19/2013,16,57,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,6,E10,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/20/2013,3/20/2013,4/16/2013,86,113,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,8,E10,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/15/2013,3/20/2013,4/16/2013,86,113,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,12,E13,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/15/2013,5/15/2013,,142,,Phase 2
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,11,E12,PHARYNGEAL ERYTHEMA,RED THROAT,,PHARYNGEAL ERYTHEMA,,HLT_0591,,HLGT_0398,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/15/2013,5/12/2013,5/19/2013,139,146,Phase 2
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,14,E12,PHARYNGEAL ERYTHEMA,RED THROAT,,PHARYNGEAL ERYTHEMA,,HLT_0591,,HLGT_0398,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/12/2013,5/12/2013,5/19/2013,139,146,Phase 2
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,16,E14,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/26/2013,6/19/2013,,177,,Phase 2
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,7,E15,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/20/2013,3/20/2013,4/16/2013,86,113,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,9,E15,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/15/2013,3/20/2013,4/16/2013,86,113,Phase 1
CDISCPILOT01,AE,01-709-1029,1029,12/25/2012,6/26/2013,12/25/2012,6/26/2013,,2013-06-26T10:58,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2012,-15,15,E16,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/12/2013,6/12/2013,,170,,Phase 2
CDISCPILOT01,AE,01-709-1081,1081,1/18/2014,5/10/2014,1/18/2014,4/27/2014,,2014-05-10T11:15,,,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/9/2014,-9,2,E06,OEDEMA PERIPHERAL,PERIPHERAL SWELLING,,OEDEMA PERIPHERAL,,HLT_0661,,HLGT_0137,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/10/2014,5/1/2014,,104,,Phase 2
CDISCPILOT01,AE,01-709-1081,1081,1/18/2014,5/10/2014,1/18/2014,4/27/2014,,2014-05-10T11:15,,,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/9/2014,-9,1,E05,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/21/2014,4/7/2014,,80,,Phase 1
CDISCPILOT01,AE,01-709-1088,1088,4/12/2014,10/9/2014,4/12/2014,10/9/2014,,2014-10-09T13:25,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/30/2014,-13,1,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/8/2014,5/8/2014,,27,,Phase 1
CDISCPILOT01,AE,01-709-1088,1088,4/12/2014,10/9/2014,4/12/2014,10/9/2014,,2014-10-09T13:25,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/30/2014,-13,2,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/2/2014,8/2/2014,,113,,Phase 2
CDISCPILOT01,AE,01-709-1099,1099,10/25/2013,4/25/2014,10/25/2013,4/25/2014,,2014-04-25T09:10,,,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2013,-11,8,E06,ACROCHORDON EXCISION,SKIN TAG REMOVAL,,ACROCHORDON EXCISION,,HLT_0629,,HLGT_0103,,SURGICAL AND MEDICAL PROCEDURES,,SURGICAL AND MEDICAL PROCEDURES,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/11/2014,3/23/2014,3/23/2014,150,150,Phase 2
CDISCPILOT01,AE,01-709-1099,1099,10/25/2013,4/25/2014,10/25/2013,4/25/2014,,2014-04-25T09:10,,,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2013,-11,2,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/12/2013,11/12/2013,,19,,Phase 1
CDISCPILOT01,AE,01-709-1099,1099,10/25/2013,4/25/2014,10/25/2013,4/25/2014,,2014-04-25T09:10,,,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2013,-11,6,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/26/2013,11/12/2013,,19,,Phase 1
CDISCPILOT01,AE,01-709-1099,1099,10/25/2013,4/25/2014,10/25/2013,4/25/2014,,2014-04-25T09:10,,,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2013,-11,4,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/12/2013,11/12/2013,,19,,Phase 1
CDISCPILOT01,AE,01-709-1099,1099,10/25/2013,4/25/2014,10/25/2013,4/25/2014,,2014-04-25T09:10,,,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2013,-11,7,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/26/2013,11/12/2013,,19,,Phase 1
CDISCPILOT01,AE,01-709-1099,1099,10/25/2013,4/25/2014,10/25/2013,4/25/2014,,2014-04-25T09:10,,,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2013,-11,3,E04,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/12/2013,11/12/2013,,19,,Phase 1
CDISCPILOT01,AE,01-709-1099,1099,10/25/2013,4/25/2014,10/25/2013,4/25/2014,,2014-04-25T09:10,,,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2013,-11,1,E01,NASOPHARYNGITIS,COLD SYMPTOMS,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/12/2013,11/6/2013,11/17/2013,13,24,Phase 1
CDISCPILOT01,AE,01-709-1099,1099,10/25/2013,4/25/2014,10/25/2013,4/25/2014,,2014-04-25T09:10,,,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/14/2013,-11,5,E01,NASOPHARYNGITIS,COLD SYMPTOMS,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/27/2013,11/6/2013,11/17/2013,13,24,Phase 1
CDISCPILOT01,AE,01-709-1102,1102,1/15/2013,3/31/2013,1/15/2013,3/27/2013,,5/12/2013,,,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/7/2013,-8,1,E01,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/11/2013,2/11/2013,,28,,Phase 1
CDISCPILOT01,AE,01-709-1102,1102,1/15/2013,3/31/2013,1/15/2013,3/27/2013,,5/12/2013,,,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/7/2013,-8,3,E01,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/12/2013,2/11/2013,,28,,Phase 1
CDISCPILOT01,AE,01-709-1102,1102,1/15/2013,3/31/2013,1/15/2013,3/27/2013,,5/12/2013,,,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/7/2013,-8,2,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/11/2013,2/11/2013,,28,,Phase 1
CDISCPILOT01,AE,01-709-1102,1102,1/15/2013,3/31/2013,1/15/2013,3/27/2013,,5/12/2013,,,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/7/2013,-8,4,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/12/2013,2/11/2013,,28,,Phase 1
CDISCPILOT01,AE,01-709-1102,1102,1/15/2013,3/31/2013,1/15/2013,3/27/2013,,5/12/2013,,,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/7/2013,-8,6,E04,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,,APPLICATION SITE VESICLES,,HLT_0180,,HLGT_0576,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/31/2013,3/26/2013,3/27/2013,71,72,Phase 1
CDISCPILOT01,AE,01-709-1102,1102,1/15/2013,3/31/2013,1/15/2013,3/27/2013,,5/12/2013,,,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/7/2013,-8,5,E05,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/31/2013,3/20/2013,3/26/2013,65,71,Phase 1
CDISCPILOT01,AE,01-709-1168,1168,8/2/2013,9/27/2013,8/2/2013,9/26/2013,,11/1/2013,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/25/2013,-8,3,E03,PRURITUS,ITCHY,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/13/2013,9/6/2013,10/11/2013,36,71,Phase 1
CDISCPILOT01,AE,01-709-1168,1168,8/2/2013,9/27/2013,8/2/2013,9/26/2013,,11/1/2013,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/25/2013,-8,5,E03,PRURITUS,ITCHY,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/1/2013,9/6/2013,10/11/2013,36,71,Phase 1
CDISCPILOT01,AE,01-709-1168,1168,8/2/2013,9/27/2013,8/2/2013,9/26/2013,,11/1/2013,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/25/2013,-8,4,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/13/2013,9/6/2013,10/11/2013,36,71,Phase 1
CDISCPILOT01,AE,01-709-1168,1168,8/2/2013,9/27/2013,8/2/2013,9/26/2013,,11/1/2013,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/25/2013,-8,6,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/1/2013,9/6/2013,10/11/2013,36,71,Phase 1
CDISCPILOT01,AE,01-709-1168,1168,8/2/2013,9/27/2013,8/2/2013,9/26/2013,,11/1/2013,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/25/2013,-8,1,E02,SKIN IRRITATION,IRRITATION SKIN,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/17/2013,8/17/2013,9/6/2013,16,36,Phase 1
CDISCPILOT01,AE,01-709-1168,1168,8/2/2013,9/27/2013,8/2/2013,9/26/2013,,11/1/2013,,,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,7/25/2013,-8,2,E02,SKIN IRRITATION,IRRITATION SKIN,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/13/2013,8/17/2013,9/6/2013,16,36,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,3,E05,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/30/2013,3/26/2013,6/18/2013,23,107,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,8,E05,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/29/2013,3/26/2013,6/18/2013,23,107,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,10,E05,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/25/2013,3/26/2013,6/18/2013,23,107,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,2,E06,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/30/2013,3/20/2013,,17,,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,1,E09,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/19/2013,3/6/2013,3/6/2013,3,3,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,4,E07,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/30/2013,3/27/2013,3/27/2013,24,24,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,6,E08,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/1/2013,4/1/2013,4/11/2013,29,39,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,7,E08,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/13/2013,4/1/2013,4/11/2013,29,39,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,5,E13,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,,ELECTROCARDIOGRAM T WAVE INVERSION,,HLT_0289,,HLGT_0130,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/30/2013,3/30/2013,,27,,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,9,E14,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/25/2013,5/17/2013,5/18/2013,75,76,Phase 1
CDISCPILOT01,AE,01-709-1217,1217,3/4/2013,6/25/2013,3/4/2013,6/11/2013,,2013-06-25T10:35,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/16/2013,-16,11,E10,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/25/2013,5/27/2013,6/18/2013,85,107,Phase 1
CDISCPILOT01,AE,01-709-1238,1238,5/15/2013,8/7/2013,5/15/2013,8/6/2013,,8/13/2013,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/2/2013,-13,2,E07,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/19/2013,5/30/2013,,16,,Phase 1
CDISCPILOT01,AE,01-709-1238,1238,5/15/2013,8/7/2013,5/15/2013,8/6/2013,,8/13/2013,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/2/2013,-13,4,E09,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,,APPLICATION SITE DISCHARGE,,HLT_0200,,HLGT_0457,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/19/2013,5/30/2013,,16,,Phase 1
CDISCPILOT01,AE,01-709-1238,1238,5/15/2013,8/7/2013,5/15/2013,8/6/2013,,8/13/2013,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/2/2013,-13,3,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/19/2013,5/30/2013,,16,,Phase 1
CDISCPILOT01,AE,01-709-1238,1238,5/15/2013,8/7/2013,5/15/2013,8/6/2013,,8/13/2013,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/2/2013,-13,6,E04,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/19/2013,6/9/2013,,26,,Phase 1
CDISCPILOT01,AE,01-709-1238,1238,5/15/2013,8/7/2013,5/15/2013,8/6/2013,,8/13/2013,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/2/2013,-13,1,E02,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/29/2013,5/28/2013,5/28/2013,14,14,Phase 1
CDISCPILOT01,AE,01-709-1238,1238,5/15/2013,8/7/2013,5/15/2013,8/6/2013,,8/13/2013,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/2/2013,-13,5,E05,HIP FRACTURE,HIP FRACTURE,,HIP FRACTURE,,HLT_0097,,HLGT_0131,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/19/2013,5/31/2013,5/31/2013,17,17,Phase 1
CDISCPILOT01,AE,01-709-1238,1238,5/15/2013,8/7/2013,5/15/2013,8/6/2013,,8/13/2013,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/2/2013,-13,8,E10,SKIN LESION EXCISION,SKIN LESION EXCISION,,SKIN LESION EXCISION,,HLT_0498,,HLGT_0450,,SURGICAL AND MEDICAL PROCEDURES,,SURGICAL AND MEDICAL PROCEDURES,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/2/2013,6/28/2013,6/28/2013,45,45,Phase 1
CDISCPILOT01,AE,01-709-1238,1238,5/15/2013,8/7/2013,5/15/2013,8/6/2013,,8/13/2013,,,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/2/2013,-13,7,E06,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/19/2013,6/9/2013,,26,,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,5,E08,BENIGN PROSTATIC HYPERPLASIA,ENLARGED PROSTATE,,BENIGN PROSTATIC HYPERPLASIA,,HLT_0215,,HLGT_0568,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,3/23/2013,3/17/2013,3/30/2013,51,64,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,6,E08,BENIGN PROSTATIC HYPERPLASIA,ENLARGED PROSTATE,,BENIGN PROSTATIC HYPERPLASIA,,HLT_0215,,HLGT_0568,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,SEVERE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,4/20/2013,3/17/2013,3/30/2013,51,64,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,3,E06,BLOOD URINE PRESENT,BLOOD IN URINE,,BLOOD URINE PRESENT,,HLT_0458,,HLGT_0289,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/23/2013,3/14/2013,,48,,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,4,E07,CYSTOSCOPY,CYSTOSCOPY,,CYSTOSCOPY,,HLT_0436,,HLGT_0041,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/23/2013,3/17/2013,3/17/2013,51,51,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,8,E12,DEHYDRATION,DEHYDRATION,,DEHYDRATION,,HLT_0533,,HLGT_0011,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/20/2013,4/13/2013,4/14/2013,78,79,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,9,E13,HYPOTENSION,LOW BLOOD PRESSURE,,HYPOTENSION,,HLT_0761,,HLGT_0412,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,4/20/2013,4/13/2013,4/14/2013,78,79,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,1,E05,LOCALISED INFECTION,INFECTED FINGER,,LOCALISED INFECTION,,HLT_0435,,HLGT_0557,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/10/2013,2/5/2013,2/13/2013,11,19,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,2,E05,LOCALISED INFECTION,INFECTED FINGER,,LOCALISED INFECTION,,HLT_0435,,HLGT_0557,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/22/2013,2/5/2013,2/13/2013,11,19,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,10,E14,ORTHOSTATIC HYPOTENSION,POSTURAL HYPOTENSION,,ORTHOSTATIC HYPOTENSION,,HLT_0194,,HLGT_0111,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/20/2013,4/20/2013,6/13/2013,85,139,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,11,E14,ORTHOSTATIC HYPOTENSION,POSTURAL HYPOTENSION,,ORTHOSTATIC HYPOTENSION,,HLT_0194,,HLGT_0111,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/13/2013,4/20/2013,6/13/2013,85,139,Phase 1
CDISCPILOT01,AE,01-709-1259,1259,1/26/2013,6/13/2013,1/26/2013,6/13/2013,,2013-06-13T12:23,,,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2013,-13,7,E11,PYREXIA,FEVER,,PYREXIA,,HLT_0310,,HLGT_0652,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/20/2013,4/13/2013,4/14/2013,78,79,Phase 1
CDISCPILOT01,AE,01-709-1285,1285,3/24/2013,5/31/2013,3/24/2013,5/23/2013,,2013-05-31T13:15,,,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,2,E04,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/19/2013,4/19/2013,5/31/2013,27,69,Phase 1
CDISCPILOT01,AE,01-709-1285,1285,3/24/2013,5/31/2013,3/24/2013,5/23/2013,,2013-05-31T13:15,,,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,5,E04,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/31/2013,4/19/2013,5/31/2013,27,69,Phase 1
CDISCPILOT01,AE,01-709-1285,1285,3/24/2013,5/31/2013,3/24/2013,5/23/2013,,2013-05-31T13:15,,,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,3,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/19/2013,4/19/2013,5/31/2013,27,69,Phase 1
CDISCPILOT01,AE,01-709-1285,1285,3/24/2013,5/31/2013,3/24/2013,5/23/2013,,2013-05-31T13:15,,,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,6,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/31/2013,4/19/2013,5/31/2013,27,69,Phase 1
CDISCPILOT01,AE,01-709-1285,1285,3/24/2013,5/31/2013,3/24/2013,5/23/2013,,2013-05-31T13:15,,,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,1,E03,HEMIANOPIA HOMONYMOUS,HOMONYMOUS HEMIANOPSIA,,HEMIANOPIA HOMONYMOUS,,HLT_0639,,HLGT_0547,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,Y,N,N,N,N,4/19/2013,4/14/2013,,22,,Phase 1
CDISCPILOT01,AE,01-709-1285,1285,3/24/2013,5/31/2013,3/24/2013,5/23/2013,,2013-05-31T13:15,,,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/17/2013,-7,4,E06,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/19/2013,5/19/2013,,57,,Phase 1
CDISCPILOT01,AE,01-709-1301,1301,7/19/2013,1/17/2014,7/19/2013,1/17/2014,,2014-01-17T10:07,,,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/14/2013,-5,1,E02,DIABETES MELLITUS,DIABETES,,DIABETES MELLITUS,,HLT_0447,,HLGT_0572,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/30/2013,8/30/2013,,43,,Phase 1
CDISCPILOT01,AE,01-709-1306,1306,2/3/2014,6/25/2014,2/3/2014,6/16/2014,,2014-06-25T10:45,,,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/19/2014,-15,5,E03,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/28/2014,5/4/2014,6/23/2014,91,141,Phase 1
CDISCPILOT01,AE,01-709-1306,1306,2/3/2014,6/25/2014,2/3/2014,6/16/2014,,2014-06-25T10:45,,,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/19/2014,-15,9,E03,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/25/2014,5/4/2014,6/23/2014,91,141,Phase 1
CDISCPILOT01,AE,01-709-1306,1306,2/3/2014,6/25/2014,2/3/2014,6/16/2014,,2014-06-25T10:45,,,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/19/2014,-15,2,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/30/2014,4/20/2014,6/23/2014,77,141,Phase 1
CDISCPILOT01,AE,01-709-1306,1306,2/3/2014,6/25/2014,2/3/2014,6/16/2014,,2014-06-25T10:45,,,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/19/2014,-15,4,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/28/2014,4/20/2014,6/23/2014,77,141,Phase 1
CDISCPILOT01,AE,01-709-1306,1306,2/3/2014,6/25/2014,2/3/2014,6/16/2014,,2014-06-25T10:45,,,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/19/2014,-15,8,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/25/2014,4/20/2014,6/23/2014,77,141,Phase 1
CDISCPILOT01,AE,01-709-1306,1306,2/3/2014,6/25/2014,2/3/2014,6/16/2014,,2014-06-25T10:45,,,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/19/2014,-15,6,E04,DRUG ERUPTION,DRUG RASH,,DRUG ERUPTION,,HLT_0430,,HLGT_0253,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/28/2014,5/20/2014,5/23/2014,107,110,Phase 2
CDISCPILOT01,AE,01-709-1306,1306,2/3/2014,6/25/2014,2/3/2014,6/16/2014,,2014-06-25T10:45,,,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/19/2014,-15,1,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/30/2014,4/20/2014,6/23/2014,77,141,Phase 1
CDISCPILOT01,AE,01-709-1306,1306,2/3/2014,6/25/2014,2/3/2014,6/16/2014,,2014-06-25T10:45,,,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/19/2014,-15,3,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/28/2014,4/20/2014,6/23/2014,77,141,Phase 1
CDISCPILOT01,AE,01-709-1306,1306,2/3/2014,6/25/2014,2/3/2014,6/16/2014,,2014-06-25T10:45,,,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/19/2014,-15,7,E01,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/25/2014,4/20/2014,6/23/2014,77,141,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,12,E10,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOSIS,,ALLERGIC GRANULOMATOUS ANGIITIS,,HLT_0114,,HLGT_0157,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/16/2013,7/4/2013,7/4/2013,16,16,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,14,E12,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/31/2013,7/28/2013,,40,,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,8,E09,BIOPSY,BIOPSY,,BIOPSY,,HLT_0685,,HLGT_0076,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/1/2013,6/26/2013,6/26/2013,8,8,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,9,E08,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/1/2013,7/1/2013,7/1/2013,13,13,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,11,E08,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/16/2013,7/1/2013,7/1/2013,13,13,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,15,E13,FEELING COLD,FEELING COLD,,FEELING COLD,,HLT_0340,,HLGT_0717,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/11/2013,9/6/2013,,80,,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,5,E06,NASAL CONGESTION,NASAL CONGESTION,,NASAL CONGESTION,,HLT_0118,,HLGT_0549,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/1/2013,6/19/2013,6/20/2013,1,2,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,6,E07,NIGHTMARE,NIGHTMARE,,NIGHTMARE,,HLT_0186,,HLGT_0049,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/1/2013,6/19/2013,6/20/2013,1,2,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,1,E02,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,,RASH MACULO-PAPULAR,,HLT_0500,,HLGT_0097,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/17/2013,6/10/2013,7/1/2013,-9,13,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,10,E02,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,,RASH MACULO-PAPULAR,,HLT_0500,,HLGT_0097,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/16/2013,6/10/2013,7/1/2013,-9,13,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,7,E04,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,,RASH MACULO-PAPULAR,,HLT_0500,,HLGT_0097,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/1/2013,6/20/2013,,2,,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,2,E03,RASH PAPULAR,PAPULAR RASH,,RASH PAPULAR,,HLT_0549,,HLGT_0007,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/19/2013,6/18/2013,7/16/2013,-1,28,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,13,E03,RASH PAPULAR,PAPULAR RASH,,RASH PAPULAR,,HLT_0549,,HLGT_0007,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/18/2013,6/18/2013,7/16/2013,-1,28,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,3,E05,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/19/2013,6/19/2013,6/19/2013,1,1,Phase 1
CDISCPILOT01,AE,01-709-1309,1309,6/19/2013,12/19/2013,6/19/2013,12/19/2013,,2013-12-19T10:35,,,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/9/2013,-10,4,E05,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/1/2013,6/19/2013,6/19/2013,1,1,Phase 1
CDISCPILOT01,AE,01-709-1312,1312,4/20/2014,10/19/2014,4/20/2014,10/19/2014,,2014-10-19T10:00,,,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/13/2014,-7,1,E04,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/17/2014,5/17/2014,,28,,Phase 1
CDISCPILOT01,AE,01-709-1312,1312,4/20/2014,10/19/2014,4/20/2014,10/19/2014,,2014-10-19T10:00,,,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/13/2014,-7,2,E05,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,,HLT_0610,,HLGT_0220,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/19/2014,10/19/2014,,183,,Phase 2
CDISCPILOT01,AE,01-709-1326,1326,4/5/2013,10/2/2013,4/5/2013,10/2/2013,,2013-10-02T09:40,,,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/21/2013,-15,5,E07,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,,APPLICATION SITE BLEEDING,,HLT_0718,,HLGT_0324,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/26/2013,6/7/2013,6/17/2013,64,74,Phase 1
CDISCPILOT01,AE,01-709-1326,1326,4/5/2013,10/2/2013,4/5/2013,10/2/2013,,2013-10-02T09:40,,,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/21/2013,-15,1,E05,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/1/2013,5/1/2013,,27,,Phase 1
CDISCPILOT01,AE,01-709-1326,1326,4/5/2013,10/2/2013,4/5/2013,10/2/2013,,2013-10-02T09:40,,,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/21/2013,-15,2,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/1/2013,5/1/2013,,27,,Phase 1
CDISCPILOT01,AE,01-709-1326,1326,4/5/2013,10/2/2013,4/5/2013,10/2/2013,,2013-10-02T09:40,,,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/21/2013,-15,6,E08,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/26/2013,7/12/2013,,99,,Phase 1
CDISCPILOT01,AE,01-709-1326,1326,4/5/2013,10/2/2013,4/5/2013,10/2/2013,,2013-10-02T09:40,,,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/21/2013,-15,4,E04,SYNCOPE,SYNCOPE,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,6/1/2013,5/21/2013,5/21/2013,47,47,Phase 1
CDISCPILOT01,AE,01-709-1326,1326,4/5/2013,10/2/2013,4/5/2013,10/2/2013,,2013-10-02T09:40,,,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/21/2013,-15,3,E03,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/1/2013,5/21/2013,5/21/2013,47,47,Phase 1
CDISCPILOT01,AE,01-709-1329,1329,8/15/2013,8/29/2013,8/15/2013,8/25/2013,,2013-08-29T10:35,,,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,8/1/2013,-14,1,E02,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/29/2013,8/25/2013,8/25/2013,11,11,Phase 1
CDISCPILOT01,AE,01-709-1329,1329,8/15/2013,8/29/2013,8/15/2013,8/25/2013,,2013-08-29T10:35,,,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,8/1/2013,-14,2,E03,PYREXIA,FEVER,,PYREXIA,,HLT_0310,,HLGT_0652,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/29/2013,8/25/2013,8/25/2013,11,11,Phase 1
CDISCPILOT01,AE,01-709-1339,1339,12/23/2012,6/24/2013,12/23/2012,6/24/2013,,2013-06-24T10:10,,,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/15/2012,-8,2,E05,BLOOD ALKALINE PHOSPHATASE INCREASED,ALK PHOS RAISED,,BLOOD ALKALINE PHOSPHATASE INCREASED,,HLT_0615,,HLGT_0298,,INVESTIGATIONS,,INVESTIGATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/12/2013,5/12/2013,,141,,Phase 2
CDISCPILOT01,AE,01-709-1339,1339,12/23/2012,6/24/2013,12/23/2012,6/24/2013,,2013-06-24T10:10,,,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/15/2012,-8,1,E04,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/19/2013,2011-11,,,,Phase 1
CDISCPILOT01,AE,01-709-1424,1424,3/3/2013,3/8/2013,3/3/2013,3/7/2013,,3/17/2013,,,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2/15/2013,-16,1,E05,SYNCOPE,SYNCOPE,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,Y,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,Y,N,3/8/2013,3/7/2013,3/7/2013,5,5,Phase 1
CDISCPILOT01,AE,01-710-1002,1002,1/14/2014,1/18/2014,1/14/2014,1/18/2014,,1/20/2014,,,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/30/2013,-15,1,E01,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,,TRANSIENT ISCHAEMIC ATTACK,,HLT_0041,,HLGT_0433,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,1/18/2014,1/16/2014,1/20/2014,3,7,Phase 1
CDISCPILOT01,AE,01-710-1002,1002,1/14/2014,1/18/2014,1/14/2014,1/18/2014,,1/20/2014,,,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/30/2013,-15,2,E01,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,,TRANSIENT ISCHAEMIC ATTACK,,HLT_0041,,HLGT_0433,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,1/20/2014,1/16/2014,1/20/2014,3,7,Phase 1
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,12,E11,CONTUSION,BRUISING OF FACE,,CONTUSION,,HLT_0713,,HLGT_0381,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/10/2013,8/8/2013,,180,,Phase 2
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,1,E01,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/22/2013,2/18/2013,2/19/2013,9,10,Phase 1
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,4,E05,DIZZINESS,FELT FAINT,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/4/2013,4/16/2013,4/16/2013,66,66,Phase 1
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,11,E10,FACIAL BONES FRACTURE,FRACTURED NOSE,,FACIAL BONES FRACTURE,,HLT_0305,,HLGT_0585,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/10/2013,8/8/2013,,180,,Phase 2
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,10,E09,FALL,FALL,,FALL,,HLT_0168,,HLGT_0446,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/10/2013,8/8/2013,8/8/2013,180,180,Phase 2
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,6,E06,NEPHROLITHIASIS,KIDNEY STONE,,NEPHROLITHIASIS,,HLT_0439,,HLGT_0546,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/4/2013,4/17/2013,4/17/2013,67,67,Phase 1
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,7,E07,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/1/2013,5/18/2013,,98,,Phase 1
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,2,E02,SALIVARY HYPERSECRETION,SALIVATION,,SALIVARY HYPERSECRETION,,HLT_0374,,HLGT_0488,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/8/2013,3/1/2013,,20,,Phase 1
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,8,E08,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/29/2013,6/29/2013,7/4/2013,140,145,Phase 2
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,9,E08,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/27/2013,6/29/2013,7/4/2013,140,145,Phase 2
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,3,E03,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/8/2013,3/1/2013,,20,,Phase 1
CDISCPILOT01,AE,01-710-1006,1006,2/10/2013,8/10/2013,2/10/2013,8/9/2013,,2013-08-10T10:10,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/27/2013,-14,5,E04,URINARY TRACT INFECTION,URINARY INFECTION,,URINARY TRACT INFECTION,,HLT_0161,,HLGT_0093,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/4/2013,4/17/2013,4/19/2013,67,69,Phase 1
CDISCPILOT01,AE,01-710-1021,1021,9/27/2013,11/12/2013,9/27/2013,10/29/2013,,11/22/2013,,,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/19/2013,-8,1,E01,CHEST PAIN,CHEST PAIN,,CHEST PAIN,,HLT_0717,,HLGT_0195,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/11/2013,10/10/2013,10/10/2013,14,14,Phase 1
CDISCPILOT01,AE,01-710-1021,1021,9/27/2013,11/12/2013,9/27/2013,10/29/2013,,11/22/2013,,,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/19/2013,-8,2,E02,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/27/2013,10/21/2013,10/31/2013,25,35,Phase 1
CDISCPILOT01,AE,01-710-1021,1021,9/27/2013,11/12/2013,9/27/2013,10/29/2013,,11/22/2013,,,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/19/2013,-8,3,E02,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/12/2013,10/21/2013,10/31/2013,25,35,Phase 1
CDISCPILOT01,AE,01-710-1027,1027,2/28/2014,8/29/2014,2/28/2014,8/29/2014,,2014-08-29T11:05,,,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/3/2014,-25,1,E05,HAEMOPTYSIS,COUGHING BLOOD,,HAEMOPTYSIS,,HLT_0192,,HLGT_0680,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2014,5/9/2014,6/1/2014,71,94,Phase 1
CDISCPILOT01,AE,01-710-1027,1027,2/28/2014,8/29/2014,2/28/2014,8/29/2014,,2014-08-29T11:05,,,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/3/2014,-25,3,E05,HAEMOPTYSIS,COUGHING BLOOD,,HAEMOPTYSIS,,HLT_0192,,HLGT_0680,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/20/2014,5/9/2014,6/1/2014,71,94,Phase 1
CDISCPILOT01,AE,01-710-1027,1027,2/28/2014,8/29/2014,2/28/2014,8/29/2014,,2014-08-29T11:05,,,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/3/2014,-25,2,E06,RALES,RALES,,RALES,,HLT_0020,,HLGT_0410,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2014,5/23/2014,6/20/2014,85,113,Phase 1
CDISCPILOT01,AE,01-710-1027,1027,2/28/2014,8/29/2014,2/28/2014,8/29/2014,,2014-08-29T11:05,,,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/3/2014,-25,4,E06,RALES,RALES,,RALES,,HLT_0020,,HLGT_0410,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/17/2014,5/23/2014,6/20/2014,85,113,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,7,E10,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/17/2013,8/3/2013,8/17/2013,62,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,12,E10,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/8/2013,8/3/2013,8/17/2013,62,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,2,E06,NASOPHARYNGITIS,COLD SYMPTOMS,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/5/2013,7/2/2013,7/9/2013,30,37,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,5,E06,NASOPHARYNGITIS,COLD SYMPTOMS,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/15/2013,7/2/2013,7/9/2013,30,37,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,4,E08,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/5/2013,7/2/2013,8/17/2013,30,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,10,E08,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/8/2013,7/2/2013,8/17/2013,30,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,6,E09,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/29/2013,7/22/2013,8/17/2013,50,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,11,E09,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/8/2013,7/22/2013,8/17/2013,50,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,8,E11,SKIN EXFOLIATION,SKIN PEELING,,SKIN EXFOLIATION,,HLT_0236,,HLGT_0726,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/17/2013,8/13/2013,8/17/2013,72,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,13,E11,SKIN EXFOLIATION,SKIN PEELING,,SKIN EXFOLIATION,,HLT_0236,,HLGT_0726,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/8/2013,8/13/2013,8/17/2013,72,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,3,E07,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/5/2013,7/2/2013,8/17/2013,30,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,9,E07,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/8/2013,7/2/2013,8/17/2013,30,76,Phase 1
CDISCPILOT01,AE,01-710-1045,1045,6/3/2013,8/17/2013,6/3/2013,8/13/2013,,9/8/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/20/2013,-14,1,E05,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/1/2013,6/22/2013,6/22/2013,20,20,Phase 1
CDISCPILOT01,AE,01-710-1053,1053,12/26/2012,2/15/2013,12/26/2012,2/10/2013,,2013-02-26T13:25,,,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/15/2012,-11,1,E03,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/6/2013,1/28/2013,2/11/2013,34,48,Phase 1
CDISCPILOT01,AE,01-710-1053,1053,12/26/2012,2/15/2013,12/26/2012,2/10/2013,,2013-02-26T13:25,,,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/15/2012,-11,3,E03,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/15/2013,1/28/2013,2/11/2013,34,48,Phase 1
CDISCPILOT01,AE,01-710-1053,1053,12/26/2012,2/15/2013,12/26/2012,2/10/2013,,2013-02-26T13:25,,,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/15/2012,-11,2,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/6/2013,1/28/2013,2/11/2013,34,48,Phase 1
CDISCPILOT01,AE,01-710-1053,1053,12/26/2012,2/15/2013,12/26/2012,2/10/2013,,2013-02-26T13:25,,,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/15/2012,-11,4,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/15/2013,1/28/2013,2/11/2013,34,48,Phase 1
CDISCPILOT01,AE,01-710-1060,1060,1/1/2013,7/5/2013,1/1/2013,7/5/2013,,2013-07-05T14:40,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/24/2012,-8,4,E07,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,,APPLICATION SITE INDURATION,,HLT_0696,,HLGT_0715,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/1/2013,1/21/2013,1/21/2013,21,21,Phase 1
CDISCPILOT01,AE,01-710-1060,1060,1/1/2013,7/5/2013,1/1/2013,7/5/2013,,2013-07-05T14:40,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/24/2012,-8,5,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/1/2013,1/23/2013,1/23/2013,23,23,Phase 1
CDISCPILOT01,AE,01-710-1060,1060,1/1/2013,7/5/2013,1/1/2013,7/5/2013,,2013-07-05T14:40,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/24/2012,-8,6,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/1/2013,1/31/2013,1/31/2013,31,31,Phase 1
CDISCPILOT01,AE,01-710-1060,1060,1/1/2013,7/5/2013,1/1/2013,7/5/2013,,2013-07-05T14:40,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/24/2012,-8,7,E09,FALL,FALLING DOWN,,FALL,,HLT_0168,,HLGT_0446,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/12/2013,2/8/2013,2/8/2013,39,39,Phase 1
CDISCPILOT01,AE,01-710-1060,1060,1/1/2013,7/5/2013,1/1/2013,7/5/2013,,2013-07-05T14:40,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/24/2012,-8,8,E10,FALL,FALLING DOWN,,FALL,,HLT_0168,,HLGT_0446,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/12/2013,2/9/2013,2/9/2013,40,40,Phase 1
CDISCPILOT01,AE,01-710-1060,1060,1/1/2013,7/5/2013,1/1/2013,7/5/2013,,2013-07-05T14:40,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/24/2012,-8,2,E04,INSOMNIA,DIFFICULTY SLEEPING,,INSOMNIA,,HLT_0297,,HLGT_0469,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/15/2013,1/4/2013,1/15/2013,4,15,Phase 1
CDISCPILOT01,AE,01-710-1060,1060,1/1/2013,7/5/2013,1/1/2013,7/5/2013,,2013-07-05T14:40,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/24/2012,-8,3,E04,INSOMNIA,DIFFICULTY SLEEPING,,INSOMNIA,,HLT_0297,,HLGT_0469,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/1/2013,1/4/2013,1/15/2013,4,15,Phase 1
CDISCPILOT01,AE,01-710-1060,1060,1/1/2013,7/5/2013,1/1/2013,7/5/2013,,2013-07-05T14:40,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/24/2012,-8,1,E05,NASAL CONGESTION,NASAL CONGESTION,,NASAL CONGESTION,,HLT_0118,,HLGT_0549,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/15/2013,1/2/2013,1/2/2013,2,2,Phase 1
CDISCPILOT01,AE,01-710-1070,1070,9/8/2012,2/23/2013,9/8/2012,1/22/2013,,7/4/2013,,,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/28/2012,-11,3,E10,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/28/2012,12/12/2012,,96,,Phase 1
CDISCPILOT01,AE,01-710-1070,1070,9/8/2012,2/23/2013,9/8/2012,1/22/2013,,7/4/2013,,,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/28/2012,-11,6,E13,GASTROINTESTINAL HAEMORRHAGE,GI BLEED,,GASTROINTESTINAL HAEMORRHAGE,,HLT_0354,,HLGT_0020,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,SEVERE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2/23/2013,2/5/2013,2/10/2013,151,156,Phase 2
CDISCPILOT01,AE,01-710-1070,1070,9/8/2012,2/23/2013,9/8/2012,1/22/2013,,7/4/2013,,,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/28/2012,-11,5,E12,HIP FRACTURE,HIP FRACTURE,,HIP FRACTURE,,HLT_0097,,HLGT_0131,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,SEVERE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2/23/2013,1/22/2013,1/25/2013,137,140,Phase 2
CDISCPILOT01,AE,01-710-1070,1070,9/8/2012,2/23/2013,9/8/2012,1/22/2013,,7/4/2013,,,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/28/2012,-11,2,E09,PRURITUS,ITCHY,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/28/2012,12/12/2012,,96,,Phase 1
CDISCPILOT01,AE,01-710-1070,1070,9/8/2012,2/23/2013,9/8/2012,1/22/2013,,7/4/2013,,,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/28/2012,-11,4,E11,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/28/2012,12/12/2012,,96,,Phase 1
CDISCPILOT01,AE,01-710-1070,1070,9/8/2012,2/23/2013,9/8/2012,1/22/2013,,7/4/2013,,,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,8/28/2012,-11,1,E08,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,,SUPRAVENTRICULAR EXTRASYSTOLES,,HLT_0188,,HLGT_0279,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/6/2012,10/6/2012,,29,,Phase 1
CDISCPILOT01,AE,01-710-1077,1077,11/17/2013,5/18/2014,11/17/2013,5/18/2014,,2014-05-18T09:50,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/3/2013,-14,3,E06,AGITATION,AGITATION,,AGITATION,,HLT_0140,,HLGT_0170,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/12/2014,1/12/2014,,57,,Phase 1
CDISCPILOT01,AE,01-710-1077,1077,11/17/2013,5/18/2014,11/17/2013,5/18/2014,,2014-05-18T09:50,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/3/2013,-14,1,E04,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/15/2013,12/12/2013,12/12/2013,26,26,Phase 1
CDISCPILOT01,AE,01-710-1077,1077,11/17/2013,5/18/2014,11/17/2013,5/18/2014,,2014-05-18T09:50,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/3/2013,-14,4,E01,ARTHRITIS,ARTHRITIS,,ARTHRITIS,,HLT_0019,,HLGT_0587,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,SEVERE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/6/2014,1977,,,,Phase 1
CDISCPILOT01,AE,01-710-1077,1077,11/17/2013,5/18/2014,11/17/2013,5/18/2014,,2014-05-18T09:50,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/3/2013,-14,5,E01,ARTHRITIS,ARTHRITIS,,ARTHRITIS,,HLT_0019,,HLGT_0587,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/3/2014,1977,,,,Phase 1
CDISCPILOT01,AE,01-710-1077,1077,11/17/2013,5/18/2014,11/17/2013,5/18/2014,,2014-05-18T09:50,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/3/2013,-14,2,E05,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/30/2013,12/27/2013,,41,,Phase 1
CDISCPILOT01,DM,01-710-1078,1078,9/17/2013,3/23/2014,9/17/2013,3/23/2014,,2014-03-23T16:00,,,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/6/2013,-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-710-1083,1083,7/22/2013,8/3/2013,7/22/2013,8/1/2013,,8/3/2013,20,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/9/2013,-13,1,E04,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCT,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,SEVERE,N,,POSSIBLE,FATAL,N,N,N,Y,Y,Y,N,8/3/2013,8/2/2013,8/2/2013,12,12,Phase 1
CDISCPILOT01,AE,01-710-1137,1137,10/11/2013,11/13/2013,10/11/2013,11/13/2013,,11/25/2013,,,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/3/2013,-8,2,E05,ERYTHEMA,REDNESS,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/25/2013,10/13/2013,,3,,Phase 1
CDISCPILOT01,AE,01-710-1137,1137,10/11/2013,11/13/2013,10/11/2013,11/13/2013,,11/25/2013,,,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/3/2013,-8,4,E07,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/13/2013,11/13/2013,,34,,Phase 1
CDISCPILOT01,AE,01-710-1137,1137,10/11/2013,11/13/2013,10/11/2013,11/13/2013,,11/25/2013,,,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/3/2013,-8,1,E04,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/25/2013,10/13/2013,,3,,Phase 1
CDISCPILOT01,AE,01-710-1137,1137,10/11/2013,11/13/2013,10/11/2013,11/13/2013,,11/25/2013,,,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/3/2013,-8,3,E06,VERTIGO,VERTIGO,,VERTIGO,,HLT_0255,,HLGT_0147,,EAR AND LABYRINTH DISORDERS,,EAR AND LABYRINTH DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/8/2013,11/4/2013,,25,,Phase 1
CDISCPILOT01,AE,01-710-1142,1142,10/2/2012,10/23/2012,10/2/2012,10/20/2012,,10/28/2012,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/12/2012,-20,1,E02,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/16/2012,10/4/2012,10/6/2012,3,5,Phase 1
CDISCPILOT01,AE,01-710-1142,1142,10/2/2012,10/23/2012,10/2/2012,10/20/2012,,10/28/2012,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/12/2012,-20,2,E03,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/16/2012,10/4/2012,10/6/2012,3,5,Phase 1
CDISCPILOT01,AE,01-710-1142,1142,10/2/2012,10/23/2012,10/2/2012,10/20/2012,,10/28/2012,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/12/2012,-20,4,E05,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,10/23/2012,10/19/2012,10/19/2012,18,18,Phase 1
CDISCPILOT01,AE,01-710-1142,1142,10/2/2012,10/23/2012,10/2/2012,10/20/2012,,10/28/2012,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/12/2012,-20,3,E07,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/16/2012,10/14/2012,10/14/2012,13,13,Phase 1
CDISCPILOT01,AE,01-710-1142,1142,10/2/2012,10/23/2012,10/2/2012,10/20/2012,,10/28/2012,,,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,9/12/2012,-20,5,E06,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,,SYNCOPE VASOVAGAL,,HLT_0003,,HLGT_0687,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/23/2012,10/19/2012,10/19/2012,18,18,Phase 1
CDISCPILOT01,AE,01-710-1154,1154,3/29/2014,5/9/2014,3/29/2014,4/27/2014,,6/13/2014,,,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/8/2014,-21,1,E04,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/25/2014,4/18/2014,,21,,Phase 1
CDISCPILOT01,AE,01-710-1154,1154,3/29/2014,5/9/2014,3/29/2014,4/27/2014,,6/13/2014,,,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/8/2014,-21,2,E04,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SEVERE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/9/2014,4/18/2014,,21,,Phase 1
CDISCPILOT01,AE,01-710-1166,1166,11/30/2012,3/30/2013,11/30/2012,3/19/2013,,5/22/2013,,,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/10/2012,-20,4,E09,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,,COMPLEX PARTIAL SEIZURES,,HLT_0558,,HLGT_0656,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,3/30/2013,3/19/2013,3/20/2013,110,111,Phase 2
CDISCPILOT01,AE,01-710-1166,1166,11/30/2012,3/30/2013,11/30/2012,3/19/2013,,5/22/2013,,,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/10/2012,-20,1,E05,FALL,FALL,,FALL,,HLT_0168,,HLGT_0446,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/30/2013,3/19/2013,3/19/2013,110,110,Phase 2
CDISCPILOT01,AE,01-710-1166,1166,11/30/2012,3/30/2013,11/30/2012,3/19/2013,,5/22/2013,,,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/10/2012,-20,2,E06,SKIN LACERATION,LACERATION OF HEAD,,SKIN LACERATION,,HLT_0075,,HLGT_0118,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/30/2013,3/19/2013,3/19/2013,110,110,Phase 2
CDISCPILOT01,AE,01-710-1166,1166,11/30/2012,3/30/2013,11/30/2012,3/19/2013,,5/22/2013,,,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/10/2012,-20,3,E07,SYNCOPE,SYNCOPE,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/30/2013,3/19/2013,3/19/2013,110,110,Phase 2
CDISCPILOT01,AE,01-710-1166,1166,11/30/2012,3/30/2013,11/30/2012,3/19/2013,,5/22/2013,,,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,11/10/2012,-20,5,E08,SYNCOPE,SYNCOPE,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,3/30/2013,3/20/2013,3/20/2013,111,111,Phase 2
CDISCPILOT01,AE,01-710-1183,1183,11/16/2013,5/17/2014,11/16/2013,5/17/2014,,2014-05-17T11:55,,,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/24/2013,-23,2,E08,ATRIOVENTRICULAR BLOCK FIRST DEGREE,FIRST DEGREE ATRIOVENTRICULAR,,ATRIOVENTRICULAR BLOCK FIRST DEGREE,,HLT_0419,,HLGT_0464,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/10/2014,3/10/2014,,115,,Phase 2
CDISCPILOT01,AE,01-710-1183,1183,11/16/2013,5/17/2014,11/16/2013,5/17/2014,,2014-05-17T11:55,,,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/24/2013,-23,1,E07,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/10/2014,3/10/2014,,115,,Phase 2
CDISCPILOT01,AE,01-710-1187,1187,11/10/2012,5/12/2013,11/10/2012,5/12/2013,,2013-05-12T11:05,,,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/26/2012,-15,1,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/23/2012,12/23/2012,,44,,Phase 1
CDISCPILOT01,AE,01-710-1235,1235,9/26/2012,3/27/2013,9/26/2012,3/27/2013,,2013-03-27T09:35,,,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/13/2012,-13,3,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/12/2013,1/29/2013,,126,,Phase 2
CDISCPILOT01,AE,01-710-1235,1235,9/26/2012,3/27/2013,9/26/2012,3/27/2013,,2013-03-27T09:35,,,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/13/2012,-13,1,E01,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/19/2012,11/22/2012,12/14/2012,58,80,Phase 1
CDISCPILOT01,AE,01-710-1235,1235,9/26/2012,3/27/2013,9/26/2012,3/27/2013,,2013-03-27T09:35,,,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/13/2012,-13,2,E02,SHOULDER PAIN,SHOULDER PAIN,,SHOULDER PAIN,,HLT_0527,,HLGT_0288,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/15/2013,1/13/2013,,110,,Phase 2
CDISCPILOT01,AE,01-710-1249,1249,12/28/2013,6/28/2014,12/28/2013,6/28/2014,,2014-06-28T11:05,,,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/19/2013,-9,3,E07,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/22/2014,2/23/2014,,58,,Phase 1
CDISCPILOT01,AE,01-710-1249,1249,12/28/2013,6/28/2014,12/28/2013,6/28/2014,,2014-06-28T11:05,,,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/19/2013,-9,1,E05,PRURITUS,ITCHY,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/22/2014,2/11/2014,2/11/2014,46,46,Phase 1
CDISCPILOT01,AE,01-710-1249,1249,12/28/2013,6/28/2014,12/28/2013,6/28/2014,,2014-06-28T11:05,,,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/19/2013,-9,2,E06,PRURITUS,ITCHY,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/22/2014,2/18/2014,2/18/2014,53,53,Phase 1
CDISCPILOT01,AE,01-710-1249,1249,12/28/2013,6/28/2014,12/28/2013,6/28/2014,,2014-06-28T11:05,,,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/19/2013,-9,4,E08,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/17/2014,4/24/2014,,118,,Phase 2
CDISCPILOT01,AE,01-710-1264,1264,6/13/2013,10/12/2013,6/13/2013,10/11/2013,,11/5/2013,,,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/2/2013,-11,5,E12,CHILLS,CHILLS,,CHILLS,,HLT_0586,,HLGT_0161,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/1/2013,9/29/2013,9/29/2013,109,109,Phase 2
CDISCPILOT01,AE,01-710-1264,1264,6/13/2013,10/12/2013,6/13/2013,10/11/2013,,11/5/2013,,,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/2/2013,-11,7,E09,CHILLS,CHILLS,,CHILLS,,HLT_0586,,HLGT_0161,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/12/2013,10/9/2013,10/9/2013,119,119,Phase 2
CDISCPILOT01,AE,01-710-1264,1264,6/13/2013,10/12/2013,6/13/2013,10/11/2013,,11/5/2013,,,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/2/2013,-11,9,E11,CHILLS,CHILLS,,CHILLS,,HLT_0586,,HLGT_0161,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/12/2013,10/11/2013,10/11/2013,121,121,Phase 2
CDISCPILOT01,AE,01-710-1264,1264,6/13/2013,10/12/2013,6/13/2013,10/11/2013,,11/5/2013,,,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/2/2013,-11,4,E07,COLD SWEAT,COLD SWEAT,,COLD SWEAT,,HLT_0124,,HLGT_0208,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/1/2013,9/29/2013,9/29/2013,109,109,Phase 2
CDISCPILOT01,AE,01-710-1264,1264,6/13/2013,10/12/2013,6/13/2013,10/11/2013,,11/5/2013,,,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/2/2013,-11,6,E08,COLD SWEAT,COLD SWEAT,,COLD SWEAT,,HLT_0124,,HLGT_0208,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/12/2013,10/9/2013,10/9/2013,119,119,Phase 2
CDISCPILOT01,AE,01-710-1264,1264,6/13/2013,10/12/2013,6/13/2013,10/11/2013,,11/5/2013,,,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/2/2013,-11,8,E10,COLD SWEAT,COLD SWEAT,,COLD SWEAT,,HLT_0124,,HLGT_0208,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/12/2013,10/11/2013,10/11/2013,121,121,Phase 2
CDISCPILOT01,AE,01-710-1264,1264,6/13/2013,10/12/2013,6/13/2013,10/11/2013,,11/5/2013,,,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/2/2013,-11,1,E13,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/11/2013,7/3/2013,7/5/2013,21,23,Phase 1
CDISCPILOT01,AE,01-710-1264,1264,6/13/2013,10/12/2013,6/13/2013,10/11/2013,,11/5/2013,,,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/2/2013,-11,2,E05,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/3/2013,8/21/2013,,70,,Phase 1
CDISCPILOT01,AE,01-710-1264,1264,6/13/2013,10/12/2013,6/13/2013,10/11/2013,,11/5/2013,,,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,6/2/2013,-11,3,E06,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/3/2013,8/21/2013,,70,,Phase 1
CDISCPILOT01,AE,01-710-1270,1270,2/12/2014,3/1/2014,2/12/2014,3/1/2014,,3/26/2014,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/1/2014,-11,1,E04,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/1/2014,2/23/2014,,12,,Phase 1
CDISCPILOT01,AE,01-710-1270,1270,2/12/2014,3/1/2014,2/12/2014,3/1/2014,,3/26/2014,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/1/2014,-11,2,E05,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/1/2014,2/23/2014,,12,,Phase 1
CDISCPILOT01,AE,01-710-1271,1271,9/27/2012,12/2/2012,9/27/2012,11/21/2012,,12/9/2012,,,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/4/2012,-23,3,E07,ATRIAL FIBRILLATION,PAROXYSMAL ATRIAL FIBRILLATIO,,ATRIAL FIBRILLATION,,HLT_0365,,HLGT_0012,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,Y,N,12/2/2012,11/21/2012,11/26/2012,56,61,Phase 1
CDISCPILOT01,AE,01-710-1271,1271,9/27/2012,12/2/2012,9/27/2012,11/21/2012,,12/9/2012,,,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/4/2012,-23,4,E06,CARDIAC FAILURE CONGESTIVE,CONGESTIVE HEART FAILURE,,CARDIAC FAILURE CONGESTIVE,,HLT_0511,,HLGT_0413,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,Y,N,12/2/2012,11/22/2012,,57,,Phase 1
CDISCPILOT01,AE,01-710-1271,1271,9/27/2012,12/2/2012,9/27/2012,11/21/2012,,12/9/2012,,,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/4/2012,-23,1,E04,DYSPNOEA,SHORTNESS OF BREATH,,DYSPNOEA,,HLT_0296,,HLGT_0255,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,12/2/2012,11/21/2012,11/21/2012,56,56,Phase 1
CDISCPILOT01,AE,01-710-1271,1271,9/27/2012,12/2/2012,9/27/2012,11/21/2012,,12/9/2012,,,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/4/2012,-23,5,E08,HYPONATRAEMIA,HYPONATREMIA,,HYPONATRAEMIA,,HLT_0688,,HLGT_0102,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,12/2/2012,11/22/2012,11/26/2012,57,61,Phase 1
CDISCPILOT01,AE,01-710-1271,1271,9/27/2012,12/2/2012,9/27/2012,11/21/2012,,12/9/2012,,,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/4/2012,-23,2,E05,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCT,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,SEVERE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,Y,N,12/2/2012,11/21/2012,11/21/2012,56,56,Phase 1
CDISCPILOT01,AE,01-710-1278,1278,12/24/2012,3/3/2013,12/24/2012,2/26/2013,,3/10/2013,,,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-11,3,E03,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/3/2013,2/24/2013,3/3/2013,63,70,Phase 1
CDISCPILOT01,AE,01-710-1278,1278,12/24/2012,3/3/2013,12/24/2012,2/26/2013,,3/10/2013,,,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-11,7,E03,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/10/2013,2/24/2013,3/3/2013,63,70,Phase 1
CDISCPILOT01,AE,01-710-1278,1278,12/24/2012,3/3/2013,12/24/2012,2/26/2013,,3/10/2013,,,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-11,4,E04,BURNING SENSATION,BURNING SENSATION,,BURNING SENSATION,,HLT_0775,,HLGT_0456,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/3/2013,2/24/2013,2/26/2013,63,65,Phase 1
CDISCPILOT01,AE,01-710-1278,1278,12/24/2012,3/3/2013,12/24/2012,2/26/2013,,3/10/2013,,,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-11,2,E02,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/21/2013,2/7/2013,3/3/2013,46,70,Phase 1
CDISCPILOT01,AE,01-710-1278,1278,12/24/2012,3/3/2013,12/24/2012,2/26/2013,,3/10/2013,,,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-11,6,E02,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/10/2013,2/7/2013,3/3/2013,46,70,Phase 1
CDISCPILOT01,AE,01-710-1278,1278,12/24/2012,3/3/2013,12/24/2012,2/26/2013,,3/10/2013,,,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-11,1,E01,SOMNOLENCE,DROWSINESS,,SOMNOLENCE,,HLT_0160,,HLGT_0254,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/24/2013,1/13/2013,1/19/2013,21,27,Phase 1
CDISCPILOT01,AE,01-710-1278,1278,12/24/2012,3/3/2013,12/24/2012,2/26/2013,,3/10/2013,,,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-11,5,E05,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/3/2013,3/2/2013,3/2/2013,69,69,Phase 1
CDISCPILOT01,AE,01-710-1300,1300,12/15/2012,2/19/2013,12/15/2012,2/15/2013,,3/19/2013,,,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/4/2012,-11,4,E05,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/19/2013,2/13/2013,,61,,Phase 1
CDISCPILOT01,AE,01-710-1300,1300,12/15/2012,2/19/2013,12/15/2012,2/15/2013,,3/19/2013,,,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/4/2012,-11,3,E04,BLISTER,BLISTERS,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/11/2013,2/10/2013,,58,,Phase 1
CDISCPILOT01,AE,01-710-1300,1300,12/15/2012,2/19/2013,12/15/2012,2/15/2013,,3/19/2013,,,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/4/2012,-11,2,E03,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/11/2013,2/10/2013,,58,,Phase 1
CDISCPILOT01,AE,01-710-1300,1300,12/15/2012,2/19/2013,12/15/2012,2/15/2013,,3/19/2013,,,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/4/2012,-11,1,E02,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/11/2013,1/31/2013,,48,,Phase 1
CDISCPILOT01,AE,01-710-1314,1314,4/24/2013,5/25/2013,4/24/2013,5/23/2013,,5/25/2013,,,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/21/2013,-3,1,E01,NASOPHARYNGITIS,COMMON COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/20/2013,5/24/2013,27,31,Phase 1
CDISCPILOT01,AE,01-710-1314,1314,4/24/2013,5/25/2013,4/24/2013,5/23/2013,,5/25/2013,,,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/21/2013,-3,2,E01,NASOPHARYNGITIS,COMMON COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/25/2013,5/20/2013,5/24/2013,27,31,Phase 1
CDISCPILOT01,AE,01-710-1315,1315,2/27/2013,7/16/2013,2/27/2013,7/6/2013,,9/2/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-15,4,E05,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/18/2013,6/18/2013,7/7/2013,112,131,Phase 2
CDISCPILOT01,AE,01-710-1315,1315,2/27/2013,7/16/2013,2/27/2013,7/6/2013,,9/2/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-15,7,E05,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/16/2013,6/18/2013,7/7/2013,112,131,Phase 2
CDISCPILOT01,AE,01-710-1315,1315,2/27/2013,7/16/2013,2/27/2013,7/6/2013,,9/2/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-15,1,E02,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/27/2013,2/26/2013,2/26/2013,-1,-1,Phase 1
CDISCPILOT01,AE,01-710-1315,1315,2/27/2013,7/16/2013,2/27/2013,7/6/2013,,9/2/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-15,2,E03,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/21/2013,5/14/2013,7/7/2013,77,131,Phase 1
CDISCPILOT01,AE,01-710-1315,1315,2/27/2013,7/16/2013,2/27/2013,7/6/2013,,9/2/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-15,5,E03,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/16/2013,5/14/2013,7/7/2013,77,131,Phase 1
CDISCPILOT01,AE,01-710-1315,1315,2/27/2013,7/16/2013,2/27/2013,7/6/2013,,9/2/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-15,3,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/18/2013,6/18/2013,7/7/2013,112,131,Phase 2
CDISCPILOT01,AE,01-710-1315,1315,2/27/2013,7/16/2013,2/27/2013,7/6/2013,,9/2/2013,,,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-15,6,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/16/2013,6/18/2013,7/7/2013,112,131,Phase 2
CDISCPILOT01,AE,01-710-1354,1354,11/11/2012,5/1/2013,11/11/2012,5/1/2013,,2013-05-01T14:05,,,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/29/2012,-13,1,E09,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/6/2013,12/30/2012,,50,,Phase 1
CDISCPILOT01,AE,01-710-1354,1354,11/11/2012,5/1/2013,11/11/2012,5/1/2013,,2013-05-01T14:05,,,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/29/2012,-13,2,E10,PRURITUS,PRURITUS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/2/2013,2/14/2013,,96,,Phase 1
CDISCPILOT01,AE,01-710-1358,1358,9/17/2012,3/12/2013,9/17/2012,2/9/2013,,3/12/2013,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/2/2012,-15,3,E06,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,,APPLICATION SITE DESQUAMATION,,HLT_0351,,HLGT_0193,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/6/2013,1/24/2013,,130,,Phase 2
CDISCPILOT01,AE,01-710-1358,1358,9/17/2012,3/12/2013,9/17/2012,2/9/2013,,3/12/2013,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/2/2012,-15,2,E05,PRURITUS,ITCHY,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/9/2013,12/22/2012,,97,,Phase 1
CDISCPILOT01,AE,01-710-1358,1358,9/17/2012,3/12/2013,9/17/2012,2/9/2013,,3/12/2013,,,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/2/2012,-15,1,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/9/2013,12/22/2012,,97,,Phase 1
CDISCPILOT01,AE,01-710-1368,1368,10/23/2013,4/24/2014,10/23/2013,4/24/2014,,2014-04-24T10:10,,,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/21/2013,-2,2,E06,DELUSION,DELUSIONS,,DELUSION,,HLT_0198,,HLGT_0565,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/9/2014,3/26/2014,,155,,Phase 2
CDISCPILOT01,AE,01-710-1368,1368,10/23/2013,4/24/2014,10/23/2013,4/24/2014,,2014-04-24T10:10,,,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/21/2013,-2,1,E05,HIP FRACTURE,FRACTURED HIP,,HIP FRACTURE,,HLT_0097,,HLGT_0131,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,SEVERE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,1/15/2014,12/25/2013,4/24/2014,64,184,Phase 1
CDISCPILOT01,AE,01-710-1368,1368,10/23/2013,4/24/2014,10/23/2013,4/24/2014,,2014-04-24T10:10,,,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/21/2013,-2,4,E05,HIP FRACTURE,FRACTURED HIP,,HIP FRACTURE,,HLT_0097,,HLGT_0131,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,SEVERE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,4/24/2014,12/25/2013,4/24/2014,64,184,Phase 1
CDISCPILOT01,AE,01-710-1368,1368,10/23/2013,4/24/2014,10/23/2013,4/24/2014,,2014-04-24T10:10,,,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,10/21/2013,-2,3,E08,PSYCHOMOTOR HYPERACTIVITY,INCREASED ACTIVITY,,PSYCHOMOTOR HYPERACTIVITY,,HLT_0383,,HLGT_0277,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/9/2014,3/26/2014,,155,,Phase 2
CDISCPILOT01,AE,01-710-1385,1385,10/29/2012,2/18/2013,10/29/2012,2/18/2013,,2/24/2013,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/21/2012,-8,7,E12,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,,ATRIAL FIBRILLATION,,HLT_0365,,HLGT_0012,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/18/2013,2/18/2013,,113,,Phase 2
CDISCPILOT01,AE,01-710-1385,1385,10/29/2012,2/18/2013,10/29/2012,2/18/2013,,2/24/2013,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/21/2012,-8,3,E08,ATRIOVENTRICULAR BLOCK FIRST DEGREE,FIRST DEGREE ATRIOVENTRICULAR,,ATRIOVENTRICULAR BLOCK FIRST DEGREE,,HLT_0419,,HLGT_0464,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/26/2012,11/26/2012,,29,,Phase 1
CDISCPILOT01,AE,01-710-1385,1385,10/29/2012,2/18/2013,10/29/2012,2/18/2013,,2/24/2013,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/21/2012,-8,6,E11,BLISTER,BLISTERS,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/21/2013,12/27/2012,,60,,Phase 1
CDISCPILOT01,AE,01-710-1385,1385,10/29/2012,2/18/2013,10/29/2012,2/18/2013,,2/24/2013,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/21/2012,-8,8,E13,ELECTROCARDIOGRAM T WAVE AMPLITUDE DEC,T WAVE FLATTENING OF,,ELECTROCARDIOGRAM T WAVE AMPLITUDE DEC,,HLT_0037,,HLGT_0030,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/18/2013,2/18/2013,,113,,Phase 2
CDISCPILOT01,AE,01-710-1385,1385,10/29/2012,2/18/2013,10/29/2012,2/18/2013,,2/24/2013,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/21/2012,-8,4,E09,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/25/2012,12/18/2012,,51,,Phase 1
CDISCPILOT01,AE,01-710-1385,1385,10/29/2012,2/18/2013,10/29/2012,2/18/2013,,2/24/2013,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/21/2012,-8,5,E10,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/21/2013,12/27/2012,,60,,Phase 1
CDISCPILOT01,AE,01-710-1385,1385,10/29/2012,2/18/2013,10/29/2012,2/18/2013,,2/24/2013,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/21/2012,-8,1,E06,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,,SUPRAVENTRICULAR TACHYCARDIA,,HLT_0692,,HLGT_0619,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/12/2012,11/12/2012,11/13/2012,15,16,Phase 1
CDISCPILOT01,AE,01-710-1385,1385,10/29/2012,2/18/2013,10/29/2012,2/18/2013,,2/24/2013,,,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,10/21/2012,-8,2,E06,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,,SUPRAVENTRICULAR TACHYCARDIA,,HLT_0692,,HLGT_0619,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/26/2012,11/12/2012,11/13/2012,15,16,Phase 1
CDISCPILOT01,AE,01-710-1408,1408,1/5/2013,7/12/2013,1/5/2013,7/12/2013,,2013-07-12T14:35,,,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/26/2012,-10,3,E07,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/7/2013,2/24/2013,5/31/2013,51,147,Phase 1
CDISCPILOT01,AE,01-710-1408,1408,1/5/2013,7/12/2013,1/5/2013,7/12/2013,,2013-07-12T14:35,,,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/26/2012,-10,4,E07,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/28/2013,2/24/2013,5/31/2013,51,147,Phase 1
CDISCPILOT01,AE,01-710-1408,1408,1/5/2013,7/12/2013,1/5/2013,7/12/2013,,2013-07-12T14:35,,,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/26/2012,-10,1,E06,NASOPHARYNGITIS,COLD SYMPTOMS,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/7/2013,1/31/2013,2/9/2013,27,36,Phase 1
CDISCPILOT01,AE,01-710-1408,1408,1/5/2013,7/12/2013,1/5/2013,7/12/2013,,2013-07-12T14:35,,,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/26/2012,-10,2,E06,NASOPHARYNGITIS,COLD SYMPTOMS,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/20/2013,1/31/2013,2/9/2013,27,36,Phase 1
CDISCPILOT01,AE,01-711-1012,1012,4/3/2013,5/2/2013,4/3/2013,4/29/2013,,9/18/2013,,,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,3/20/2013,-14,1,E06,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/17/2013,4/16/2013,,14,,Phase 1
CDISCPILOT01,AE,01-711-1012,1012,4/3/2013,5/2/2013,4/3/2013,4/29/2013,,9/18/2013,,,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,3/20/2013,-14,3,E06,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/2/2013,4/16/2013,,14,,Phase 1
CDISCPILOT01,AE,01-711-1012,1012,4/3/2013,5/2/2013,4/3/2013,4/29/2013,,9/18/2013,,,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,3/20/2013,-14,2,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/17/2013,4/16/2013,5/2/2013,14,30,Phase 1
CDISCPILOT01,AE,01-711-1012,1012,4/3/2013,5/2/2013,4/3/2013,4/29/2013,,9/18/2013,,,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,3/20/2013,-14,4,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/2/2013,4/16/2013,5/2/2013,14,30,Phase 1
CDISCPILOT01,AE,01-711-1012,1012,4/3/2013,5/2/2013,4/3/2013,4/29/2013,,9/18/2013,,,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,3/20/2013,-14,7,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/17/2013,4/16/2013,5/2/2013,14,30,Phase 1
CDISCPILOT01,AE,01-711-1012,1012,4/3/2013,5/2/2013,4/3/2013,4/29/2013,,9/18/2013,,,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,3/20/2013,-14,6,E08,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,,APPLICATION SITE URTICARIA,,HLT_0196,,HLGT_0233,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/2/2013,4/29/2013,5/1/2013,27,29,Phase 1
CDISCPILOT01,AE,01-711-1012,1012,4/3/2013,5/2/2013,4/3/2013,4/29/2013,,9/18/2013,,,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,3/20/2013,-14,5,E07,NASOPHARYNGITIS,COLD SYMPTOMS,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/2/2013,4/27/2013,,25,,Phase 1
CDISCPILOT01,AE,01-711-1036,1036,7/29/2012,2/10/2013,7/29/2012,2/10/2013,,2013-02-10T10:25,,,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/20/2012,-9,2,E04,EAR INFECTION,EAR INFECTION,,EAR INFECTION,,HLT_0757,,HLGT_0760,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/12/2012,8/4/2012,8/12/2012,7,15,Phase 1
CDISCPILOT01,AE,01-711-1036,1036,7/29/2012,2/10/2013,7/29/2012,2/10/2013,,2013-02-10T10:25,,,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/20/2012,-9,4,E04,EAR INFECTION,EAR INFECTION,,EAR INFECTION,,HLT_0757,,HLGT_0760,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/29/2012,8/4/2012,8/12/2012,7,15,Phase 1
CDISCPILOT01,AE,01-711-1036,1036,7/29/2012,2/10/2013,7/29/2012,2/10/2013,,2013-02-10T10:25,,,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/20/2012,-9,3,E05,GLOSSITIS,GLOSSITIS,,GLOSSITIS,,HLT_0250,,HLGT_0427,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/12/2012,8/12/2012,,15,,Phase 1
CDISCPILOT01,AE,01-711-1036,1036,7/29/2012,2/10/2013,7/29/2012,2/10/2013,,2013-02-10T10:25,,,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/20/2012,-9,1,E03,HEADACHE,INTERMITTENT HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/29/2012,7/29/2012,,1,,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,8,E19,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/28/2013,5/18/2013,,46,,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,13,E22,CERUMEN IMPACTION,CERUMEN IMPACTION,,CERUMEN IMPACTION,,HLT_0018,,HLGT_0158,,EAR AND LABYRINTH DISORDERS,,EAR AND LABYRINTH DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/1/2013,6/1/2013,,60,,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,12,E23,CONJUNCTIVAL HAEMORRHAGE,SUBCONJUNCTIVAL HEMORRHAGE,,CONJUNCTIVAL HAEMORRHAGE,,HLT_0013,,HLGT_0720,,EYE DISORDERS,,EYE DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/1/2013,5/30/2013,,58,,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,3,E18,NASOPHARYNGITIS,COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,SEVERE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/29/2013,4/28/2013,5/11/2013,26,39,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,5,E18,NASOPHARYNGITIS,COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/1/2013,4/28/2013,5/11/2013,26,39,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,6,E18,NASOPHARYNGITIS,COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/15/2013,4/28/2013,5/11/2013,26,39,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,2,E16,PARAESTHESIA ORAL,TINGLING MOUTH,,PARAESTHESIA ORAL,,HLT_0727,,HLGT_0035,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/17/2013,4/11/2013,,9,,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,9,E20,RASH PRURITIC,ITCHY RASH,,RASH PRURITIC,,HLT_0127,,HLGT_0753,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/28/2013,5/27/2013,5/31/2013,55,59,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,11,E20,RASH PRURITIC,ITCHY RASH,,RASH PRURITIC,,HLT_0127,,HLGT_0753,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/1/2013,5/27/2013,5/31/2013,55,59,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,4,E24,SUPRAVENTRICULAR EXTRASYSTOLES,ECTOPIC ATRIAL BEATS,,SUPRAVENTRICULAR EXTRASYSTOLES,,HLT_0188,,HLGT_0279,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/29/2013,4/29/2013,5/15/2013,27,43,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,7,E24,SUPRAVENTRICULAR EXTRASYSTOLES,ECTOPIC ATRIAL BEATS,,SUPRAVENTRICULAR EXTRASYSTOLES,,HLT_0188,,HLGT_0279,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/28/2013,4/29/2013,5/15/2013,27,43,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,1,E15,TINNITUS,TINNITUS,,TINNITUS,,HLT_0570,,HLGT_0180,,EAR AND LABYRINTH DISORDERS,,EAR AND LABYRINTH DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/17/2013,2007-10,,,,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,10,E21,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRAC,,VENTRICULAR EXTRASYSTOLES,,HLT_0050,,HLGT_0594,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/28/2013,5/28/2013,6/1/2013,56,60,Phase 1
CDISCPILOT01,AE,01-711-1143,1143,4/3/2013,6/1/2013,4/3/2013,5/30/2013,,9/22/2013,,,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/30/2013,-4,14,E21,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRAC,,VENTRICULAR EXTRASYSTOLES,,HLT_0050,,HLGT_0594,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/22/2013,5/28/2013,6/1/2013,56,60,Phase 1
CDISCPILOT01,AE,01-711-1433,1433,1/27/2013,2/6/2013,1/27/2013,2/5/2013,,2013-02-06T10:52,,,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,1/23/2013,-4,3,E03,ASTHENIA,WEAKNESS,,ASTHENIA,,HLT_0205,,HLGT_0614,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/6/2013,2/5/2013,,10,,Phase 1
CDISCPILOT01,AE,01-711-1433,1433,1/27/2013,2/6/2013,1/27/2013,2/5/2013,,2013-02-06T10:52,,,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,1/23/2013,-4,1,E01,HYPERTENSION,HYPERTENSION,,HYPERTENSION,,HLT_0228,,HLGT_0476,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/25/2013,7/23/2012,,-18,,Phase 1
CDISCPILOT01,AE,01-711-1433,1433,1/27/2013,2/6/2013,1/27/2013,2/5/2013,,2013-02-06T10:52,,,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,1/23/2013,-4,2,E01,HYPERTENSION,HYPERTENSION,,HYPERTENSION,,HLT_0228,,HLGT_0476,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/6/2013,7/23/2012,,-18,,Phase 1
CDISCPILOT01,AE,01-713-1043,1043,9/15/2013,3/24/2014,9/15/2013,3/24/2014,,2014-03-24T14:30,,,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/17/2013,-29,1,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/30/2013,9/26/2013,,12,,Phase 1
CDISCPILOT01,AE,01-713-1043,1043,9/15/2013,3/24/2014,9/15/2013,3/24/2014,,2014-03-24T14:30,,,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/17/2013,-29,4,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/13/2013,9/26/2013,,12,,Phase 1
CDISCPILOT01,AE,01-713-1043,1043,9/15/2013,3/24/2014,9/15/2013,3/24/2014,,2014-03-24T14:30,,,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/17/2013,-29,7,E07,CATARACT OPERATION,CATARACT EXTRACTION,,CATARACT OPERATION,,HLT_0432,,HLGT_0058,,SURGICAL AND MEDICAL PROCEDURES,,SURGICAL AND MEDICAL PROCEDURES,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/24/2014,3/8/2014,3/8/2014,175,175,Phase 2
CDISCPILOT01,AE,01-713-1043,1043,9/15/2013,3/24/2014,9/15/2013,3/24/2014,,2014-03-24T14:30,,,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/17/2013,-29,2,E04,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/11/2013,10/11/2013,10/11/2013,27,27,Phase 1
CDISCPILOT01,AE,01-713-1043,1043,9/15/2013,3/24/2014,9/15/2013,3/24/2014,,2014-03-24T14:30,,,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/17/2013,-29,5,E04,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/13/2013,10/11/2013,10/11/2013,27,27,Phase 1
CDISCPILOT01,AE,01-713-1043,1043,9/15/2013,3/24/2014,9/15/2013,3/24/2014,,2014-03-24T14:30,,,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/17/2013,-29,3,E05,VOMITING,EMESIS,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/11/2013,10/11/2013,10/11/2013,27,27,Phase 1
CDISCPILOT01,AE,01-713-1043,1043,9/15/2013,3/24/2014,9/15/2013,3/24/2014,,2014-03-24T14:30,,,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/17/2013,-29,6,E05,VOMITING,EMESIS,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/13/2013,10/11/2013,10/11/2013,27,27,Phase 1
CDISCPILOT01,AE,01-713-1073,1073,3/30/2014,10/5/2014,3/30/2014,10/5/2014,,2014-10-05T10:30,,,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/15/2014,-15,1,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/21/2014,7/14/2014,,107,,Phase 2
CDISCPILOT01,DM,01-713-1106,1106,10/31/2012,5/6/2013,10/31/2012,5/6/2013,,2013-05-06T11:25,,,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/3/2012,-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-713-1141,1141,5/31/2013,8/6/2013,5/31/2013,7/1/2013,,2013-08-06T12:00,,,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/23/2013,-8,3,E04,BACK PAIN,BACK PAIN,,BACK PAIN,,HLT_0115,,HLGT_0508,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/6/2013,6/30/2013,,31,,Phase 1
CDISCPILOT01,AE,01-713-1141,1141,5/31/2013,8/6/2013,5/31/2013,7/1/2013,,2013-08-06T12:00,,,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/23/2013,-8,4,E05,DELIRIUM,DELIRIUM,,DELIRIUM,,HLT_0376,,HLGT_0176,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,8/6/2013,7/1/2013,7/15/2013,32,46,Phase 1
CDISCPILOT01,AE,01-713-1141,1141,5/31/2013,8/6/2013,5/31/2013,7/1/2013,,2013-08-06T12:00,,,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/23/2013,-8,1,E03,RASH PRURITIC,PRURITIC RASH,,RASH PRURITIC,,HLT_0127,,HLGT_0753,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/26/2013,6/21/2013,7/15/2013,22,46,Phase 1
CDISCPILOT01,AE,01-713-1141,1141,5/31/2013,8/6/2013,5/31/2013,7/1/2013,,2013-08-06T12:00,,,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/23/2013,-8,2,E03,RASH PRURITIC,PRURITIC RASH,,RASH PRURITIC,,HLT_0127,,HLGT_0753,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/6/2013,6/21/2013,7/15/2013,22,46,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,4,E05,ASTHENIA,LOWER EXTREMITIES WEAKNESS OF,,ASTHENIA,,HLT_0205,,HLGT_0614,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/7/2013,9/5/2013,,28,,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,6,E05,ASTHENIA,LOWER EXTREMITIES WEAKNESS OF,,ASTHENIA,,HLT_0205,,HLGT_0614,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/19/2013,9/5/2013,,28,,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,12,E10,CERVICITIS,CERVICITIS,,CERVICITIS,,HLT_0651,,HLGT_0282,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/26/2013,11/23/2013,12/2/2013,107,116,Phase 2
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,14,E10,CERVICITIS,CERVICITIS,,CERVICITIS,,HLT_0651,,HLGT_0282,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/1/2014,11/23/2013,12/2/2013,107,116,Phase 2
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,2,E02,DYSPEPSIA,HEARTBURN,,DYSPEPSIA,,HLT_0244,,HLGT_0716,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/24/2013,8/22/2013,8/22/2013,14,14,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,7,E06,DYSPEPSIA,INDIGESTION,,DYSPEPSIA,,HLT_0244,,HLGT_0716,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/19/2013,9/12/2013,,35,,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,1,E01,DYSURIA,MICTURITION BURNING,,DYSURIA,,HLT_0637,,HLGT_0210,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/24/2013,8/19/2013,8/23/2013,11,15,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,9,E08,GASTROENTERITIS VIRAL,STOMACH FLU,,GASTROENTERITIS VIRAL,,HLT_0211,,HLGT_0385,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,11/6/2013,10/10/2013,10/13/2013,63,66,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,10,E11,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISE,,GASTROOESOPHAGEAL REFLUX DISEASE,,HLT_0407,,HLGT_0304,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/6/2013,10/10/2013,,63,,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,8,E07,PELVIC PAIN,PELVIC PAIN,,PELVIC PAIN,,HLT_0189,,HLGT_0691,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/6/2013,10/10/2013,1/18/2014,63,163,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,15,E07,PELVIC PAIN,PELVIC PAIN,,PELVIC PAIN,,HLT_0189,,HLGT_0691,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/24/2014,10/10/2013,1/18/2014,63,163,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,3,E04,URINARY TRACT INFECTION,URINARY TRACT INFECTION,,URINARY TRACT INFECTION,,HLT_0161,,HLGT_0093,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/5/2013,8/28/2013,9/8/2013,20,31,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,5,E04,URINARY TRACT INFECTION,URINARY TRACT INFECTION,,URINARY TRACT INFECTION,,HLT_0161,,HLGT_0093,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/19/2013,8/28/2013,9/8/2013,20,31,Phase 1
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,11,E09,VAGINAL MYCOSIS,VAGINAL YEAST INFECTION,,VAGINAL MYCOSIS,,HLT_0508,,HLGT_0643,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/26/2013,11/23/2013,12/2/2013,107,116,Phase 2
CDISCPILOT01,AE,01-713-1179,1179,8/9/2013,2/5/2014,8/9/2013,2/5/2014,,2014-02-05T15:15,,,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/11/2013,-29,13,E09,VAGINAL MYCOSIS,VAGINAL YEAST INFECTION,,VAGINAL MYCOSIS,,HLT_0508,,HLGT_0643,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/1/2014,11/23/2013,12/2/2013,107,116,Phase 2
CDISCPILOT01,AE,01-713-1209,1209,5/27/2013,11/22/2013,5/27/2013,11/22/2013,,2013-11-22T10:05,,,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/16/2013,-11,1,E05,ABDOMINAL PAIN,ABDOMINAL PAIN,,ABDOMINAL PAIN,,HLT_0217,,HLGT_0419,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/14/2013,5/30/2013,,4,,Phase 1
CDISCPILOT01,AE,01-713-1209,1209,5/27/2013,11/22/2013,5/27/2013,11/22/2013,,2013-11-22T10:05,,,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/16/2013,-11,3,E05,ABDOMINAL PAIN,ABDOMINAL PAIN,,ABDOMINAL PAIN,,HLT_0217,,HLGT_0419,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/19/2013,5/30/2013,,4,,Phase 1
CDISCPILOT01,AE,01-713-1209,1209,5/27/2013,11/22/2013,5/27/2013,11/22/2013,,2013-11-22T10:05,,,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/16/2013,-11,2,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/14/2013,6/2/2013,,7,,Phase 1
CDISCPILOT01,AE,01-713-1209,1209,5/27/2013,11/22/2013,5/27/2013,11/22/2013,,2013-11-22T10:05,,,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,5/16/2013,-11,4,E08,DIZZINESS,LIGHTHEADEDNESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/14/2013,10/31/2013,,158,,Phase 2
CDISCPILOT01,AE,01-713-1256,1256,9/19/2012,3/25/2013,9/19/2012,3/25/2013,,2013-03-25T10:30,,,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/10/2012,-9,1,E03,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/31/2012,10/30/2012,10/31/2012,42,43,Phase 1
CDISCPILOT01,AE,01-713-1256,1256,9/19/2012,3/25/2013,9/19/2012,3/25/2013,,2013-03-25T10:30,,,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/10/2012,-9,2,E03,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/14/2012,10/30/2012,10/31/2012,42,43,Phase 1
CDISCPILOT01,AE,01-713-1269,1269,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T14:00,,,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/14/2014,-13,1,E01,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/10/2014,2/2/2014,,7,,Phase 1
CDISCPILOT01,AE,01-713-1269,1269,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T14:00,,,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/14/2014,-13,2,E02,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/20/2014,4/18/2014,,82,,Phase 1
CDISCPILOT01,AE,01-713-1269,1269,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T14:00,,,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/14/2014,-13,4,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/13/2014,7/10/2014,,165,,Phase 2
CDISCPILOT01,AE,01-713-1269,1269,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T14:00,,,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/14/2014,-13,6,E04,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/28/2014,7/10/2014,,165,,Phase 2
CDISCPILOT01,AE,01-713-1269,1269,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T14:00,,,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/14/2014,-13,3,E03,SHOULDER PAIN,SHOULDER PAIN,,SHOULDER PAIN,,HLT_0527,,HLGT_0288,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/15/2014,6/1/2014,,126,,Phase 2
CDISCPILOT01,AE,01-713-1269,1269,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T14:00,,,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/14/2014,-13,5,E03,SHOULDER PAIN,SHOULDER PAIN,,SHOULDER PAIN,,HLT_0527,,HLGT_0288,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/28/2014,6/1/2014,,126,,Phase 2
CDISCPILOT01,AE,01-713-1448,1448,1/19/2014,5/17/2014,1/19/2014,5/16/2014,,7/27/2014,,,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/5/2014,-14,1,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/14/2014,3/19/2014,5/23/2014,60,125,Phase 1
CDISCPILOT01,AE,01-713-1448,1448,1/19/2014,5/17/2014,1/19/2014,5/16/2014,,7/27/2014,,,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/5/2014,-14,3,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/7/2014,3/19/2014,5/23/2014,60,125,Phase 1
CDISCPILOT01,AE,01-713-1448,1448,1/19/2014,5/17/2014,1/19/2014,5/16/2014,,7/27/2014,,,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/5/2014,-14,2,E04,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/14/2014,3/27/2014,5/23/2014,68,125,Phase 1
CDISCPILOT01,AE,01-713-1448,1448,1/19/2014,5/17/2014,1/19/2014,5/16/2014,,7/27/2014,,,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/5/2014,-14,4,E04,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/7/2014,3/27/2014,5/23/2014,68,125,Phase 1
CDISCPILOT01,AE,01-714-1035,1035,4/17/2014,10/16/2014,4/17/2014,10/16/2014,,2014-10-16T12:00,,,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/3/2014,-14,7,E09,BRONCHITIS,BRONCHITIS,,BRONCHITIS,,HLT_0634,,HLGT_0523,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/6/2014,7/18/2014,7/24/2014,93,99,Phase 1
CDISCPILOT01,AE,01-714-1035,1035,4/17/2014,10/16/2014,4/17/2014,10/16/2014,,2014-10-16T12:00,,,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/3/2014,-14,1,E04,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANC,,BUNDLE BRANCH BLOCK RIGHT,,HLT_0751,,HLGT_0597,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/26/2014,5/26/2014,6/4/2014,40,49,Phase 1
CDISCPILOT01,AE,01-714-1035,1035,4/17/2014,10/16/2014,4/17/2014,10/16/2014,,2014-10-16T12:00,,,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/3/2014,-14,5,E04,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANC,,BUNDLE BRANCH BLOCK RIGHT,,HLT_0751,,HLGT_0597,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/17/2014,5/26/2014,6/4/2014,40,49,Phase 1
CDISCPILOT01,AE,01-714-1035,1035,4/17/2014,10/16/2014,4/17/2014,10/16/2014,,2014-10-16T12:00,,,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/3/2014,-14,4,E07,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,,HLT_0610,,HLGT_0220,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/4/2014,6/4/2014,,49,,Phase 1
CDISCPILOT01,AE,01-714-1035,1035,4/17/2014,10/16/2014,4/17/2014,10/16/2014,,2014-10-16T12:00,,,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/3/2014,-14,2,E05,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERSION,,ELECTROCARDIOGRAM T WAVE INVERSION,,HLT_0289,,HLGT_0130,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/26/2014,5/26/2014,,40,,Phase 1
CDISCPILOT01,AE,01-714-1035,1035,4/17/2014,10/16/2014,4/17/2014,10/16/2014,,2014-10-16T12:00,,,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/3/2014,-14,3,E06,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,,SUPRAVENTRICULAR EXTRASYSTOLES,,HLT_0188,,HLGT_0279,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/4/2014,6/4/2014,6/17/2014,49,62,Phase 1
CDISCPILOT01,AE,01-714-1035,1035,4/17/2014,10/16/2014,4/17/2014,10/16/2014,,2014-10-16T12:00,,,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/3/2014,-14,6,E06,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,,SUPRAVENTRICULAR EXTRASYSTOLES,,HLT_0188,,HLGT_0279,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/10/2014,6/4/2014,6/17/2014,49,62,Phase 1
CDISCPILOT01,AE,01-714-1068,1068,8/8/2013,10/16/2013,8/8/2013,10/8/2013,,10/23/2013,,,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/31/2013,-8,3,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/3/2013,9/20/2013,,44,,Phase 1
CDISCPILOT01,AE,01-714-1068,1068,8/8/2013,10/16/2013,8/8/2013,10/8/2013,,10/23/2013,,,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/31/2013,-8,5,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/16/2013,9/20/2013,,44,,Phase 1
CDISCPILOT01,AE,01-714-1068,1068,8/8/2013,10/16/2013,8/8/2013,10/8/2013,,10/23/2013,,,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/31/2013,-8,4,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/3/2013,9/20/2013,,44,,Phase 1
CDISCPILOT01,AE,01-714-1068,1068,8/8/2013,10/16/2013,8/8/2013,10/8/2013,,10/23/2013,,,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/31/2013,-8,6,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/16/2013,9/20/2013,,44,,Phase 1
CDISCPILOT01,AE,01-714-1068,1068,8/8/2013,10/16/2013,8/8/2013,10/8/2013,,10/23/2013,,,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/31/2013,-8,1,E04,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/22/2013,8/12/2013,8/22/2013,5,15,Phase 1
CDISCPILOT01,AE,01-714-1068,1068,8/8/2013,10/16/2013,8/8/2013,10/8/2013,,10/23/2013,,,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,7/31/2013,-8,2,E04,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/5/2013,8/12/2013,8/22/2013,5,15,Phase 1
CDISCPILOT01,AE,01-714-1195,1195,4/26/2013,10/23/2013,4/26/2013,10/23/2013,,2013-10-23T10:55,,,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2013,-10,3,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/13/2013,7/17/2013,18,83,Phase 1
CDISCPILOT01,AE,01-714-1195,1195,4/26/2013,10/23/2013,4/26/2013,10/23/2013,,2013-10-23T10:55,,,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2013,-10,8,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,,APPLICATION SITE ERYTHEMA,,HLT_0617,,HLGT_0152,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/9/2013,5/13/2013,7/17/2013,18,83,Phase 1
CDISCPILOT01,AE,01-714-1195,1195,4/26/2013,10/23/2013,4/26/2013,10/23/2013,,2013-10-23T10:55,,,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2013,-10,5,E08,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/17/2013,,22,,Phase 1
CDISCPILOT01,AE,01-714-1195,1195,4/26/2013,10/23/2013,4/26/2013,10/23/2013,,2013-10-23T10:55,,,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2013,-10,1,E04,DIARRHOEA,LOOSE STOOLS,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/12/2013,7/17/2013,17,83,Phase 1
CDISCPILOT01,AE,01-714-1195,1195,4/26/2013,10/23/2013,4/26/2013,10/23/2013,,2013-10-23T10:55,,,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2013,-10,6,E04,DIARRHOEA,LOOSE STOOLS,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/9/2013,5/12/2013,7/17/2013,17,83,Phase 1
CDISCPILOT01,AE,01-714-1195,1195,4/26/2013,10/23/2013,4/26/2013,10/23/2013,,2013-10-23T10:55,,,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2013,-10,9,E09,DYSURIA,URINATION DIFFICULTY,,DYSURIA,,HLT_0637,,HLGT_0210,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/9/2013,7/25/2013,8/6/2013,91,103,Phase 1
CDISCPILOT01,AE,01-714-1195,1195,4/26/2013,10/23/2013,4/26/2013,10/23/2013,,2013-10-23T10:55,,,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2013,-10,2,E05,HYPERHIDROSIS,SWEATING,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/12/2013,7/17/2013,17,83,Phase 1
CDISCPILOT01,AE,01-714-1195,1195,4/26/2013,10/23/2013,4/26/2013,10/23/2013,,2013-10-23T10:55,,,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2013,-10,7,E05,HYPERHIDROSIS,SWEATING,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/9/2013,5/12/2013,7/17/2013,17,83,Phase 1
CDISCPILOT01,AE,01-714-1195,1195,4/26/2013,10/23/2013,4/26/2013,10/23/2013,,2013-10-23T10:55,,,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/16/2013,-10,4,E07,SOMNOLENCE,DROWSINESS,,SOMNOLENCE,,HLT_0160,,HLGT_0254,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/14/2013,,19,,Phase 1
CDISCPILOT01,AE,01-714-1288,1288,12/4/2013,6/17/2014,12/4/2013,6/17/2014,,2014-06-17T13:00,,,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-10,7,E13,ARTHRALGIA,KNEE PAIN,,ARTHRALGIA,,HLT_0375,,HLGT_0610,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/1/2014,3/8/2014,,95,,Phase 1
CDISCPILOT01,AE,01-714-1288,1288,12/4/2013,6/17/2014,12/4/2013,6/17/2014,,2014-06-17T13:00,,,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-10,6,E12,BACK PAIN,LOW BACK PAIN,,BACK PAIN,,HLT_0115,,HLGT_0508,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/2/2014,2/24/2014,4/8/2014,83,126,Phase 1
CDISCPILOT01,AE,01-714-1288,1288,12/4/2013,6/17/2014,12/4/2013,6/17/2014,,2014-06-17T13:00,,,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-10,8,E12,BACK PAIN,LOW BACK PAIN,,BACK PAIN,,HLT_0115,,HLGT_0508,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/29/2014,2/24/2014,4/8/2014,83,126,Phase 1
CDISCPILOT01,AE,01-714-1288,1288,12/4/2013,6/17/2014,12/4/2013,6/17/2014,,2014-06-17T13:00,,,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-10,5,E11,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/2/2014,1/22/2014,1/25/2014,50,53,Phase 1
CDISCPILOT01,AE,01-714-1288,1288,12/4/2013,6/17/2014,12/4/2013,6/17/2014,,2014-06-17T13:00,,,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-10,2,E08,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/17/2013,12/14/2013,12/15/2013,11,12,Phase 1
CDISCPILOT01,AE,01-714-1288,1288,12/4/2013,6/17/2014,12/4/2013,6/17/2014,,2014-06-17T13:00,,,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-10,1,E07,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/17/2013,12/13/2013,12/13/2013,10,10,Phase 1
CDISCPILOT01,AE,01-714-1288,1288,12/4/2013,6/17/2014,12/4/2013,6/17/2014,,2014-06-17T13:00,,,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-10,3,E09,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/19/2014,1/11/2014,,39,,Phase 1
CDISCPILOT01,AE,01-714-1288,1288,12/4/2013,6/17/2014,12/4/2013,6/17/2014,,2014-06-17T13:00,,,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-10,4,E10,NASOPHARYNGITIS,HEAD COLD,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/2/2014,1/22/2014,1/25/2014,50,53,Phase 1
CDISCPILOT01,AE,01-714-1288,1288,12/4/2013,6/17/2014,12/4/2013,6/17/2014,,2014-06-17T13:00,,,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2013,-10,9,E14,SINUS BRADYCARDIA,BRADYCARDIA SINUS,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/27/2014,5/27/2014,,175,,Phase 2
CDISCPILOT01,AE,01-714-1375,1375,2/26/2013,9/7/2013,2/26/2013,9/7/2013,,2013-09-07T13:58,,,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-3,2,E07,EAR PAIN,EAR PAIN,,EAR PAIN,,HLT_0631,,HLGT_0432,,EAR AND LABYRINTH DISORDERS,,EAR AND LABYRINTH DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/6/2013,4/4/2013,4/15/2013,38,49,Phase 1
CDISCPILOT01,AE,01-714-1375,1375,2/26/2013,9/7/2013,2/26/2013,9/7/2013,,2013-09-07T13:58,,,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-3,4,E07,EAR PAIN,EAR PAIN,,EAR PAIN,,HLT_0631,,HLGT_0432,,EAR AND LABYRINTH DISORDERS,,EAR AND LABYRINTH DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/26/2013,4/4/2013,4/15/2013,38,49,Phase 1
CDISCPILOT01,AE,01-714-1375,1375,2/26/2013,9/7/2013,2/26/2013,9/7/2013,,2013-09-07T13:58,,,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-3,6,E09,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/22/2013,6/16/2013,,111,,Phase 2
CDISCPILOT01,AE,01-714-1375,1375,2/26/2013,9/7/2013,2/26/2013,9/7/2013,,2013-09-07T13:58,,,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-3,8,E09,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/23/2013,6/16/2013,,111,,Phase 2
CDISCPILOT01,AE,01-714-1375,1375,2/26/2013,9/7/2013,2/26/2013,9/7/2013,,2013-09-07T13:58,,,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-3,5,E08,PRURITUS,PRURITIS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/22/2013,5/29/2013,,93,,Phase 1
CDISCPILOT01,AE,01-714-1375,1375,2/26/2013,9/7/2013,2/26/2013,9/7/2013,,2013-09-07T13:58,,,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-3,7,E08,PRURITUS,PRURITIS,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/23/2013,5/29/2013,,93,,Phase 1
CDISCPILOT01,AE,01-714-1375,1375,2/26/2013,9/7/2013,2/26/2013,9/7/2013,,2013-09-07T13:58,,,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-3,1,E06,SKIN IRRITATION,IRRITATION SKIN,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/6/2013,3/30/2013,4/6/2013,33,40,Phase 1
CDISCPILOT01,AE,01-714-1375,1375,2/26/2013,9/7/2013,2/26/2013,9/7/2013,,2013-09-07T13:58,,,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/23/2013,-3,3,E06,SKIN IRRITATION,IRRITATION SKIN,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/8/2013,3/30/2013,4/6/2013,33,40,Phase 1
CDISCPILOT01,AE,01-714-1425,1425,8/15/2013,8/22/2013,8/15/2013,8/19/2013,,2013-08-22T14:55,,,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,8/11/2013,-4,1,E04,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,,ATRIOVENTRICULAR BLOCK SECOND DEGREE,,HLT_0415,,HLGT_0086,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/13/2013,8/13/2013,,-2,,Phase 1
CDISCPILOT01,DM,01-715-1085,1085,2/16/2013,8/18/2013,2/16/2013,8/18/2013,,2013-08-18T10:22,,,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/3/2013,-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-715-1107,1107,2/26/2013,5/13/2013,2/26/2013,5/7/2013,,2013-08-14T09:52,,,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/12/2013,-14,1,E01,DERMATITIS CONTACT,CONTACT DERMATITIS,,DERMATITIS CONTACT,,HLT_0056,,HLGT_0331,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/13/2013,5/7/2013,5/21/2013,71,85,Phase 1
CDISCPILOT01,AE,01-715-1107,1107,2/26/2013,5/13/2013,2/26/2013,5/7/2013,,2013-08-14T09:52,,,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/12/2013,-14,3,E01,DERMATITIS CONTACT,CONTACT DERMATITIS,,DERMATITIS CONTACT,,HLT_0056,,HLGT_0331,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/14/2013,5/7/2013,5/21/2013,71,85,Phase 1
CDISCPILOT01,AE,01-715-1107,1107,2/26/2013,5/13/2013,2/26/2013,5/7/2013,,2013-08-14T09:52,,,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2/12/2013,-14,2,E02,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/13/2013,5/13/2013,,77,,Phase 1
CDISCPILOT01,DM,01-715-1155,1155,12/13/2013,4/26/2014,12/13/2013,1/25/2014,,4/26/2014,,,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/29/2013,-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-715-1207,1207,11/18/2012,6/1/2013,11/18/2012,5/27/2013,,2013-06-01T09:30,,,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,11/12/2012,-6,1,E01,NEPHROLITHIASIS,KIDNEY STONES,,NEPHROLITHIASIS,,HLT_0439,,HLGT_0546,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/13/2013,1/10/2013,1/10/2013,54,54,Phase 1
CDISCPILOT01,AE,01-715-1319,1319,2/17/2013,3/18/2013,2/17/2013,3/5/2013,,2013-03-18T10:28,,,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/3/2013,-14,1,E03,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/18/2013,3/18/2013,3/18/2013,30,30,Phase 1
CDISCPILOT01,AE,01-715-1321,1321,2/11/2014,4/22/2014,2/11/2014,4/21/2014,,2014-04-22T11:12,,,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/6/2014,-5,3,E03,APPLICATION SITE REACTION,APPLICATION SITE REACTION,,APPLICATION SITE REACTION,,HLT_0339,,HLGT_0668,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/22/2014,4/21/2014,,70,,Phase 1
CDISCPILOT01,AE,01-715-1321,1321,2/11/2014,4/22/2014,2/11/2014,4/21/2014,,2014-04-22T11:12,,,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/6/2014,-5,1,E02,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/14/2014,3/14/2014,3/14/2014,32,32,Phase 1
CDISCPILOT01,AE,01-715-1321,1321,2/11/2014,4/22/2014,2/11/2014,4/21/2014,,2014-04-22T11:12,,,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/6/2014,-5,2,E02,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/26/2014,3/14/2014,3/14/2014,32,32,Phase 1
CDISCPILOT01,AE,01-715-1321,1321,2/11/2014,4/22/2014,2/11/2014,4/21/2014,,2014-04-22T11:12,,,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/6/2014,-5,4,E04,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/22/2014,4/22/2014,,71,,Phase 1
CDISCPILOT01,DM,01-715-1397,1397,4/3/2013,10/3/2013,4/3/2013,10/2/2013,,2013-10-03T10:50,,,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/20/2013,-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-715-1405,1405,7/6/2013,7/13/2013,7/6/2013,7/7/2013,,1/11/2014,,,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/27/2013,-9,4,E05,CONFUSIONAL STATE,CONFUSION,,CONFUSIONAL STATE,,HLT_0642,,HLGT_0329,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/13/2013,7/8/2013,7/8/2013,3,3,Phase 1
CDISCPILOT01,AE,01-715-1405,1405,7/6/2013,7/13/2013,7/6/2013,7/7/2013,,1/11/2014,,,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/27/2013,-9,3,E04,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/13/2013,7/8/2013,7/8/2013,3,3,Phase 1
CDISCPILOT01,AE,01-715-1405,1405,7/6/2013,7/13/2013,7/6/2013,7/7/2013,,1/11/2014,,,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/27/2013,-9,2,E03,HYPERHIDROSIS,SWEATING,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/13/2013,7/8/2013,7/8/2013,3,3,Phase 1
CDISCPILOT01,AE,01-715-1405,1405,7/6/2013,7/13/2013,7/6/2013,7/7/2013,,1/11/2014,,,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/27/2013,-9,1,E02,PALPITATIONS,PALPITATIONS,,PALPITATIONS,,HLT_0493,,HLGT_0593,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/13/2013,7/8/2013,7/8/2013,3,3,Phase 1
CDISCPILOT01,AE,01-715-1405,1405,7/6/2013,7/13/2013,7/6/2013,7/7/2013,,1/11/2014,,,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/27/2013,-9,5,E01,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/13/2013,7/13/2013,7/13/2013,8,8,Phase 1
CDISCPILOT01,AE,01-715-1405,1405,7/6/2013,7/13/2013,7/6/2013,7/7/2013,,1/11/2014,,,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/27/2013,-9,6,E01,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/11/2014,7/13/2013,7/13/2013,8,8,Phase 1
CDISCPILOT01,AE,01-716-1024,1024,7/9/2012,1/20/2013,7/9/2012,1/20/2013,,2013-01-20T11:10,,,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/6/2012,-3,3,E13,EMPHYSEMA,EMPHYSEMA,,EMPHYSEMA,,HLT_0698,,HLGT_0221,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/30/2012,12/16/2012,,161,,Phase 2
CDISCPILOT01,AE,01-716-1024,1024,7/9/2012,1/20/2013,7/9/2012,1/20/2013,,2013-01-20T11:10,,,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/6/2012,-3,1,E12,NASOPHARYNGITIS,COLD SYMPTOMS,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/24/2012,8/20/2012,9/27/2012,43,81,Phase 1
CDISCPILOT01,AE,01-716-1024,1024,7/9/2012,1/20/2013,7/9/2012,1/20/2013,,2013-01-20T11:10,,,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,7/6/2012,-3,2,E12,NASOPHARYNGITIS,COLD SYMPTOMS,,NASOPHARYNGITIS,,HLT_0036,,HLGT_0709,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/30/2012,8/20/2012,9/27/2012,43,81,Phase 1
CDISCPILOT01,AE,01-716-1026,1026,4/2/2014,10/16/2014,4/2/2014,10/16/2014,,2014-10-16T13:35,,,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/23/2014,-10,4,E08,EAR INFECTION,EAR INFECTION,,EAR INFECTION,,HLT_0757,,HLGT_0760,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/31/2014,7/16/2014,7/25/2014,106,115,Phase 2
CDISCPILOT01,AE,01-716-1026,1026,4/2/2014,10/16/2014,4/2/2014,10/16/2014,,2014-10-16T13:35,,,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/23/2014,-10,7,E09,EAR INFECTION,EAR INFECTION,,EAR INFECTION,,HLT_0757,,HLGT_0760,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/28/2014,8/15/2014,8/27/2014,136,148,Phase 2
CDISCPILOT01,AE,01-716-1026,1026,4/2/2014,10/16/2014,4/2/2014,10/16/2014,,2014-10-16T13:35,,,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/23/2014,-10,5,E10,ELECTROCARDIOGRAM T WAVE AMPLITUDE DEC,T WAVE FLATTENING OF,,ELECTROCARDIOGRAM T WAVE AMPLITUDE DEC,,HLT_0037,,HLGT_0030,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/31/2014,7/31/2014,,121,,Phase 2
CDISCPILOT01,AE,01-716-1026,1026,4/2/2014,10/16/2014,4/2/2014,10/16/2014,,2014-10-16T13:35,,,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/23/2014,-10,3,E05,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,,ELECTROCARDIOGRAM T WAVE INVERSION,,HLT_0289,,HLGT_0130,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/18/2014,4/18/2014,7/31/2014,17,121,Phase 1
CDISCPILOT01,AE,01-716-1026,1026,4/2/2014,10/16/2014,4/2/2014,10/16/2014,,2014-10-16T13:35,,,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/23/2014,-10,6,E05,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,,ELECTROCARDIOGRAM T WAVE INVERSION,,HLT_0289,,HLGT_0130,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/28/2014,4/18/2014,7/31/2014,17,121,Phase 1
CDISCPILOT01,AE,01-716-1026,1026,4/2/2014,10/16/2014,4/2/2014,10/16/2014,,2014-10-16T13:35,,,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/23/2014,-10,1,E06,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/18/2014,4/17/2014,,16,,Phase 1
CDISCPILOT01,AE,01-716-1026,1026,4/2/2014,10/16/2014,4/2/2014,10/16/2014,,2014-10-16T13:35,,,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/23/2014,-10,2,E07,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/18/2014,4/17/2014,,16,,Phase 1
CDISCPILOT01,DM,01-716-1030,1030,12/28/2013,1/10/2014,12/28/2013,1/2/2014,,2014-01-10T12:30,,,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,12/25/2013,-3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-716-1044,1044,4/27/2013,11/3/2013,4/27/2013,11/3/2013,,2013-11-03T13:10,,,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/20/2013,-7,3,E05,CONFUSIONAL STATE,CONFUSION,,CONFUSIONAL STATE,,HLT_0642,,HLGT_0329,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/16/2013,10/15/2013,,172,,Phase 2
CDISCPILOT01,AE,01-716-1044,1044,4/27/2013,11/3/2013,4/27/2013,11/3/2013,,2013-11-03T13:10,,,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/20/2013,-7,1,E04,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/24/2013,5/21/2013,5/26/2013,25,30,Phase 1
CDISCPILOT01,AE,01-716-1044,1044,4/27/2013,11/3/2013,4/27/2013,11/3/2013,,2013-11-03T13:10,,,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,4/20/2013,-7,2,E04,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/13/2013,5/21/2013,5/26/2013,25,30,Phase 1
CDISCPILOT01,AE,01-716-1063,1063,5/9/2013,8/28/2013,5/9/2013,8/25/2013,,11/17/2013,,,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/6/2013,-3,2,E09,FATIGUE,TIREDNESS,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/4/2013,7/1/2013,,54,,Phase 1
CDISCPILOT01,AE,01-716-1063,1063,5/9/2013,8/28/2013,5/9/2013,8/25/2013,,11/17/2013,,,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/6/2013,-3,1,E11,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/9/2013,5/9/2013,,366,,Phase 2
CDISCPILOT01,AE,01-716-1063,1063,5/9/2013,8/28/2013,5/9/2013,8/25/2013,,11/17/2013,,,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/6/2013,-3,6,E10,LETHARGY,LETHARGY,,LETHARGY,,HLT_0027,,HLGT_0448,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/31/2013,7/31/2013,,84,,Phase 1
CDISCPILOT01,AE,01-716-1063,1063,5/9/2013,8/28/2013,5/9/2013,8/25/2013,,11/17/2013,,,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/6/2013,-3,3,E12,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/4/2013,7/4/2013,7/28/2013,57,81,Phase 1
CDISCPILOT01,AE,01-716-1063,1063,5/9/2013,8/28/2013,5/9/2013,8/25/2013,,11/17/2013,,,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/6/2013,-3,4,E12,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/31/2013,7/4/2013,7/28/2013,57,81,Phase 1
CDISCPILOT01,AE,01-716-1063,1063,5/9/2013,8/28/2013,5/9/2013,8/25/2013,,11/17/2013,,,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/6/2013,-3,5,E13,RESTLESSNESS,RESTLESSNESS,,RESTLESSNESS,,HLT_0427,,HLGT_0510,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/31/2013,7/28/2013,7/31/2013,81,84,Phase 1
CDISCPILOT01,AE,01-716-1063,1063,5/9/2013,8/28/2013,5/9/2013,8/25/2013,,11/17/2013,,,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/6/2013,-3,7,E13,RESTLESSNESS,RESTLESSNESS,,RESTLESSNESS,,HLT_0427,,HLGT_0510,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/28/2013,7/28/2013,7/31/2013,81,84,Phase 1
CDISCPILOT01,AE,01-716-1071,1071,6/8/2013,8/1/2013,6/8/2013,8/1/2013,,12/16/2013,,,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/3/2013,-5,2,E10,FATIGUE,TIREDNESS,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/26/2013,7/13/2013,,36,,Phase 1
CDISCPILOT01,AE,01-716-1071,1071,6/8/2013,8/1/2013,6/8/2013,8/1/2013,,12/16/2013,,,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/3/2013,-5,1,E09,HYPERSOMNIA,SLEEP EXCESSIVE,,HYPERSOMNIA,,HLT_0231,,HLGT_0628,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/26/2013,7/13/2013,,36,,Phase 1
CDISCPILOT01,AE,01-716-1071,1071,6/8/2013,8/1/2013,6/8/2013,8/1/2013,,12/16/2013,,,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/3/2013,-5,3,E08,SYNCOPE,SYNCOPE,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/1/2013,7/31/2013,7/31/2013,54,54,Phase 1
CDISCPILOT01,AE,01-716-1094,1094,12/19/2012,1/26/2013,12/19/2012,1/24/2013,,6/22/2013,,,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/16/2012,-3,1,E07,ATRIAL FLUTTER,ATRIAL FLUTTER,,ATRIAL FLUTTER,,HLT_0477,,HLGT_0627,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/19/2013,1/19/2013,,32,,Phase 1
CDISCPILOT01,AE,01-716-1094,1094,12/19/2012,1/26/2013,12/19/2012,1/24/2013,,6/22/2013,,,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/16/2012,-3,2,E08,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANC,,BUNDLE BRANCH BLOCK RIGHT,,HLT_0751,,HLGT_0597,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/19/2013,1/19/2013,,32,,Phase 1
CDISCPILOT01,AE,01-716-1094,1094,12/19/2012,1/26/2013,12/19/2012,1/24/2013,,6/22/2013,,,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,12/16/2012,-3,3,E09,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,,VENTRICULAR SEPTAL DEFECT,,HLT_0589,,HLGT_0747,,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/19/2013,1/19/2013,,32,,Phase 1
CDISCPILOT01,AE,01-716-1103,1103,3/20/2014,9/20/2014,3/20/2014,9/20/2014,,2014-09-20T12:10,,,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/18/2014,-2,2,E06,BLISTER,BLISTERS,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/23/2014,7/9/2014,7/16/2014,112,119,Phase 2
CDISCPILOT01,AE,01-716-1103,1103,3/20/2014,9/20/2014,3/20/2014,9/20/2014,,2014-09-20T12:10,,,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/18/2014,-2,4,E08,BLISTER,BLISTERS,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SEVERE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/19/2014,8/17/2014,8/24/2014,151,158,Phase 2
CDISCPILOT01,AE,01-716-1103,1103,3/20/2014,9/20/2014,3/20/2014,9/20/2014,,2014-09-20T12:10,,,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/18/2014,-2,5,E08,BLISTER,BLISTERS,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SEVERE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/30/2014,8/17/2014,8/24/2014,151,158,Phase 2
CDISCPILOT01,AE,01-716-1103,1103,3/20/2014,9/20/2014,3/20/2014,9/20/2014,,2014-09-20T12:10,,,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/18/2014,-2,3,E07,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/23/2014,7/9/2014,,112,,Phase 2
CDISCPILOT01,AE,01-716-1103,1103,3/20/2014,9/20/2014,3/20/2014,9/20/2014,,2014-09-20T12:10,,,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,3/18/2014,-2,1,E05,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/23/2014,7/9/2014,,112,,Phase 2
CDISCPILOT01,AE,01-716-1108,1108,2/12/2013,8/10/2013,2/12/2013,8/10/2013,,2013-08-10T09:55,,,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/4/2013,-8,1,E04,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,,HLT_0610,,HLGT_0220,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/12/2013,4/12/2013,,60,,Phase 1
CDISCPILOT01,AE,01-716-1108,1108,2/12/2013,8/10/2013,2/12/2013,8/10/2013,,2013-08-10T09:55,,,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/4/2013,-8,2,E05,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/10/2013,5/1/2013,,79,,Phase 1
CDISCPILOT01,AE,01-716-1151,1151,2/1/2013,6/7/2013,2/1/2013,5/11/2013,,8/13/2013,,,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/23/2013,-9,3,E07,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/15/2013,3/15/2013,,43,,Phase 1
CDISCPILOT01,AE,01-716-1151,1151,2/1/2013,6/7/2013,2/1/2013,5/11/2013,,8/13/2013,,,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/23/2013,-9,1,E05,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOM,,MALIGNANT FIBROUS HISTIOCYTOMA,,HLT_0245,,HLGT_0507,,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,Y,N,N,N,N,N,N,2/27/2013,2/19/2013,3/22/2013,19,50,Phase 1
CDISCPILOT01,AE,01-716-1151,1151,2/1/2013,6/7/2013,2/1/2013,5/11/2013,,8/13/2013,,,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/23/2013,-9,4,E05,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOM,,MALIGNANT FIBROUS HISTIOCYTOMA,,HLT_0245,,HLGT_0507,,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",,MILD,N,,NONE,RECOVERED/RESOLVED,Y,N,N,N,N,N,N,4/2/2013,2/19/2013,3/22/2013,19,50,Phase 1
CDISCPILOT01,AE,01-716-1151,1151,2/1/2013,6/7/2013,2/1/2013,5/11/2013,,8/13/2013,,,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/23/2013,-9,2,E06,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/15/2013,3/15/2013,,43,,Phase 1
CDISCPILOT01,AE,01-716-1157,1157,10/2/2013,4/5/2014,10/2/2013,4/4/2014,,2014-04-05T11:10,,,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/23/2013,-9,2,E06,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/4/2013,10/25/2013,,24,,Phase 1
CDISCPILOT01,AE,01-716-1157,1157,10/2/2013,4/5/2014,10/2/2013,4/4/2014,,2014-04-05T11:10,,,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/23/2013,-9,3,E07,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/4/2013,10/25/2013,,24,,Phase 1
CDISCPILOT01,AE,01-716-1157,1157,10/2/2013,4/5/2014,10/2/2013,4/4/2014,,2014-04-05T11:10,,,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/23/2013,-9,1,E05,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/4/2013,10/17/2013,11/4/2013,16,34,Phase 1
CDISCPILOT01,AE,01-716-1157,1157,10/2/2013,4/5/2014,10/2/2013,4/4/2014,,2014-04-05T11:10,,,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/23/2013,-9,4,E05,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/6/2013,10/17/2013,11/4/2013,16,34,Phase 1
CDISCPILOT01,AE,01-716-1160,1160,4/5/2013,10/11/2013,4/5/2013,10/11/2013,,2013-10-11T13:30,,,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/23/2013,-13,2,E03,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/9/2013,,35,,Phase 1
CDISCPILOT01,AE,01-716-1160,1160,4/5/2013,10/11/2013,4/5/2013,10/11/2013,,2013-10-11T13:30,,,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,3/23/2013,-13,1,E02,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/9/2013,,35,,Phase 1
CDISCPILOT01,AE,01-716-1167,1167,10/8/2012,4/13/2013,10/8/2012,4/12/2013,,2013-04-13T11:10,,,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/30/2012,-8,3,E05,BLISTER,BLISTERS,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/3/2012,12/3/2012,,57,,Phase 1
CDISCPILOT01,AE,01-716-1167,1167,10/8/2012,4/13/2013,10/8/2012,4/12/2013,,2013-04-13T11:10,,,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/30/2012,-8,4,E06,HYPERSENSITIVITY,ALLERGY,,HYPERSENSITIVITY,,HLT_0473,,HLGT_0765,,IMMUNE SYSTEM DISORDERS,,IMMUNE SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/24/2013,3/10/2013,4/10/2013,154,185,Phase 2
CDISCPILOT01,AE,01-716-1167,1167,10/8/2012,4/13/2013,10/8/2012,4/12/2013,,2013-04-13T11:10,,,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/30/2012,-8,5,E06,HYPERSENSITIVITY,ALLERGY,,HYPERSENSITIVITY,,HLT_0473,,HLGT_0765,,IMMUNE SYSTEM DISORDERS,,IMMUNE SYSTEM DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/13/2013,3/10/2013,4/10/2013,154,185,Phase 2
CDISCPILOT01,AE,01-716-1167,1167,10/8/2012,4/13/2013,10/8/2012,4/12/2013,,2013-04-13T11:10,,,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/30/2012,-8,1,E03,PRURITUS,ITCH,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/19/2012,11/17/2012,,41,,Phase 1
CDISCPILOT01,AE,01-716-1167,1167,10/8/2012,4/13/2013,10/8/2012,4/12/2013,,2013-04-13T11:10,,,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/30/2012,-8,2,E04,SWELLING,SWELLING,,SWELLING,,HLT_0658,,HLGT_0484,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/19/2012,11/17/2012,,41,,Phase 1
CDISCPILOT01,AE,01-716-1177,1177,9/2/2014,3/5/2015,9/2/2014,3/5/2015,,2015-03-05T14:40,,,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/29/2014,-4,1,E03,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/20/2014,8/24/2014,,-9,,Phase 1
CDISCPILOT01,AE,01-716-1189,1189,10/9/2012,3/3/2013,10/9/2012,2/27/2013,,4/8/2013,,,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/7/2012,-2,2,E05,DELUSION,DELUSIONS,,DELUSION,,HLT_0198,,HLGT_0565,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/27/2012,11/24/2012,,47,,Phase 1
CDISCPILOT01,AE,01-716-1189,1189,10/9/2012,3/3/2013,10/9/2012,2/27/2013,,4/8/2013,,,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/7/2012,-2,1,E04,HALLUCINATION,HALLUCINATION,,HALLUCINATION,,HLT_0026,,HLGT_0649,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/27/2012,11/24/2012,,47,,Phase 1
CDISCPILOT01,AE,01-716-1189,1189,10/9/2012,3/3/2013,10/9/2012,2/27/2013,,4/8/2013,,,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/7/2012,-2,4,E07,PROSTATE CANCER,PROSTATE CANCER,,PROSTATE CANCER,,HLT_0412,,HLGT_0190,,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",,SEVERE,N,,NONE,NOT RECOVERED/NOT RESOLVED,Y,N,N,N,N,N,N,3/3/2013,2/7/2013,,122,,Phase 2
CDISCPILOT01,AE,01-716-1189,1189,10/9/2012,3/3/2013,10/9/2012,2/27/2013,,4/8/2013,,,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,10/7/2012,-2,3,E06,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/5/2013,1/5/2013,,89,,Phase 1
CDISCPILOT01,AE,01-716-1229,1229,2/20/2013,4/2/2013,2/20/2013,3/31/2013,,2013-04-02T11:15,,,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/14/2013,-6,2,E03,BLOOD CHOLESTEROL INCREASED,HIGH CHOLESTEROL,,BLOOD CHOLESTEROL INCREASED,,HLT_0210,,HLGT_0430,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/6/2013,3/6/2013,,15,,Phase 1
CDISCPILOT01,AE,01-716-1229,1229,2/20/2013,4/2/2013,2/20/2013,3/31/2013,,2013-04-02T11:15,,,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/14/2013,-6,1,E01,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/20/2013,2/20/2013,,1,,Phase 1
CDISCPILOT01,AE,01-716-1298,1298,4/8/2013,7/6/2013,4/8/2013,6/28/2013,,10/7/2013,,,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/4/2013,-4,3,E07,BLISTER,BLISTERS,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/6/2013,6/8/2013,7/6/2013,62,90,Phase 1
CDISCPILOT01,AE,01-716-1298,1298,4/8/2013,7/6/2013,4/8/2013,6/28/2013,,10/7/2013,,,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/4/2013,-4,6,E07,BLISTER,BLISTERS,,BLISTER,,HLT_0752,,HLGT_0267,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/7/2013,6/8/2013,7/6/2013,62,90,Phase 1
CDISCPILOT01,AE,01-716-1298,1298,4/8/2013,7/6/2013,4/8/2013,6/28/2013,,10/7/2013,,,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/4/2013,-4,1,E05,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/22/2013,4/22/2013,7/6/2013,15,90,Phase 1
CDISCPILOT01,AE,01-716-1298,1298,4/8/2013,7/6/2013,4/8/2013,6/28/2013,,10/7/2013,,,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/4/2013,-4,4,E05,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/7/2013,4/22/2013,7/6/2013,15,90,Phase 1
CDISCPILOT01,AE,01-716-1298,1298,4/8/2013,7/6/2013,4/8/2013,6/28/2013,,10/7/2013,,,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/4/2013,-4,2,E06,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/22/2013,4/22/2013,7/6/2013,15,90,Phase 1
CDISCPILOT01,AE,01-716-1298,1298,4/8/2013,7/6/2013,4/8/2013,6/28/2013,,10/7/2013,,,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,4/4/2013,-4,5,E06,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/7/2013,4/22/2013,7/6/2013,15,90,Phase 1
CDISCPILOT01,AE,01-716-1308,1308,8/28/2013,10/7/2013,8/28/2013,10/7/2013,,2013-10-07T15:50,,,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,8/23/2013,-5,1,E01,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/23/2013,9/20/2013,,24,,Phase 1
CDISCPILOT01,AE,01-716-1311,1311,5/14/2014,9/30/2014,5/14/2014,9/21/2014,,11/15/2014,,,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/8/2014,-6,2,E07,ABDOMINAL PAIN,ABDOMINAL PAIN,,ABDOMINAL PAIN,,HLT_0217,,HLGT_0419,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/7/2014,7/22/2014,8/2/2014,70,81,Phase 1
CDISCPILOT01,AE,01-716-1311,1311,5/14/2014,9/30/2014,5/14/2014,9/21/2014,,11/15/2014,,,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/8/2014,-6,1,E06,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/11/2014,5/28/2014,9/22/2014,15,132,Phase 1
CDISCPILOT01,AE,01-716-1311,1311,5/14/2014,9/30/2014,5/14/2014,9/21/2014,,11/15/2014,,,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/8/2014,-6,4,E06,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,9/30/2014,5/28/2014,9/22/2014,15,132,Phase 1
CDISCPILOT01,AE,01-716-1311,1311,5/14/2014,9/30/2014,5/14/2014,9/21/2014,,11/15/2014,,,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,5/8/2014,-6,3,E08,ULCER,ULCER,,ULCER,,HLT_0040,,HLGT_0245,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/7/2014,8/2/2014,,81,,Phase 1
CDISCPILOT01,AE,01-716-1364,1364,7/4/2013,1/9/2014,7/4/2013,1/9/2014,,2014-01-09T15:30,,,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/27/2013,-7,2,E05,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/2/2013,9/2/2013,,61,,Phase 1
CDISCPILOT01,AE,01-716-1364,1364,7/4/2013,1/9/2014,7/4/2013,1/9/2014,,2014-01-09T15:30,,,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,6/27/2013,-7,1,E04,PRURITUS,ITCH,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/18/2013,8/18/2013,,46,,Phase 1
CDISCPILOT01,AE,01-716-1373,1373,12/14/2012,2/28/2013,12/14/2012,2/27/2013,,2013-02-28T10:23,,,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2012,-20,1,E05,COGNITIVE DISORDER,COGNITIVE IMPAIRMENT,,COGNITIVE DISORDER,,HLT_0265,,HLGT_0506,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/14/2012,12/14/2012,,1,,Phase 1
CDISCPILOT01,AE,01-716-1373,1373,12/14/2012,2/28/2013,12/14/2012,2/27/2013,,2013-02-28T10:23,,,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,11/24/2012,-20,2,E04,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,12/30/2012,12/15/2012,,2,,Phase 1
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,2,E03,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/19/2013,5/5/2013,,1,,Phase 1
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,5,E05,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/22/2013,2013-07,9/26/2013,,145,Phase 1
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,7,E05,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/5/2013,2013-07,9/26/2013,,145,Phase 1
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,9,E07,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/5/2013,9/26/2013,11/11/2013,145,191,Phase 2
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,10,E07,HEADACHE,HEADACHE,,HEADACHE,,HLT_0064,,HLGT_0344,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/20/2013,9/26/2013,11/11/2013,145,191,Phase 2
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,4,E02,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/19/2013,5/7/2013,,3,,Phase 1
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,1,E08,URTICARIA,WELTS,,URTICARIA,,HLT_0420,,HLGT_0705,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/5/2013,5/5/2013,5/7/2013,1,3,Phase 1
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,3,E08,URTICARIA,WELTS,,URTICARIA,,HLT_0420,,HLGT_0705,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/19/2013,5/5/2013,5/7/2013,1,3,Phase 1
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,6,E06,VISION BLURRED,BLURRED VISION,,VISION BLURRED,,HLT_0120,,HLGT_0598,,EYE DISORDERS,,EYE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/22/2013,2013-07,10/4/2013,,153,Phase 1
CDISCPILOT01,AE,01-716-1418,1418,5/5/2013,11/20/2013,5/5/2013,11/20/2013,,2013-11-20T11:44,,,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/27/2013,-8,8,E06,VISION BLURRED,BLURRED VISION,,VISION BLURRED,,HLT_0120,,HLGT_0598,,EYE DISORDERS,,EYE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/5/2013,2013-07,10/4/2013,,153,Phase 1
CDISCPILOT01,AE,01-716-1441,1441,1/22/2014,7/22/2014,1/22/2014,7/22/2014,,2014-07-22T10:00,,,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/13/2014,-9,1,E06,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/19/2014,5/11/2014,,110,,Phase 2
CDISCPILOT01,AE,01-716-1447,1447,12/16/2013,6/17/2014,12/16/2013,6/17/2014,,2014-06-17T12:00,,,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2013,-6,5,E10,CHEST PAIN,CHEST PAIN,,CHEST PAIN,,HLT_0717,,HLGT_0195,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/12/2014,4/5/2014,4/9/2014,111,115,Phase 2
CDISCPILOT01,AE,01-716-1447,1447,12/16/2013,6/17/2014,12/16/2013,6/17/2014,,2014-06-17T12:00,,,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2013,-6,4,E08,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,,ELECTROCARDIOGRAM T WAVE INVERSION,,HLT_0289,,HLGT_0130,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/14/2014,3/14/2014,,89,,Phase 1
CDISCPILOT01,AE,01-716-1447,1447,12/16/2013,6/17/2014,12/16/2013,6/17/2014,,2014-06-17T12:00,,,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2013,-6,2,E07,ERYTHEMA,ERYTHEMA,,ERYTHEMA,,HLT_0284,,HLGT_0192,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/27/2014,1/14/2014,,30,,Phase 1
CDISCPILOT01,AE,01-716-1447,1447,12/16/2013,6/17/2014,12/16/2013,6/17/2014,,2014-06-17T12:00,,,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2013,-6,1,E06,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/11/2014,1/1/2014,,17,,Phase 1
CDISCPILOT01,AE,01-716-1447,1447,12/16/2013,6/17/2014,12/16/2013,6/17/2014,,2014-06-17T12:00,,,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/10/2013,-6,3,E09,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/27/2014,1/14/2014,,30,,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,7,E11,ANXIETY,ANXIETY,,ANXIETY,,HLT_0559,,HLGT_0570,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/28/2014,1/15/2014,,2,,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,17,E20,BACK PAIN,BACK PAIN,,BACK PAIN,,HLT_0115,,HLGT_0508,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/3/2014,5/21/2014,,128,,Phase 2
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,3,E06,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/28/2014,1/15/2014,2/18/2014,2,36,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,12,E06,COUGH,COUGH,,COUGH,,HLT_0701,,HLGT_0280,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/25/2014,1/15/2014,2/18/2014,2,36,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,2,E16,DIARRHOEA,SOFT STOOLS,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/14/2014,1/13/2014,2/10/2014,-1,28,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,10,E16,DIARRHOEA,SOFT STOOLS,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/11/2014,1/13/2014,2/10/2014,-1,28,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,1,E09,ENURESIS,BED WETTING,,ENURESIS,,HLT_0107,,HLGT_0623,,RENAL AND URINARY DISORDERS,,RENAL AND URINARY DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/14/2014,2013-05,,,,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,5,E08,FATIGUE,FATIGUE,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/28/2014,1/15/2014,,2,,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,8,E12,IRRITABILITY,IRRITABILITY,,IRRITABILITY,,HLT_0627,,HLGT_0461,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/28/2014,1/15/2014,,2,,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,4,E07,RHINORRHOEA,RUNNY NOSE,,RHINORRHOEA,,HLT_0635,,HLGT_0460,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/28/2014,1/15/2014,2/8/2014,2,26,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,9,E07,RHINORRHOEA,RUNNY NOSE,,RHINORRHOEA,,HLT_0635,,HLGT_0460,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/9/2014,1/15/2014,2/8/2014,2,26,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,15,E18,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/8/2014,4/8/2014,,85,,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,6,E10,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/28/2014,1/15/2014,2/9/2014,2,27,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,11,E10,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/11/2014,1/15/2014,2/9/2014,2,27,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,13,E17,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/11/2014,3/9/2014,3/15/2014,55,61,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,14,E17,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/8/2014,3/9/2014,3/15/2014,55,61,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,16,E19,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/6/2014,4/21/2014,,98,,Phase 1
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,18,E21,WOUND,WOUND NOS,,WOUND,,HLT_0542,,HLGT_0540,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/3/2014,6/3/2014,6/10/2014,141,148,Phase 2
CDISCPILOT01,AE,01-717-1004,1004,1/14/2014,7/16/2014,1/14/2014,7/16/2014,,2014-07-16T13:21,,,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,1/1/2014,-13,19,E21,WOUND,WOUND NOS,,WOUND,,HLT_0542,,HLGT_0540,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/1/2014,6/3/2014,6/10/2014,141,148,Phase 2
CDISCPILOT01,AE,01-717-1109,1109,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T10:53,,,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/20/2014,-7,4,E06,CONFUSIONAL STATE,CONFUSION,,CONFUSIONAL STATE,,HLT_0642,,HLGT_0329,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/23/2014,2/20/2014,,25,,Phase 1
CDISCPILOT01,AE,01-717-1109,1109,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T10:53,,,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/20/2014,-7,3,E08,HYPERHIDROSIS,SWEATING INCREASED,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/23/2014,2/15/2014,2/17/2014,20,22,Phase 1
CDISCPILOT01,AE,01-717-1109,1109,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T10:53,,,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/20/2014,-7,1,E03,INCREASED APPETITE,INCREASED APPETITE,,INCREASED APPETITE,,HLT_0566,,HLGT_0769,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/10/2014,1/29/2014,7/16/2014,3,171,Phase 1
CDISCPILOT01,AE,01-717-1109,1109,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T10:53,,,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/20/2014,-7,8,E03,INCREASED APPETITE,INCREASED APPETITE,,INCREASED APPETITE,,HLT_0566,,HLGT_0769,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/18/2014,1/29/2014,7/16/2014,3,171,Phase 1
CDISCPILOT01,AE,01-717-1109,1109,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T10:53,,,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/20/2014,-7,5,E10,INSOMNIA,INSOMNIA,,INSOMNIA,,HLT_0297,,HLGT_0469,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/23/2014,2/22/2014,,27,,Phase 1
CDISCPILOT01,AE,01-717-1109,1109,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T10:53,,,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/20/2014,-7,6,E09,PRURITUS GENERALISED,GENERALIZED PRURITUS,,PRURITUS GENERALISED,,HLT_0123,,HLGT_0689,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/10/2014,3/4/2014,,37,,Phase 1
CDISCPILOT01,AE,01-717-1109,1109,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T10:53,,,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/20/2014,-7,2,E07,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/23/2014,2/15/2014,,20,,Phase 1
CDISCPILOT01,AE,01-717-1109,1109,1/27/2014,7/28/2014,1/27/2014,7/28/2014,,2014-07-28T10:53,,,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/20/2014,-7,7,E11,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRAC,,VENTRICULAR EXTRASYSTOLES,,HLT_0050,,HLGT_0594,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/18/2014,4/18/2014,,82,,Phase 1
CDISCPILOT01,AE,01-717-1174,1174,1/22/2013,7/24/2013,1/22/2013,7/24/2013,,2013-07-24T15:15,,,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/16/2013,-6,3,E07,INSOMNIA,INSOMNIA,,INSOMNIA,,HLT_0297,,HLGT_0469,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/18/2013,4/17/2013,4/19/2013,86,88,Phase 1
CDISCPILOT01,AE,01-717-1174,1174,1/22/2013,7/24/2013,1/22/2013,7/24/2013,,2013-07-24T15:15,,,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/16/2013,-6,2,E04,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/4/2013,2/3/2013,,13,,Phase 1
CDISCPILOT01,AE,01-717-1174,1174,1/22/2013,7/24/2013,1/22/2013,7/24/2013,,2013-07-24T15:15,,,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/16/2013,-6,6,E04,PRURITUS,ITCHING,,PRURITUS,,HLT_0778,,HLGT_0695,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/7/2013,2/3/2013,,13,,Phase 1
CDISCPILOT01,AE,01-717-1174,1174,1/22/2013,7/24/2013,1/22/2013,7/24/2013,,2013-07-24T15:15,,,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/16/2013,-6,4,E06,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SEVERE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/18/2013,4/25/2013,4/26/2013,94,95,Phase 1
CDISCPILOT01,AE,01-717-1174,1174,1/22/2013,7/24/2013,1/22/2013,7/24/2013,,2013-07-24T15:15,,,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/16/2013,-6,1,E03,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/4/2013,1/26/2013,,5,,Phase 1
CDISCPILOT01,AE,01-717-1174,1174,1/22/2013,7/24/2013,1/22/2013,7/24/2013,,2013-07-24T15:15,,,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/16/2013,-6,5,E03,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/7/2013,1/26/2013,,5,,Phase 1
CDISCPILOT01,AE,01-717-1201,1201,12/19/2013,2/21/2014,12/19/2013,2/21/2014,,2014-02-21T11:14,,,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/12/2013,-7,2,E07,ALOPECIA,HAIR LOSS,,ALOPECIA,,HLT_0077,,HLGT_0234,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/17/2014,1/15/2014,,28,,Phase 1
CDISCPILOT01,AE,01-717-1201,1201,12/19/2013,2/21/2014,12/19/2013,2/21/2014,,2014-02-21T11:14,,,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,12/12/2013,-7,1,E06,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/3/2014,12/19/2013,,1,,Phase 1
CDISCPILOT01,AE,01-717-1344,1344,1/11/2014,3/14/2014,1/11/2014,3/14/2014,,2014-03-14T14:14,,,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/1/2014,-10,2,E04,FATIGUE,FATIGUE,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/7/2014,2/1/2014,2/18/2014,22,39,Phase 1
CDISCPILOT01,AE,01-717-1344,1344,1/11/2014,3/14/2014,1/11/2014,3/14/2014,,2014-03-14T14:14,,,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/1/2014,-10,3,E04,FATIGUE,FATIGUE,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/19/2014,2/1/2014,2/18/2014,22,39,Phase 1
CDISCPILOT01,AE,01-717-1344,1344,1/11/2014,3/14/2014,1/11/2014,3/14/2014,,2014-03-14T14:14,,,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/1/2014,-10,1,E03,NASAL CONGESTION,NOSE CONGESTION,,NASAL CONGESTION,,HLT_0118,,HLGT_0549,,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/7/2014,2/1/2014,2/6/2014,22,27,Phase 1
CDISCPILOT01,AE,01-717-1344,1344,1/11/2014,3/14/2014,1/11/2014,3/14/2014,,2014-03-14T14:14,,,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/1/2014,-10,4,E05,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/14/2014,2/28/2014,3/1/2014,49,50,Phase 1
CDISCPILOT01,AE,01-717-1344,1344,1/11/2014,3/14/2014,1/11/2014,3/14/2014,,2014-03-14T14:14,,,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/1/2014,-10,5,E06,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/14/2014,2/28/2014,3/1/2014,49,50,Phase 1
CDISCPILOT01,AE,01-717-1357,1357,5/1/2013,10/20/2013,5/1/2013,10/14/2013,,2013-10-20T10:52,,,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/21/2013,-10,4,E08,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,,APPLICATION SITE PERSPIRATION,,HLT_0283,,HLGT_0403,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/13/2013,6/11/2013,10/15/2013,42,168,Phase 1
CDISCPILOT01,AE,01-717-1357,1357,5/1/2013,10/20/2013,5/1/2013,10/14/2013,,2013-10-20T10:52,,,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/21/2013,-10,9,E08,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,,APPLICATION SITE PERSPIRATION,,HLT_0283,,HLGT_0403,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/20/2013,6/11/2013,10/15/2013,42,168,Phase 1
CDISCPILOT01,AE,01-717-1357,1357,5/1/2013,10/20/2013,5/1/2013,10/14/2013,,2013-10-20T10:52,,,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/21/2013,-10,1,E04,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/15/2013,1994-04,,,,Phase 1
CDISCPILOT01,AE,01-717-1357,1357,5/1/2013,10/20/2013,5/1/2013,10/14/2013,,2013-10-20T10:52,,,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/21/2013,-10,8,E12,DIZZINESS,DIZZINESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/21/2013,8/10/2013,8/10/2013,102,102,Phase 2
CDISCPILOT01,AE,01-717-1357,1357,5/1/2013,10/20/2013,5/1/2013,10/14/2013,,2013-10-20T10:52,,,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/21/2013,-10,7,E11,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/24/2013,7/22/2013,7/22/2013,83,83,Phase 1
CDISCPILOT01,AE,01-717-1357,1357,5/1/2013,10/20/2013,5/1/2013,10/14/2013,,2013-10-20T10:52,,,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/21/2013,-10,3,E09,OEDEMA PERIPHERAL,ANKLE EDEMA,,OEDEMA PERIPHERAL,,HLT_0661,,HLGT_0137,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/29/2013,5/29/2013,,29,,Phase 1
CDISCPILOT01,AE,01-717-1357,1357,5/1/2013,10/20/2013,5/1/2013,10/14/2013,,2013-10-20T10:52,,,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/21/2013,-10,2,E07,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/29/2013,5/23/2013,,23,,Phase 1
CDISCPILOT01,AE,01-717-1357,1357,5/1/2013,10/20/2013,5/1/2013,10/14/2013,,2013-10-20T10:52,,,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/21/2013,-10,5,E07,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/19/2013,5/23/2013,,23,,Phase 1
CDISCPILOT01,AE,01-717-1357,1357,5/1/2013,10/20/2013,5/1/2013,10/14/2013,,2013-10-20T10:52,,,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/21/2013,-10,6,E10,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/24/2013,7/7/2013,7/8/2013,68,69,Phase 1
CDISCPILOT01,AE,01-717-1446,1446,9/1/2013,3/4/2014,9/1/2013,3/3/2014,,2014-03-17T09:52,,,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-12,1,E01,ANXIETY,ANXIETY AGGRAVATED,,ANXIETY,,HLT_0559,,HLGT_0570,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/16/2013,9/15/2013,9/16/2013,15,16,Phase 1
CDISCPILOT01,AE,01-717-1446,1446,9/1/2013,3/4/2014,9/1/2013,3/3/2014,,2014-03-17T09:52,,,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-12,2,E01,ANXIETY,ANXIETY AGGRAVATED,,ANXIETY,,HLT_0559,,HLGT_0570,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/6/2013,9/15/2013,9/16/2013,15,16,Phase 1
CDISCPILOT01,AE,01-717-1446,1446,9/1/2013,3/4/2014,9/1/2013,3/3/2014,,2014-03-17T09:52,,,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-12,7,E07,PAIN,STINGING,,PAIN,,HLT_0314,,HLGT_0478,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/19/2014,1/13/2014,1/14/2014,135,136,Phase 2
CDISCPILOT01,AE,01-717-1446,1446,9/1/2013,3/4/2014,9/1/2013,3/3/2014,,2014-03-17T09:52,,,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-12,8,E08,PAIN,STINGING,,PAIN,,HLT_0314,,HLGT_0478,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/16/2014,1/28/2014,,150,,Phase 2
CDISCPILOT01,AE,01-717-1446,1446,9/1/2013,3/4/2014,9/1/2013,3/3/2014,,2014-03-17T09:52,,,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-12,5,E06,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/8/2013,10/7/2013,10/11/2013,37,41,Phase 1
CDISCPILOT01,AE,01-717-1446,1446,9/1/2013,3/4/2014,9/1/2013,3/3/2014,,2014-03-17T09:52,,,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-12,6,E06,RASH,RASH,,RASH,,HLT_0762,,HLGT_0198,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/16/2013,10/7/2013,10/11/2013,37,41,Phase 1
CDISCPILOT01,AE,01-717-1446,1446,9/1/2013,3/4/2014,9/1/2013,3/3/2014,,2014-03-17T09:52,,,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-12,4,E03,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/6/2013,10/6/2013,3/3/2014,36,184,Phase 1
CDISCPILOT01,AE,01-717-1446,1446,9/1/2013,3/4/2014,9/1/2013,3/3/2014,,2014-03-17T09:52,,,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-12,9,E03,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/4/2014,10/6/2013,3/3/2014,36,184,Phase 1
CDISCPILOT01,AE,01-717-1446,1446,9/1/2013,3/4/2014,9/1/2013,3/3/2014,,2014-03-17T09:52,,,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/20/2013,-12,3,E04,SKIN IRRITATION,SKIN IRRITATION,,SKIN IRRITATION,,HLT_0583,,HLGT_0384,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/6/2013,9/19/2013,,19,,Phase 1
CDISCPILOT01,AE,01-718-1066,1066,7/7/2013,7/30/2013,7/7/2013,7/16/2013,,1/13/2014,,,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-9,2,E11,AGITATION,AGITATION,,AGITATION,,HLT_0140,,HLGT_0170,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/30/2013,7/18/2013,,12,,Phase 1
CDISCPILOT01,AE,01-718-1066,1066,7/7/2013,7/30/2013,7/7/2013,7/16/2013,,1/13/2014,,,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-9,4,E10,INFLAMMATION,INFLAMMATION LOCALIZED,,INFLAMMATION,,HLT_0582,,HLGT_0004,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/30/2013,7/30/2013,,24,,Phase 1
CDISCPILOT01,AE,01-718-1066,1066,7/7/2013,7/30/2013,7/7/2013,7/16/2013,,1/13/2014,,,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-9,1,E07,SYNCOPE,SYNCOPE,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,7/30/2013,7/16/2013,7/20/2013,10,14,Phase 1
CDISCPILOT01,AE,01-718-1066,1066,7/7/2013,7/30/2013,7/7/2013,7/16/2013,,1/13/2014,,,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-9,3,E08,SYNCOPE,SYNCOPE,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,7/30/2013,7/30/2013,,24,,Phase 1
CDISCPILOT01,AE,01-718-1079,1079,9/19/2012,11/6/2012,9/19/2012,10/31/2012,,3/5/2013,,,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/11/2012,-8,2,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/15/2012,10/5/2012,,17,,Phase 1
CDISCPILOT01,AE,01-718-1079,1079,9/19/2012,11/6/2012,9/19/2012,10/31/2012,,3/5/2013,,,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/11/2012,-8,3,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,SEVERE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/6/2012,10/5/2012,,17,,Phase 1
CDISCPILOT01,AE,01-718-1079,1079,9/19/2012,11/6/2012,9/19/2012,10/31/2012,,3/5/2013,,,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,9/11/2012,-8,1,E02,CONFUSIONAL STATE,CONFUSION,,CONFUSIONAL STATE,,HLT_0642,,HLGT_0329,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/15/2012,10/5/2012,,17,,Phase 1
CDISCPILOT01,AE,01-718-1101,1101,2/17/2013,8/2/2013,2/17/2013,7/31/2013,,2013-08-02T11:30,,,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/1/2013,-16,3,E05,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/12/2013,4/14/2013,7/6/2013,57,140,Phase 1
CDISCPILOT01,AE,01-718-1101,1101,2/17/2013,8/2/2013,2/17/2013,7/31/2013,,2013-08-02T11:30,,,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/1/2013,-16,6,E05,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/2/2013,4/14/2013,7/6/2013,57,140,Phase 1
CDISCPILOT01,AE,01-718-1101,1101,2/17/2013,8/2/2013,2/17/2013,7/31/2013,,2013-08-02T11:30,,,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/1/2013,-16,5,E06,MYOCARDIAL INFARCTION,INFERIOR MYOCARDIAL INFARCTIO,,MYOCARDIAL INFARCTION,,HLT_0649,,HLGT_0688,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/6/2013,7/6/2013,,140,,Phase 2
CDISCPILOT01,AE,01-718-1101,1101,2/17/2013,8/2/2013,2/17/2013,7/31/2013,,2013-08-02T11:30,,,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/1/2013,-16,2,E04,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/13/2013,4/13/2013,5/12/2013,56,85,Phase 1
CDISCPILOT01,AE,01-718-1101,1101,2/17/2013,8/2/2013,2/17/2013,7/31/2013,,2013-08-02T11:30,,,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/1/2013,-16,4,E04,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/14/2013,4/13/2013,5/12/2013,56,85,Phase 1
CDISCPILOT01,AE,01-718-1101,1101,2/17/2013,8/2/2013,2/17/2013,7/31/2013,,2013-08-02T11:30,,,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2/1/2013,-16,1,E03,VOMITING,VOMITING,,VOMITING,,HLT_0016,,HLGT_0350,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/14/2013,3/6/2013,3/6/2013,18,18,Phase 1
CDISCPILOT01,AE,01-718-1139,1139,5/19/2013,11/17/2013,5/19/2013,11/17/2013,,2013-11-17T10:30,,,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/3/2013,-16,3,E07,DIARRHOEA,DIARRHEA,,DIARRHOEA,,HLT_0148,,HLGT_0588,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/17/2013,11/16/2013,11/16/2013,182,182,Phase 2
CDISCPILOT01,AE,01-718-1139,1139,5/19/2013,11/17/2013,5/19/2013,11/17/2013,,2013-11-17T10:30,,,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/3/2013,-16,1,E06,SOMNOLENCE,SLEEPINESS,,SOMNOLENCE,,HLT_0160,,HLGT_0254,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/15/2013,6/3/2013,7/16/2013,16,59,Phase 1
CDISCPILOT01,AE,01-718-1139,1139,5/19/2013,11/17/2013,5/19/2013,11/17/2013,,2013-11-17T10:30,,,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,5/3/2013,-16,2,E06,SOMNOLENCE,SLEEPINESS,,SOMNOLENCE,,HLT_0160,,HLGT_0254,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/15/2013,6/3/2013,7/16/2013,16,59,Phase 1
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,3,E04,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/17/2013,3/15/2013,3/15/2013,56,56,Phase 1
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,8,E07,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/7/2013,6/16/2013,,149,,Phase 2
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,1,E05,BRADYCARDIA,BRADYCARDIA,,BRADYCARDIA,,HLT_0640,,HLGT_0294,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/16/2013,2/16/2013,3/17/2013,29,58,Phase 1
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,4,E05,BRADYCARDIA,BRADYCARDIA,,BRADYCARDIA,,HLT_0640,,HLGT_0294,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/12/2013,2/16/2013,3/17/2013,29,58,Phase 1
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,6,E06,BRADYCARDIA,BRADYCARDIA,,BRADYCARDIA,,HLT_0640,,HLGT_0294,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/10/2013,5/10/2013,7/7/2013,112,170,Phase 2
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,9,E06,BRADYCARDIA,BRADYCARDIA,,BRADYCARDIA,,HLT_0640,,HLGT_0294,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,7/31/2013,5/10/2013,7/7/2013,112,170,Phase 2
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,7,E08,FOOD CRAVING,CARBOHYDRATE CRAVING,,FOOD CRAVING,,HLT_0754,,HLGT_0376,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/7/2013,6/9/2013,,142,,Phase 2
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,10,E09,SINUS BRADYCARDIA,SINUS BRADYCARDIA,,SINUS BRADYCARDIA,,HLT_0644,,HLGT_0500,,CARDIAC DISORDERS,,CARDIAC DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/31/2013,7/31/2013,,194,,Phase 2
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,2,E03,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/17/2013,3/6/2013,3/26/2013,47,67,Phase 1
CDISCPILOT01,AE,01-718-1150,1150,1/19/2013,7/31/2013,1/19/2013,7/29/2013,,2013-07-31T14:05,,,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,1/12/2013,-7,5,E03,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,,UPPER RESPIRATORY TRACT INFECTION,,HLT_0520,,HLGT_0489,,INFECTIONS AND INFESTATIONS,,INFECTIONS AND INFESTATIONS,,MODERATE,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/12/2013,3/6/2013,3/26/2013,47,67,Phase 1
CDISCPILOT01,AE,01-718-1170,1170,9/16/2013,11/3/2013,9/16/2013,10/12/2013,,3/15/2014,,,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2013,-22,6,E04,AGITATION,INCREASED AGITATION,,AGITATION,,HLT_0140,,HLGT_0170,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,SEVERE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/3/2013,10/16/2013,,31,,Phase 1
CDISCPILOT01,AE,01-718-1170,1170,9/16/2013,11/3/2013,9/16/2013,10/12/2013,,3/15/2014,,,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2013,-22,3,E06,BODY TEMPERATURE INCREASED,TEMPERATURE ELEVATION,,BODY TEMPERATURE INCREASED,,HLT_0734,,HLGT_0351,,INVESTIGATIONS,,INVESTIGATIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/3/2013,10/11/2013,10/12/2013,26,27,Phase 1
CDISCPILOT01,AE,01-718-1170,1170,9/16/2013,11/3/2013,9/16/2013,10/12/2013,,3/15/2014,,,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2013,-22,1,E02,DIZZINESS,LIGHTHEADEDNESS,,DIZZINESS,,HLT_0619,,HLGT_0751,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/3/2013,10/7/2013,10/7/2013,22,22,Phase 1
CDISCPILOT01,AE,01-718-1170,1170,9/16/2013,11/3/2013,9/16/2013,10/12/2013,,3/15/2014,,,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2013,-22,2,E05,HYPERHIDROSIS,DIAPHORESIS,,HYPERHIDROSIS,,HLT_0587,,HLGT_0005,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/3/2013,10/11/2013,10/12/2013,26,27,Phase 1
CDISCPILOT01,AE,01-718-1170,1170,9/16/2013,11/3/2013,9/16/2013,10/12/2013,,3/15/2014,,,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2013,-22,4,E07,HYPERTENSION,HYPERTENSION,,HYPERTENSION,,HLT_0228,,HLGT_0476,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/3/2013,10/11/2013,10/12/2013,26,27,Phase 1
CDISCPILOT01,AE,01-718-1170,1170,9/16/2013,11/3/2013,9/16/2013,10/12/2013,,3/15/2014,,,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/25/2013,-22,5,E03,SYNCOPE,SYNCOPE,,SYNCOPE,,HLT_0440,,HLGT_0310,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,Y,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,11/3/2013,10/12/2013,10/13/2013,27,28,Phase 1
CDISCPILOT01,DM,01-718-1172,1172,9/21/2013,11/29/2013,9/21/2013,11/29/2013,,3/21/2014,,,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,9/15/2013,-6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Phase 1
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,9,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/11/2014,12/29/2013,2/19/2014,100,152,Phase 2
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,10,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/8/2014,12/29/2013,2/19/2014,100,152,Phase 2
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,11,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/8/2014,12/29/2013,2/19/2014,100,152,Phase 2
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,1,E02,BALANCE DISORDER,UNSTEADINESS,,BALANCE DISORDER,,HLT_0541,,HLGT_0101,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/17/2013,10/9/2013,11/15/2013,19,56,Phase 1
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,4,E02,BALANCE DISORDER,UNSTEADINESS,,BALANCE DISORDER,,HLT_0541,,HLGT_0101,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/19/2013,10/9/2013,11/15/2013,19,56,Phase 1
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,6,E02,BALANCE DISORDER,UNSTEADINESS,,BALANCE DISORDER,,HLT_0541,,HLGT_0101,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/16/2013,10/9/2013,11/15/2013,19,56,Phase 1
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,3,E04,CONTUSION,BRUISING OF FACE,,CONTUSION,,HLT_0713,,HLGT_0381,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,10/17/2013,10/15/2013,11/2/2013,25,43,Phase 1
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,5,E04,CONTUSION,BRUISING OF FACE,,CONTUSION,,HLT_0713,,HLGT_0381,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/2/2013,10/15/2013,11/2/2013,25,43,Phase 1
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,7,E04,CONTUSION,BRUISING OF FACE,,CONTUSION,,HLT_0713,,HLGT_0381,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/16/2013,10/15/2013,11/2/2013,25,43,Phase 1
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,8,E05,COORDINATION ABNORMAL,INCOORDINATION,,COORDINATION ABNORMAL,,HLT_0315,,HLGT_0015,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,11/16/2013,11/15/2013,11/15/2013,56,56,Phase 1
CDISCPILOT01,AE,01-718-1250,1250,9/21/2013,2/8/2014,9/21/2013,1/31/2014,,3/8/2014,,,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,8/21/2013,-31,2,E03,FALL,FALL,,FALL,,HLT_0168,,HLGT_0446,,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",,MILD,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/17/2013,10/9/2013,10/9/2013,19,19,Phase 1
CDISCPILOT01,AE,01-718-1254,1254,7/10/2013,1/9/2014,7/10/2013,1/9/2014,,2014-01-09T11:10,,,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-12,4,E02,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLORATIO,,APPLICATION SITE DISCOLOURATION,,HLT_0121,,HLGT_0273,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/20/2013,8/13/2013,,35,,Phase 1
CDISCPILOT01,AE,01-718-1254,1254,7/10/2013,1/9/2014,7/10/2013,1/9/2014,,2014-01-09T11:10,,,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-12,5,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/20/2013,8/13/2013,,35,,Phase 1
CDISCPILOT01,AE,01-718-1254,1254,7/10/2013,1/9/2014,7/10/2013,1/9/2014,,2014-01-09T11:10,,,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-12,1,E07,ARTHRALGIA,PAIN IN HIP,,ARTHRALGIA,,HLT_0375,,HLGT_0610,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/25/2013,7/13/2013,,4,,Phase 1
CDISCPILOT01,AE,01-718-1254,1254,7/10/2013,1/9/2014,7/10/2013,1/9/2014,,2014-01-09T11:10,,,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-12,2,E01,ARTHRALGIA,KNEE PAIN,,ARTHRALGIA,,HLT_0375,,HLGT_0610,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/25/2013,7/25/2013,7/25/2013,16,16,Phase 1
CDISCPILOT01,AE,01-718-1254,1254,7/10/2013,1/9/2014,7/10/2013,1/9/2014,,2014-01-09T11:10,,,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-12,3,E01,ARTHRALGIA,KNEE PAIN,,ARTHRALGIA,,HLT_0375,,HLGT_0610,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/6/2013,7/25/2013,7/25/2013,16,16,Phase 1
CDISCPILOT01,AE,01-718-1254,1254,7/10/2013,1/9/2014,7/10/2013,1/9/2014,,2014-01-09T11:10,,,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-12,9,E09,DYSPHAGIA,SWALLOWING DIFFICULT,,DYSPHAGIA,,HLT_0563,,HLGT_0405,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/26/2013,10/31/2013,,114,,Phase 2
CDISCPILOT01,AE,01-718-1254,1254,7/10/2013,1/9/2014,7/10/2013,1/9/2014,,2014-01-09T11:10,,,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-12,8,E08,FOOD CRAVING,CARBOHYDRATE CRAVING,,FOOD CRAVING,,HLT_0754,,HLGT_0376,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MODERATE,N,,,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,11/26/2013,10/31/2013,,114,,Phase 2
CDISCPILOT01,AE,01-718-1254,1254,7/10/2013,1/9/2014,7/10/2013,1/9/2014,,2014-01-09T11:10,,,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-12,6,E06,SOMNOLENCE,SOMNOLENCE,,SOMNOLENCE,,HLT_0160,,HLGT_0254,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,9/5/2013,9/3/2013,9/19/2013,56,72,Phase 1
CDISCPILOT01,AE,01-718-1254,1254,7/10/2013,1/9/2014,7/10/2013,1/9/2014,,2014-01-09T11:10,,,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,6/28/2013,-12,7,E06,SOMNOLENCE,SOMNOLENCE,,SOMNOLENCE,,HLT_0160,,HLGT_0254,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,10/3/2013,9/3/2013,9/19/2013,56,72,Phase 1
CDISCPILOT01,AE,01-718-1328,1328,2/1/2013,5/1/2013,2/1/2013,4/18/2013,,7/24/2013,,,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-4,1,E07,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/4/2013,3/23/2013,3/25/2013,51,53,Phase 1
CDISCPILOT01,AE,01-718-1328,1328,2/1/2013,5/1/2013,2/1/2013,4/18/2013,,7/24/2013,,,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-4,2,E08,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,4/4/2013,3/23/2013,3/25/2013,51,53,Phase 1
CDISCPILOT01,AE,01-718-1328,1328,2/1/2013,5/1/2013,2/1/2013,4/18/2013,,7/24/2013,,,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-4,3,E09,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/4/2013,4/2/2013,4/21/2013,61,80,Phase 1
CDISCPILOT01,AE,01-718-1328,1328,2/1/2013,5/1/2013,2/1/2013,4/18/2013,,7/24/2013,,,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,1/28/2013,-4,4,E09,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/1/2013,4/2/2013,4/21/2013,61,80,Phase 1
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,5,E09,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/23/2013,4/27/2013,4/27/2013,59,59,Phase 1
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,6,E08,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/12/2013,5/12/2013,74,74,Phase 1
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,7,E07,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/16/2013,5/16/2013,78,78,Phase 1
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,8,E10,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/23/2013,5/20/2013,5/20/2013,82,82,Phase 1
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,10,E13,APPLICATION SITE REACTION,APPLICATION SITE REACTION,,APPLICATION SITE REACTION,,HLT_0339,,HLGT_0668,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,7/18/2013,6/23/2013,8/13/2013,116,167,Phase 2
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,11,E13,APPLICATION SITE REACTION,APPLICATION SITE REACTION,,APPLICATION SITE REACTION,,HLT_0339,,HLGT_0668,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/15/2013,6/23/2013,8/13/2013,116,167,Phase 2
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,4,E06,CONFUSIONAL STATE,CONFUSION,,CONFUSIONAL STATE,,HLT_0642,,HLGT_0329,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/25/2013,4/17/2013,,49,,Phase 1
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,3,E03,DERMATITIS ATOPIC,ATOPIC DERMATITIS,,DERMATITIS ATOPIC,,HLT_0480,,HLGT_0257,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,4/25/2013,1982,,,,Phase 1
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,12,E14,HYPERTENSION,HYPERTENSION,,HYPERTENSION,,HLT_0228,,HLGT_0476,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MODERATE,N,,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/15/2013,8/15/2013,8/29/2013,169,183,Phase 2
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,13,E14,HYPERTENSION,HYPERTENSION,,HYPERTENSION,,HLT_0228,,HLGT_0476,,VASCULAR DISORDERS,,VASCULAR DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,8/29/2013,8/15/2013,8/29/2013,169,183,Phase 2
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,1,E05,SKIN ULCER,SKIN EROSION,,SKIN ULCER,,HLT_0005,,HLGT_0017,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,3/16/2013,3/8/2013,3/22/2013,9,23,Phase 1
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,2,E05,SKIN ULCER,SKIN EROSION,,SKIN ULCER,,HLT_0005,,HLGT_0017,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,3/28/2013,3/8/2013,3/22/2013,9,23,Phase 1
CDISCPILOT01,AE,01-718-1355,1355,2/28/2013,8/29/2013,2/28/2013,8/29/2013,,2013-08-29T14:00,,,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2/12/2013,-16,9,E11,SOMNOLENCE,SLEEPINESS,,SOMNOLENCE,,HLT_0160,,HLGT_0254,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,6/20/2013,5/25/2013,,87,,Phase 1
CDISCPILOT01,AE,01-718-1371,1371,4/26/2013,8/8/2013,4/26/2013,8/1/2013,,8/8/2013,,,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-15,3,E08,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,5/24/2013,5/24/2013,,29,,Phase 1
CDISCPILOT01,AE,01-718-1371,1371,4/26/2013,8/8/2013,4/26/2013,8/1/2013,,8/8/2013,,,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-15,6,E08,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,,APPLICATION SITE IRRITATION,,HLT_0061,,HLGT_0346,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,8/8/2013,5/24/2013,,29,,Phase 1
CDISCPILOT01,AE,01-718-1371,1371,4/26/2013,8/8/2013,4/26/2013,8/1/2013,,8/8/2013,,,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-15,1,E06,FATIGUE,FATIGUE,,FATIGUE,,HLT_0043,,HLGT_0181,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/24/2013,5/9/2013,5/11/2013,14,16,Phase 1
CDISCPILOT01,AE,01-718-1371,1371,4/26/2013,8/8/2013,4/26/2013,8/1/2013,,8/8/2013,,,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-15,5,E13,"HALLUCINATION, VISUAL",VISUAL HALLUCINATIONS,,"HALLUCINATION, VISUAL",,HLT_0369,,HLGT_0663,,PSYCHIATRIC DISORDERS,,PSYCHIATRIC DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/20/2013,6/2/2013,6/3/2013,38,39,Phase 1
CDISCPILOT01,AE,01-718-1371,1371,4/26/2013,8/8/2013,4/26/2013,8/1/2013,,8/8/2013,,,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-15,2,E07,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MILD,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,5/24/2013,5/9/2013,5/11/2013,14,16,Phase 1
CDISCPILOT01,AE,01-718-1371,1371,4/26/2013,8/8/2013,4/26/2013,8/1/2013,,8/8/2013,,,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,4/11/2013,-15,4,E11,PARTIAL SEIZURES WITH SECONDARY GENERA,PARTIAL SEIZURES WITH SECONDA,,PARTIAL SEIZURES WITH SECONDARY GENERA,,HLT_0603,,HLGT_0719,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,SEVERE,Y,,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,6/20/2013,6/2/2013,6/5/2013,38,41,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,3,E07,AMNESIA,SHORT-TERM MEMORY LOSS,,AMNESIA,,HLT_0501,,HLGT_0641,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/17/2013,1/1/2013,1/19/2013,16,34,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,7,E07,AMNESIA,SHORT-TERM MEMORY LOSS,,AMNESIA,,HLT_0501,,HLGT_0641,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/28/2013,1/1/2013,1/19/2013,16,34,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,10,E11,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/28/2013,1/27/2013,1/27/2013,42,42,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,12,E13,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,,APPLICATION SITE DERMATITIS,,HLT_0343,,HLGT_0241,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MILD,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/18/2013,1/29/2013,,44,,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,9,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,1/28/2013,1/27/2013,1/28/2013,42,43,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,11,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,,APPLICATION SITE PRURITUS,,HLT_0317,,HLGT_0338,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,,MODERATE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2/18/2013,1/27/2013,1/28/2013,42,43,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,1,E04,BACK PAIN,BACK PAIN,,BACK PAIN,,HLT_0115,,HLGT_0508,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,,MILD,N,,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/31/2012,12/18/2012,12/18/2012,2,2,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,13,E14,DECREASED APPETITE,DECREASED APPETITE,,DECREASED APPETITE,,HLT_0574,,HLGT_0231,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/18/2013,2/4/2013,2/25/2013,50,71,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,15,E14,DECREASED APPETITE,DECREASED APPETITE,,DECREASED APPETITE,,HLT_0574,,HLGT_0231,,METABOLISM AND NUTRITION DISORDERS,,METABOLISM AND NUTRITION DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/3/2013,2/4/2013,2/25/2013,50,71,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,5,E08,LETHARGY,LETHARGY,,LETHARGY,,HLT_0027,,HLGT_0448,,NERVOUS SYSTEM DISORDERS,,NERVOUS SYSTEM DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/17/2013,1/5/2013,1/5/2013,20,20,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,2,E05,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,12/31/2012,12/26/2012,12/26/2012,10,10,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,4,E06,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/17/2013,1/3/2013,1/9/2013,18,24,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,6,E09,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/17/2013,1/16/2013,1/16/2013,31,31,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,8,E12,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,SEVERE,N,,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,1/28/2013,1/21/2013,1/24/2013,36,39,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,14,E15,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2/18/2013,2/4/2013,2/25/2013,50,71,Phase 1
CDISCPILOT01,AE,01-718-1427,1427,12/17/2012,2/18/2013,12/17/2012,2/11/2013,,6/3/2013,,,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,12/13/2012,-4,16,E15,NAUSEA,NAUSEA,,NAUSEA,,HLT_0742,,HLGT_0326,,GASTROINTESTINAL DISORDERS,,GASTROINTESTINAL DISORDERS,,MODERATE,N,,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,6/3/2013,2/4/2013,2/25/2013,50,71,Phase 1
